Back to mobile site

Form N-VPFS TRANSAMERICA LIFE INSURA For: Dec 31

April 18, 2025 1:20 PM EDT

 

FINANCIAL STATEMENTS – STATUTORY BASIS

AND SUPPLEMENTARY INFORMATION

Transamerica Life Insurance Company

Years Ended December 31, 2024, 2023 and 2022


Transamerica Life Insurance Company

Financial Statements – Statutory Basis

and Supplementary Information

Years Ended December 31, 2024, 2023 and 2022

Contents

Report of Independent Auditors

     3  

Audited Financial Statements

  

Balance Sheets – Statutory Basis

     6  

Statements of Operations – Statutory Basis

     7  

Statements of Changes in Capital and Surplus – Statutory Basis

     8  

Statements of Cash Flow – Statutory Basis

     10  

Notes to Financial Statements – Statutory Basis

     12  

  1. Organization and Nature of Business

     12  

  2. Basis of Presentation and Summary of Significant Accounting Policies

     12  

  3. Accounting Changes and Correction of Errors

     28  

  4. Fair Values of Financial Instruments

     29  

  5. Investments

     38  

  6. Policy and Contract Attributes

     62  

  7. Reinsurance

     77  

  8. Income Taxes

     80  

  9. Capital and Surplus

     87  

  10. Securities Lending

     89  

  11. Retirement and Compensation Plans

     90  

  12. Related Party Transactions

     91  

  13. Managing General Agents and Third-Party Administrators

     98  

  14. Commitments and Contingencies

     98  

  15. Sales, Transfer, and Servicing of Financial Assets and Extinguishments of Liabilities

     104  

  16. Subsequent Events

     106  

Appendix A – Listing of Affiliated Companies

     107  

Statutory-Basis Financial Statement Schedules

     109  

Summary of Investments – Other Than Investments in Related Parties

     111  

Supplementary Insurance Information

     112  

Reinsurance

     113  


LOGO

Report of Independent Auditors

The Board of Directors

Transamerica Life Insurance Company

Opinion

We have audited the statutory-basis financial statements of Transamerica Life Insurance Company (the Company), which comprise the balance sheet as of December 31, 2024, and the related statements of operations, changes in capital and surplus and cash flows for the year then ended, and the related notes to the financial statements (collectively referred to as the “financial statements”).

Unmodified Opinion on Statutory Basis of Accounting

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024, and the results of its operations and its cash flows for the year then ended, on the basis of accounting described in Note 2.

Adverse Opinion on U.S. Generally Accepted Accounting Principles

In our opinion, because of the significance of the matter described in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles section of our report, the financial statements do not present fairly, in accordance with accounting principles generally accepted in the United States of America, the financial position of the Company at December 31, 2024, or the results of its operations or its cash flows for the year then ended.

Basis for Opinion

We conducted our audit in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

 

1


LOGO

 

Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles

As described in Note 2 to the financial statements, the Company prepared these financial statements using accounting practices prescribed or permitted by the Iowa Insurance Division, which is a basis of accounting other than accounting principles generally accepted in the United States of America. The effects on the financial statements of the variances between these statutory accounting practices described in Note 2 and accounting principles generally accepted in the United States of America, although not reasonably determinable, are presumed to be material and pervasive.

Report of Other Auditors on 2023 and 2022 Financial Statements

The statutory-basis financial statements of the Company for the years ended December 31, 2023 and 2022, were audited by another auditor who expressed an adverse opinion with respect to conformity with U.S. generally accepted accounting principles and an unmodified opinion with respect to conformity with accounting practices prescribed or permitted by the Iowa Insurance Division on those statements on April 11, 2024.

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with the accounting practices prescribed or permitted by the Iowa Insurance Division. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date that the financial statements are issued.

Auditor’s Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

 

2


LOGO

 

In performing an audit in accordance with GAAS, we:

 

   

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

   

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

 

   

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

 

   

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

 

   

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/ Ernst & Young LLP

Philadelphia, PA

April 10, 2025

 

3


LOGO

Report of Independent Auditors

To the Board of Directors of Transamerica Life Insurance Company

Opinions

We have audited the accompanying statutory basis financial statements of Transamerica Life Insurance Company (the “Company”), which comprise the balance sheets – statutory basis as of December 31, 2023 and 2022, and the related statements of operations - statutory basis, of changes in capital and surplus - statutory basis, and of cash flow - statutory basis for each of the three years in the period ended December 31, 2023, including the related notes and summary of investments - other than investments in related parties at December 31, 2023, supplementary insurance information at December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021, and reinsurance at December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021 listed in the accompanying index (collectively referred to as the “financial statements”).

Unmodified Opinion on Statutory Basis of Accounting

In our opinion, the accompanying financial statements present fairly, in all material respects, the admitted assets, liabilities and capital and surplus of the Company as of December 31, 2023 and 2022 and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in accordance with the accounting practices prescribed or permitted by the Iowa Insurance Division described in Note 2.

Adverse Opinion on U.S. Generally Accepted Accounting Principles

In our opinion, because of the significance of the matter discussed in the “Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles” section of our report, the accompanying financial statements do not present fairly, in accordance with accounting principles generally accepted in the United States of America, the financial position of the Company as of December 31, 2023 and 2022, or the results of its operations or its cash flows for each of the three years in the period ended December 31, 2023.

Basis for Opinions

We conducted our audit in accordance with auditing standards generally accepted in the United States of America (US GAAS). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles

As described in Note 2 to the financial statements, the financial statements are prepared by the Company on the basis of the accounting practices prescribed or permitted by the Iowa Insurance Division, which is a basis of accounting other than accounting principles generally accepted in the United States of America.

The effects on the financial statements of the variances between the statutory basis of accounting described in Note 2 and accounting principles generally accepted in the United States of America, although not reasonably determinable, are presumed to be material.

 

PricewaterhouseCoopers LLP, One North Wacker, Chicago, IL 60606

T: (312) 298 2000, www.pwc.com/us

 

4


LOGO

 

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with the accounting practices prescribed or permitted by the Iowa Insurance Division. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date the financial statements are available to be issued.

Auditors’ Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with US GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with US GAAS, we:

 

   

Exercise professional judgment and maintain professional skepticism throughout the audit.

   

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

   

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

   

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

   

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/PricewaterhouseCoopers LLP

Chicago, Illinois

April 11, 2024

 

5


Transamerica Life Insurance Company

Balance Sheets – Statutory Basis

(Dollars in Millions)

 

     December 31  
     2024     2023  

Admitted assets

    

Cash, cash equivalents and short-term investments

    $ 1,844     $ 3,305  

Bonds

     49,516       46,351  

Preferred stocks

     44       59  

Common stocks

     3,447       3,877  

Mortgage loans on real estate

     8,885       9,409  

Real estate

     39       41  

Policy loans

     2,239       2,109  

Securities lending reinvested collateral assets

     1,667       2,292  

Derivatives

     399       1,143  

Receivable for derivative cash collateral

     466       361  

Other invested assets

     3,277       3,395  
  

 

 

 

Total cash and invested assets

     71,823       72,342  

Accrued investment income

     653       626  

Premiums deferred and uncollected

     70       151  

Net deferred income tax asset

     773       772  

Variable annuity reserve hedge offset deferral

     883       445  

Other assets

     1,411       1,649  

Separate account assets

     103,494       98,852  
  

 

 

 

Total admitted assets

    $ 179,107     $ 174,837  
  

 

 

 

Liabilities and capital and surplus

    

Aggregate reserves for policies and contracts

   $ 53,684     $ 52,496  

Policy and contract claim reserves

     1,048       983  

Liability for deposit-type contracts

     693       717  

Other policyholders’ funds

     47       46  

Transfers from separate accounts due or accrued

     (254     (421

Funds held under reinsurance treaties

     7,046       7,480  

Asset valuation reserve

     1,347       1,302  

Derivatives

     1,481       1,214  

Payable for collateral under securities loaned and other transactions

     1,764       3,098  

Borrowed money

     1,500       1,738  

Other liabilities

     1,332       1,414  

Separate account liabilities

     103,494       98,852  
  

 

 

 

Total liabilities

     173,182       168,919  
  

 

 

 

Total capital and surplus

     5,925       5,918  
  

 

 

 

Total liabilities and capital and surplus

    $   179,107     $   174,837  
  

 

 

 

See accompanying notes.

 

6


Transamerica Life Insurance Company

Statements of Operations – Statutory Basis

(Dollars in Millions)

 

     Year Ended December 31  
     2024     2023     2022  

Revenues

      

Premiums and other considerations

   $   18,684     $   9,516     $   19,813  

Net investment income

     3,683       3,597       3,297  

Commissions and expense allowances on reinsurance ceded

     428       329       1,075  

Reserve adjustment on reinsurance ceded

     (133     (139     (147

Consideration received on reinsurance recapture and novations

     243       140       210  

Fee revenue and other income

     1,804       2,119       1,982  
  

 

 

 

Total revenue

     24,709       15,562       26,230  

Benefits and expenses

      

Death benefits

     2,713       2,433       2,650  

Annuity benefits

     1,485       1,466       1,552  

Accident and health benefits

     1,104       1,046       1,021  

Surrender benefits

     18,829       14,692       20,498  

Other benefits

     282       257       244  

Net increase (decrease) in reserves

     1,218       (5,482     6,563  

Commissions

     1,442       1,343       1,688  

Taxes, licenses and fees

     176       163       153  

Funds withheld ceded investment income

     180       95       98  

Net transfers to (from) separate accounts

     (6,163     (4,801     (10,952

IMR adjustment due to reinsurance

           248       (432

General insurance expenses and other

     1,143       1,291       1,198  
  

 

 

 

Total benefits and expenses

     22,409       12,751       24,281  
  

 

 

 

Gain (loss) from operations before dividends and federal income taxes

     2,300       2,811       1,949  

Dividends to policyholders

     8       8       10  
  

 

 

 

Gain (loss) from operations before federal income taxes

     2,292       2,803       1,939  

Federal income tax (benefit) expense

     (59     75       (80
  

 

 

 

Net gain (loss) from operations

     2,351       2,728       2,019  

Net realized capital gains (losses), after tax and amounts transferred to interest maintenance reserve

     (1,439     (1,999     (4,211
  

 

 

 

Net income (loss)

   $ 912     $ 729     $ (2,192
  

 

 

 

See accompanying notes.

 

7


Transamerica Life Insurance Company

Statements of Changes in Capital and Surplus – Statutory Basis

(Dollars in Millions)

 

     Common
Stock
     Paid-in
Surplus
    Special
Surplus
Funds
    Unassigned
Surplus
    Total Capital
and Surplus
 

Balance at January 1, 2022

   $ 7      $ 4,565     $ (250   $   2,955     $ 7,277  

Net income (loss)

                        (2,192     (2,192

Change in net unrealized capital gains/losses, net of taxes

                  630       384       1,014  

Change in net deferred income tax asset

                        702       702  

Change in nonadmitted assets

                        (834     (834

Change in reserve on account of change valuation basis

                        641       641  

Change in asset valuation reserve

                        139       139  

Change in surplus as a result of reinsurance

                        (871     (871

Capital contribution

            100                   100  

Dividends to stockholders

                        (425     (425

Other changes - net

            (1           113       112  
  

 

 

 

Balance at December 31, 2022

   $ 7      $ 4,664     $ 380     $ 612     $   5,663  

Net income (loss)

                        729       729  

Change in net unrealized capital gains/losses, net of taxes

                  136       1,148       1,284  

Change in net deferred income tax asset

                        149       149  

Change in nonadmitted assets

                        (417     (417

Change in asset valuation reserve

                        (191     (191

Change in surplus as a result of reinsurance

                        (435     (435

Dividends to stockholders

                        (858     (858

Other changes - net

            8             (14     (6
  

 

 

 

Balance at December 31, 2023

   $   7      $   4,672     $   516     $ 723     $ 5,918  
  

 

 

 

Continued on next page.

 

8


Transamerica Life Insurance Company

Statements of Changes in Capital and Surplus – Statutory Basis

(Dollars in Millions)

 

     Common
Stock
     Paid-in
Surplus
    Special
Surplus
Funds
     Unassigned
Surplus
    Total Capital
and Surplus
 

Balance at December 31, 2023

   $ 7      $ 4,672     $ 516      $ 723     $ 5,918  

Net income (loss)

                         912       912  

Change in net unrealized capital gains/losses, net of taxes

                  527        (681     (154

Change in net deferred income tax asset

                         (5     (5

Change in nonadmitted assets

                         17       17  

Change in asset valuation reserve

                         (45     (45

Change in surplus as a result of reinsurance

                         (257     (257

Dividends to stockholders

                         (415     (415

Other changes - net

            (11            (35     (46
  

 

 

 

Balance at December 31, 2024

    $     7      $    4,661     $    1,043      $    214     $    5,925  
  

 

 

 

See accompanying notes.

 

9


Transamerica Life Insurance Company

Statements of Cash Flow – Statutory Basis

(Dollars in Millions)

 

     Year Ended December 31  
     2024     2023     2022  

Operating activities

      

Premiums and annuity considerations

   $ 18,782     $ 13,933     $ 14,606  

Net investment income

     3,599       3,580       3,146  

Other income

     2,158       1,940       2,251  

Benefit and loss related payments

     (24,412     (19,702     (26,105

Net transfers from separate accounts

     6,094       4,842       11,122  

Commissions and operating expenses

     (2,968     (2,787     (2,771

Dividends paid to policyholders

     (5     (5     (6

Federal income taxes (paid) received

     51       18       204  
  

 

 

 

Net cash provided by (used in) operating activities

   $ 3,299     $ 1,819     $ 2,447  

Investing activities

      

Proceeds from investments sold, matured or repaid

   $ 6,719     $ 8,889     $ 10,356  

Costs of investments acquired

     (9,363     (8,332     (10,957

Net change in policy loans

     (131     (81     (35
  

 

 

 

Net cash provided by (used in) investing activities

   $ (2,775   $ 476     $ (636

Financing and miscellaneous activities

      

Capital and paid in surplus received (returned)

   $ (16   $ 6     $ 101  

Dividends to stockholders

     (415     (858     (425

Net deposits (withdrawals) on deposit-type contracts

     (32     (45     (67

Net change in borrowed money

     (236     (1,354     (777

Net change in funds held under reinsurance treaties

     (433     43       41  

Net change in payable for collateral under securities lending and other transactions

     (1,335     828       (42

Other cash (applied) provided

     482       (30     (348
  

 

 

 

Net cash provided by (used in) financing and miscellaneous activities

   $ (1,985   $ (1,410   $ (1,517
  

 

 

 

Net increase (decrease) in cash, cash equivalents and short-term investments

     (1,461     885       294  

Cash, cash equivalents and short-term investments:

      

Beginning of year

     3,305       2,420       2,126  
  

 

 

 

End of year

    $    1,844     $    3,305     $    2,420  
  

 

 

 

See accompanying notes.

 

10


Transamerica Life Insurance Company

Statements of Cash Flow (supplemental) – Statutory Basis

(Dollars in Millions)

 

     Year Ended December 31  
Supplemental disclosures of cash flow information    2024      2023     2022  

Non-cash activities during the year not included in the Statutory Statements of Cash Flows:

       

Receipt of bonds, other invested assets and interest related to affiliated reinsurance treaty

   $    —      $    792     $    4,706  

Increase of funds withheld related to affiliated reinsurance agreement

            (4,394      

Release of funds withheld related to affiliated reinsurance recaptures

                  42  

Release of reinsurance payable related to affiliate reinsurance recapture

                  22  

See accompanying notes.

 

11


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Years Ended December 31, 2024, 2023 and 2022

1. Organization and Nature of Business

Transamerica Life Insurance Company (the Company) is a stock life insurance company domiciled in the State of Iowa, and is owned by Commonwealth General Corporation (CGC). CGC is an indirect, wholly-owned subsidiary of Aegon Ltd., a holding company organized under the laws of Bermuda.

Nature of Business

The Company sells individual life insurance, including indexed universal life, whole life, term life, and final expense whole life. It also sells variable and registered index-linked annuities. In addition, the Company offers supplemental health insurance, group life insurance, group annuity contracts and stable value solutions. The Company is licensed in 49 states and the District of Columbia, Guam, Puerto Rico, and US Virgin Islands. Sales of the Company’s products are primarily through a network of independent agents and broker-dealers, affiliated agencies, and financial institutions.

2. Basis of Presentation and Summary of Significant Accounting Policies

The accompanying financial statements have been prepared in conformity with accounting practices prescribed or permitted by the Iowa Insurance Division (IID), which differ from accounting principles generally accepted in the United States of America (GAAP).

The IID recognizes only statutory accounting practices prescribed or permitted by the State of Iowa for determining and reporting the financial condition and results of operations of an insurance company, and for determining its solvency under the Iowa Insurance Law. The National Association of Insurance Commissioners’ (NAIC) Accounting Practices and Procedures Manual (NAIC SAP) has been adopted as a component of prescribed or permitted practices by the State of Iowa. The Commissioner of Insurance has the right to permit specific practices that deviate from prescribed practices.

The following is a summary of the accounting practices permitted and prescribed by the IID and reflected in the Company’s financial statements which differs from NAIC SAP:

The State of Iowa has adopted a prescribed accounting practice that differs from that found in the NAIC SAP related to credit for reinsurance. As prescribed by Iowa Administrative Code 191-5.33 (10)(d), the Commissioner has deemed the book value of assets held in a comfort trust as acceptable security for purposes of taking reserve credit for liabilities ceded to an unauthorized reinsurer while it seeks reciprocal jurisdiction status. Under Statement of Statutory Accounting Principles (SSAP) No. 61, Life, Deposit-Type and Accident and Health Reinsurance, the market value of trust assets is considered allowable security. Reciprocal jurisdiction status was granted in 2023.

 

12


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The State of Iowa has adopted prescribed accounting practices that differ from the NAIC SAP related to the reported value of certain assets supporting the Company’s guaranteed and registered index-linked annuity (RILA) separate accounts. As prescribed by Iowa Administrative Code 508A.1.4, the Company is entitled to generally value these assets at amortized cost, whereas the assets would be required to be reported at fair value under Statement of Statutory Accounting Principles (SSAP) No. 56, Separate Accounts, of the NAIC SAP. There are no impacts to the Company’s income or surplus as a result of utilizing these prescribed practices.

Pursuant to Iowa Administrative Code 521A.5(1)c, the State of Iowa has allowed a permitted accounting practice that differs from that found in NAIC SAP related to the valuation of a foreign insurance subsidiary, controlled and affiliated (SCA) entity. With the explicit permission of the IID, the Company values Transamerica Life (Bermuda) Ltd. (TLB), a foreign SCA, in accordance with SSAP No. 97, Subsidiary, Controlled and Affiliated Entities, paragraph 8.b.i, as a U.S. insurance SCA entity at its underlying audited U.S. statutory equity. Absent this permitted practice, TLB would be valued in accordance with SSAP No. 97, paragraph 8.b.iv, as a foreign insurance SCA at its audited foreign statutory basis financial statements with certain adjustments.

A reconciliation of the Company’s net income (loss) and capital and surplus between NAIC SAP and practices prescribed and permitted by the State of Iowa is shown below:

 

     SSAP #      F/S Page      F/S Line      2024      2023      2022  
  

 

 

    

 

 

    

 

 

 

Net income (loss), State of Iowa basis

     XXX        XXX        XXX       $ 912      $ 729      $ (2,192)   

State prescribed practices that are an increase(decrease) from NAIC SAP:

                 

None

                            —   

State permitted practices that are an increase(decrease) from NAIC SAP:

                 

None

                            —   
           

 

 

 

Net income (loss), NAIC SAP

     XXX        XXX        XXX       $ 912      $ 729      $ (2,192)   
           

 

 

 

Statutory surplus, state of Iowa basis

     XXX        XXX        XXX       $ 5,925      $ 5,918      $ 5,663   

State prescribed practices that are an increase(decrease) from NAIC SAP:

                 

Comfort trust

     61        3        1                      263   

State permitted practices that are an increase(decrease) from NAIC SAP:

                 

TLB valuation

     97        2        2.2        272        47        72   
           

 

 

 

Statutory surplus, NAIC SAP

     XXX        XXX        XXX       $    5,653      $    5,871      $    5,328   
           

 

 

 

 

13


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Use of Estimates

The preparation of financial statements of insurance companies requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates and assumptions could change in the future as more information becomes known, which could impact the amounts reported and disclosed herein.

The effects of the following variances from GAAP on the accompanying statutory-basis financial statements have not been determined by the Company, but are presumed to be material. Significant accounting policies and variances from GAAP are as follows:

Investments

Investments in bonds, except those to which the Securities Valuation Office (SVO) of the NAIC has ascribed a NAIC designation of 6, are reported at amortized cost using the interest method. Bonds containing call provisions, except make-whole call provisions, are amortized to the call or maturity value/date which produces the lowest asset value, often referred to as yield-to-worst method. Bonds ascribed a NAIC designation of 6 are reported at the lower of amortized cost or fair value with unrealized gains and losses reported in changes in capital and surplus. Prepayment penalty or acceleration fees received in the event a bond is liquidated prior to its scheduled termination date are reported as investment income.

Hybrid securities, as defined by the NAIC, are securities designed with characteristics of both debt and equity and provide protection to the issuer’s senior note holders. These securities meet the definition of a bond, in accordance with SSAP No. 26, Bonds, and therefore, are reported at amortized cost or fair value based upon their NAIC rating.

For GAAP, such fixed maturity investments would be designated at purchase as held-to-maturity, trading or available-for-sale. Held-to-maturity fixed investments would be reported at amortized cost, and the remaining fixed maturity investments would be reported at fair value with unrealized holding gains and losses reported in earnings for those designated as trading and as a separate component of other comprehensive income (OCI) for those designated as available-for- sale.

Single class and multi-class mortgage-backed/asset-backed securities are valued at amortized cost using the interest method, including anticipated prepayments, except for those with an initial NAIC designation of 6, which are valued at the lower of amortized cost or fair value. These securities are adjusted for the effects of changes in prepayment assumptions on the related accretion of discount or amortization of premium using either the retrospective or prospective methods. Prepayment assumptions are obtained from dealer surveys or internal estimates and are based on the current interest rate and economic environment. For statutory reporting, the retrospective adjustment method is used to value all such securities, except principal-only and interest-only securities, which are valued using the prospective method.

For GAAP, all securities purchased or retained that represent beneficial interests in securitized assets, other than high credit quality securities, are adjusted using the prospective method when there is a change in estimated future cash flows. If high credit quality securities are adjusted, the retrospective method is used.

 

14


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The Company closely monitors below investment grade holdings and investment grade issuers where the Company has concerns to determine if an other-than-temporary impairment (OTTI) has occurred. The Company also regularly monitors industry sectors. The Company considers relevant facts and circumstances in evaluating whether the impairment is other-than-temporary including: (1) the probability of the Company collecting all amounts due according to the contractual terms of the security in effect at the date of acquisition; (2) the Company’s decision to sell a security prior to its maturity at an amount below its carrying amount; and (3) the Company’s ability to hold a structured security for a period of time to allow for recovery of the value to its carrying amount. Additionally, financial condition, near term prospects of the issuer and nationally recognized credit rating changes are monitored. Non-structured securities in unrealized loss positions that are considered other-than-temporary are written down to fair value. The Company will record a charge to the Statements of Operations for the amount of the impairment.

For structured securities, cash flow trends and underlying levels of collateral are monitored. An OTTI is considered to have occurred if the fair value of the structured security is less than its amortized cost basis and the entity intends to sell the security or the entity does not have the intent and ability to hold the security for a period of time sufficient to recover the amortized cost basis. An OTTI is also considered to have occurred if the discounted estimated future cash flows are less than the amortized cost basis of the security and the security is in an unrealized loss position. Structured securities considered other-than-temporarily impaired are written down to discounted estimated cash flows if the impairment is the result of cash flow analysis. If the Company has an intent to sell or lack of ability to hold a structured security, it is written down to fair value. The Company will record a charge to the Statements of Operations for the amount of the impairments.

For GAAP, for debt securities classified as available-for-sale, management first assesses whether the Company has the intent to sell, or whether it is more likely than not it will be required to sell the security before the amortized cost basis is fully recovered. If either criterion is met, the amortized cost is written down to fair value through earnings as an impairment. If neither criterion is met, the securities are further evaluated to determine if the cause of the decline in fair value resulted from credit losses or other factors. When a credit loss is determined to exist and the present value of cash flows expected to be collected is less than the amortized cost of the security, an allowance for credit loss is recorded along with a charge to earnings, limited by the amount that the fair value is less than amortized cost. Any remaining unrealized loss after recording the allowance for credit loss is the non-credit amount and is recorded to other comprehensive income.

Investments in both affiliated and unaffiliated redeemable preferred stocks in good standing (those with NAIC designations 1 to 3) are reported at cost or amortized cost, depending on the characteristics of the securities. Investments in both affiliated and unaffiliated redeemable preferred stocks not in good standing (those with NAIC designations 4 to 6) are reported at the lower of cost, amortized cost, or fair value, depending on the characteristics of the securities. Investment in perpetual preferred stocks are reported at fair value, not to exceed any currently effective call price. Investment in mandatory convertible preferred stocks (regardless if the preferred stock is redeemable or perpetual) are reported at fair value, not to exceed any currently effective call price, in the periods prior to conversion. For preferred stocks reported at fair value,

 

15


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

the related net unrealized capital gains and losses for all NAIC designations are reported in accordance with SSAP No. 7, Asset Valuation Reserve and Interest Maintenance Reserve.

Common stocks of affiliated noninsurance subsidiaries are reported based on underlying audited GAAP equity. The net change in the subsidiaries’ equity is included in net unrealized capital gains or losses and are reported in changes in capital and surplus.

Common stocks of unaffiliated companies, which include shares of mutual funds, are reported at fair value and the related net unrealized capital gains or losses are reported in changes in capital and surplus.

The Company owns stock issued by the Federal Home Loan Bank (FHLB), which is only redeemable at par, and its fair value is presumed to be par, unless other-than-temporarily impaired.

If the Company determines that a decline in the fair value of a common stock or a preferred stock is other-than-temporary, the Company writes it down to fair value as the new cost basis and the amount of the write down is accounted for as a realized loss in the Statements of Operations. The Company considers the following factors in determining whether a decline in value is other-than- temporary: (a) the financial condition and prospects of the issuer; (b) whether or not the Company has made a decision to sell the investment; and (c) the length of time and extent to which the value has been below cost.

Mortgage loans are reported at unpaid principal balances, less an allowance for impairment. A mortgage loan is considered to be impaired when it is probable that the Company will be unable to collect all principal and interest amounts due according to the contractual terms of the mortgage agreement. When management determines the impairment is other-than-temporary, the mortgage loan is written down to realizable value and a realized loss is recognized. Prepayment penalty or acceleration fees received in the event a loan is liquidated prior to its scheduled termination date are reported as investment income.

Valuation allowances are established for mortgage loans, if necessary, based on the difference between the net value of the collateral, determined as the fair value of the collateral less estimated costs to obtain and sell, and the recorded investment in the mortgage loan. Under GAAP, an allowance for credit loss is recognized in earnings at time of purchase or origination based on an expected lifetime credit loss, which is an amount that represents the portion of the amortized cost basis of the mortgage loans that the Company does not expect to collect.

The initial valuation allowance and subsequent changes in the allowance for mortgage loans are charged or credited directly to unassigned surplus as part of the change in asset valuation reserve (AVR), rather than being included as a component of earnings as would be required under GAAP.

Land is reported at cost. Real estate occupied by the Company is reported at depreciated cost net of encumbrances. Real estate held for the production of income is reported at depreciated cost net of encumbrances. Real estate the Company classifies as held for sale is measured at lower of carrying amount or fair value less encumbrances and estimated costs to sell. Depreciation is calculated on a straight-line basis over the estimated useful lives of the properties. The Company

 

16


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

recognizes an impairment loss if the Company determines that the carrying amount of the real estate is not recoverable and exceeds its fair value. The Company deems that the carrying amount of the asset is not recoverable if the carrying amount exceeds the sum of undiscounted cash flows expected to result from the use and disposition. The impairment loss is measured as the amount by which the asset’s carrying value exceeds its fair value.

Investments in real estate are reported net of related obligations rather than on a gross basis as for GAAP. Real estate owned and occupied by the Company is included in investments rather than reported as an operating asset as under GAAP, and investment income and operating expenses for statutory reporting include rent for the Company’s occupancy of those properties. Changes between depreciated cost and admitted amounts are credited or charged directly to unassigned surplus rather than to income as would be required under GAAP.

The Company has interests in joint ventures and limited partnerships. The Company carries these investments based on its interest in the underlying audited GAAP equity of the investee.

For a decline in the fair value of an investment in a joint venture or limited partnership which is determined to be other-than-temporary, the Company writes it down to fair value as the new cost basis and the amount of the write down is accounted for as a realized loss in the Statements of Operations. The Company considers an impairment to have occurred if it is probable that the Company will be unable to recover the carrying amount of the investment or if there is evidence indicating inability of the investee to sustain earnings which would justify the carrying amount of the investment.

Investments in Low Income Housing Tax Credit (LIHTC) properties are valued at amortized cost. Tax credits are recognized in operations in the tax reporting year in which the tax credit is utilized by the Company. The carrying value is amortized over the life of the investment. Amortization is calculated as a ratio of the current year tax credits and tax benefits compared to the total expected tax credits and tax benefits over the life of the investment.

Cash equivalents are short-term highly liquid investments with original maturities of three months or less (principally stated at amortized cost) or money market mutual funds which are reported at fair value.

Short-term investments include investments with remaining maturities of one year or less at the time of acquisition and are principally stated at amortized cost.

Other invested assets include surplus notes which are valued at either amortized cost (those that have an NAIC designation of 1 or 2) or the lesser of amortized cost or fair value (those that have an NAIC designation of 3 through 6).

Policy loans are reported at unpaid principal balances.

Realized capital gains and losses are determined using the specific identification method and are recorded net of related federal income taxes. Changes in admitted asset carrying amounts of bonds, mortgage loans, common and preferred stocks are credited or charged directly to unassigned surplus.

 

17


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Interest income is recognized on an accrual basis. The Company does not accrue income on bonds in default, mortgage loans on real estate in default and/or foreclosure or which are delinquent more than twelve months, or real estate where rent is in arrears for more than three months. Income is also not accrued when collection is uncertain. Due and accrued amounts determined to be uncollectible are written off through the Statements of Operations.

Valuation Reserves

Under a formula prescribed by the NAIC, the Company defers the portion of realized capital gains and losses on sales of fixed income investments, primarily bonds and mortgage loans, attributable to changes in the general level of interest rates and amortizes those deferrals into net investment income over the remaining period to maturity of the bond or mortgage loan based on groupings of individual securities sold in five year bands. The net deferral is reported as the interest maintenance reserve (IMR) in the accompanying Balance Sheets. Realized capital gains and losses are reported in income net of federal income tax and transfers to the IMR. Under GAAP, realized capital gains and losses are reported in the Statements of Operations on a pre-tax basis in the period that the assets giving rise to the gains or losses are sold.

The AVR provides a valuation allowance for invested assets. The AVR is determined by an NAIC prescribed formula with changes reflected directly in unassigned surplus; AVR is not recognized for GAAP.

Derivative Instruments

Overview: The Company may use various derivative instruments (options, caps, floors, swaps, forwards, and futures) to manage risks related to its ongoing business operations. On the transaction date of the derivative instrument, the Company designates the derivative as either (A) hedging (fair value, foreign currency fair value, cash flow, foreign currency cash flow, forecasted transactions, or net investment in a foreign operation), (B) replication, (C) income generation, or (D) held for other investment/risk management activities, which do not qualify for hedge accounting under SSAP No. 86, Derivatives.

 

  (A)

Derivative instruments used in hedging transactions that meet the criteria of an effective hedge are valued and reported in a manner that is consistent with the hedged asset or liability (amortized cost or fair value). Embedded derivatives are not accounted for separately from the host contract. Derivative instruments used in hedging transactions that do not meet or no longer meet the criteria of an effective hedge are accounted for at fair value, and the changes in the fair value are recorded in unassigned surplus as unrealized gains and losses. Under GAAP, the effective and ineffective portions of a single hedge are accounted for separately, and the change in fair value for cash flow hedges is credited or charged directly to a separate component of OCI rather than to income as required for fair value hedges, and an embedded derivative within a contract that is not clearly and closely related to the economic characteristics and the risk of the host contract is accounted for separately from the host contract and valued and reported at fair value.

 

  (B)

Derivative instruments are also used in replication (synthetic asset) transactions (RSAT). A replication transaction is a derivative transaction entered into in conjunction with a

 

18


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

 

cash instrument to reproduce the investment characteristics of an otherwise permissible investment. In these transactions, the derivative is accounted for in a manner consistent with the cash instrument and replicated asset. For GAAP, the derivative is reported at fair value, with the changes in fair value reported in income.

 

  (C)

Derivative instruments used in income generation relationships are accounted for on a basis that is consistent with the associated covered asset or underlying interest to which the derivative relates (amortized cost or fair value).

 

  (D)

Derivative instruments held for other investment/risk management activities are measured at fair value with value adjustments recorded in unassigned surplus.

Derivative instruments are subject to market risk, which is the possibility that future changes in market prices may make the instruments less valuable. The Company uses derivatives as hedges, consequently, when the value of the hedged asset or liability changes, the value of the hedging derivative is expected to move in the opposite direction. Market risk is a consideration when changes in the value of the derivative and the hedged item do not completely offset (correlation or basis risk) which is mitigated by active measuring and monitoring.

The Company is exposed to credit-related losses in the event of non-performance by counterparties to derivative instruments, but it does not expect any counterparties to fail to meet their obligations given their high credit rating of ‘BBB’ or better. The credit exposure of interest rate swaps and currency swaps is represented by the fair value of contracts, aggregated at a counterparty level, with a positive fair value at the reporting date. The Company has entered into collateral agreements with certain counterparties wherein the counterparty is required to post assets on the Company’s behalf. The posted amount is equal to the difference between the net positive fair value of the contracts and an agreed upon threshold that is based on the credit rating of the counterparty. Inversely, if the net fair value of all contracts with this counterparty is negative, then the Company is required to post assets instead.

Cash flows from derivative instruments are presented within the Investing activities section of the Statements of Cash Flows, with the exception of cash received from written options, which are presented within the Financing activities section.

Instruments:

Interest rate swaps are used in the overall asset/liability management process to modify the interest rate characteristics of the underlying asset or liability. These interest rate swaps generally provide for the exchange of the difference between fixed and floating rate amounts based on an underlying notional amount. Typically, no cash is exchanged at the outset of the swap contract and a single net payment is exchanged each due date. Swaps that meet hedge accounting rules are carried in a manner consistent with the hedged item, generally at amortized cost, in the financial statements. If the swap is terminated prior to maturity, proceeds are exchanged equal to the fair value of the contract. These gains and losses may be included in IMR or AVR if the underlying instrument receives that treatment. Swaps not meeting hedge accounting rules are carried at fair value with fair value adjustments recorded in unassigned surplus.

 

19


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Cross currency swaps are utilized to mitigate risks when the Company holds foreign denominated assets or liabilities; therefore, converting the asset or liability to a U.S. dollar denominated security. These cross currency swap agreements involve the exchange of two principal amounts in two different currencies at the prevailing currency rate at contract inception. During the life of the swap, the counterparties exchange fixed or floating rate interest payments in the swapped currencies. At maturity, the principal amounts are again swapped at a pre-determined rate of exchange. Each asset or liability is hedged individually where the terms of the swap must meet the terms of the hedged instrument. For swaps qualifying for hedge accounting, the premium or discount is amortized into income over the life of the contract and the foreign currency translation adjustment is recorded as unrealized gain/loss in capital and surplus. Swaps not meeting hedge accounting rules are carried at fair value with fair value adjustments recorded in capital and surplus. If a swap is terminated prior to maturity, proceeds are exchanged equal to the fair value of the contract. These gains and losses may be included in IMR or AVR if the hedged instrument receives that treatment.

Total return swaps are used in the asset/liability management process to mitigate the market risk on minimum guarantee insurance contracts linked to an index. These total return swaps generally provide for the exchange of the difference between fixed leg (tied to the Standard & Poor’s (S&P) or other global market financial index) and floating leg (tied to the Secured Overnight Financing Rate (SOFR)) amounts based on an underlying notional amount (also tied to the underlying index). Typically, no cash is exchanged at the outset of the swap contract and a single net payment is exchanged each due date. Swaps that meet hedge accounting rules are carried in a manner consistent with the hedged item, generally at amortized cost, in the financial statements. If the swap is terminated prior to maturity, proceeds are exchanged equal to the fair value of the contract. These gains and losses may be included in IMR or AVR if the underlying instrument receives that treatment. Swaps not meeting hedge accounting rules are carried at fair value with fair value adjustments recorded in capital and surplus.

Variance swaps are used in the asset/liability management process to mitigate the gamma risk created when the Company has issued minimum guarantee insurance contracts linked to an index. These variance swaps are similar to volatility options where the underlying index provides for the market value movements. Variance swaps do not accrue interest. Typically, no cash is exchanged at the outset of initiating the variance swap, and a single receipt or payment occurs at the maturity or termination of the contract. Variance swaps that meet hedge accounting rules are carried in a manner consistent with the hedged item, generally at amortized cost, on the financial statements. If terminated prior to maturity, proceeds are exchanged equal to the fair value of the contract. These gains and losses may be included in IMR or AVR if the underlying instrument receives that treatment. Swaps not meeting hedge accounting rules are carried at fair value with fair value adjustments recorded in capital and surplus.

Bond forwards are used to hedge the interest rate risk that future liability claims increase as rates decrease, leading to higher guarantee values. Bond return swaps are also used to hedge interest rate risk of the underlying liability by exchanging performance and interest of a treasury asset for a funding level plus spread.

Futures contracts are used to hedge the liability risk when the Company issues products providing the customer a return based on various global market indices. Futures are marked to market on a

 

20


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

daily basis whereby a cash payment is made or received by the Company. These payments are recognized as realized gains or losses in the financial statements.

The Company issues products providing the customer a return based on the various global equity market indices. The Company uses options to hedge the liability option risk associated with these products. Options are marked to fair value in the Balance Sheets and fair value adjustments are recorded as capital and surplus in the financial statements. These gains and losses may be included in IMR or AVR if the underlying instrument receives that treatment.

Caps are used in the asset/liability management process to mitigate the interest rate risk created due to a rapidly rising interest rate environment. The caps are similar to options where the underlying interest rate index provides for the market value movements. The caps do not accrue interest until the interest rate environment exceeds the caps strike rate. Cash is exchanged at the onset, and a single receipt or payment occurs at the maturity or termination of the contract. Caps that meet hedge accounting rules are carried in a manner consistent with the hedged item, generally at amortized cost, on the financial statements. If terminated prior to maturity, proceeds are exchanged equal to the fair value of the contract. These gains and losses may be included in IMR or AVR if the underlying instrument receives that treatment. Caps that do not meet hedge accounting rules are carried at fair value with fair value adjustments recorded in unassigned surplus.

The Company uses zero cost collars to hedge the interest rate risk associated with rising short term interest rates, whereby the exposure would otherwise adversely impact the Company’s capital generation. The collar position(s) help range bound the floating rate by combining a cap and floor position.

The Company may sell products with expected benefit payments extending beyond investment assets currently available in the market. Because assets will have to be purchased in the future to fund future liability cash flows, the Company is exposed to the risk of future investments made at lower yields than what is assumed at the time of pricing. Forward-starting interest rate swaps are utilized to lock-in the current forward rate. The accrual of income begins at the forward date, rather than at the inception date. These forward-starting swaps meet hedge accounting rules and are carried at cost in the financial statements. Gains and losses realized upon termination of the forward-starting swap are deferred and used to adjust the basis of the asset purchased in the hedged forecasted period. The basis adjustment is then amortized into income as a yield adjustment to the asset over its life.

The Company issues fixed liabilities that have a guaranteed minimum crediting rate. The Company uses receiver swaptions, whereby the swaption is designed to generate cash flows to offset lower yields on assets during a low interest rate environment. The Company pays a single premium at the beginning of the contract and is amortized throughout the life of the swaption. These swaptions are marked to fair value in the Balance Sheets and the fair value adjustment is recorded in unassigned surplus. These gains and losses may be included in IMR or AVR if the underlying instrument receives that treatment.

The Company replicates investment grade corporate bonds or sovereign debt by combining a highly rated security as a cash component with a written credit default swap which, in effect, converts the high quality asset into an investment grade corporate asset or a sovereign debt. The

 

21


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

benefits of using the swap market to replicate credit include possible enhanced relative values as well as ease of executing larger transactions in a shortened time frame. Generally, a premium is received by the Company on a periodic basis and recognized in investment income. In the event the representative issuer defaults on its debt obligation referenced in the contract, a payment equal to the notional amount of the contract will be made by the Company and recognized as a capital loss.

The Company may designate and account for fair value hedges when the effectiveness requirements of SSAP No. 86 are achieved. The following hedge type relationships are considered: (A) an interest rate swap that converts a fixed rate asset to a floating rate asset; (B) an interest rate swap that converts a fixed rate liability to a floating rate liability; (C) a cross currency interest rate swap that converts a foreign denominated fixed rate asset to a USD floating rate asset; and (D) a cross currency interest rate swap that converts a foreign denominated fixed rate liability to a USD floating rate liability.

The Company may designate and account for cash flow hedges when the effectiveness requirements of SSAP No. 86 are achieved. The following hedge-type relationships are considered: (A) an interest rate swap that converts a floating rate asset to a fixed rate asset; (B) a cross currency interest rate swap that converts a foreign denominated floating or fixed rate asset to a USD fixed rate asset; (C) a cross currency interest rate swap that converts a foreign denominated floating rate asset to a USD fixed rate asset; (D) a cross currency interest rate swap that converts a foreign denominated floating rate liability to a USD fixed rate liability; and (E) a forward starting interest rate swap to hedge the forecasted purchases of fixed rate assets.

Any deferred gain (loss) related to forecasted transaction cash flow hedging is recognized in income as the purchased asset affects income. If the forecasted transaction no longer qualifies for hedge accounting or if the forecasted transaction is no longer probable, the forward-starting swap will cease to be valued at amortized cost and will be marked to market through surplus. For the year ended December 31, 2024, none of the Company’s cash flow hedges have been discontinued, as it was probable that the original forecasted transactions would occur by the end of the originally specified time period documented at inception of the hedging relationship.

The Company may enter into derivative transactions that economically mitigate risk associated with interest rate, exchange rate, credit, and equity movements within the marketplace. Due to the natural economic benefits of the hedge in relation to the hedged item, the Company chooses not to seek hedge accounting in these instances. Examples of these types of derivative transactions and the associated risks are as follows: (A) futures that hedge equity risk on universal life liabilities; (B) futures, options swaps, or forward contracts that hedge the equity or interest rate risk on minimum rate guarantee liabilities; (C) credit default swaps purchase of protection that hedge the credit risk of specific bonds; (D) interest rate caps that hedge a rapidly rising interest rate environment and withdrawal activity in pension products; and (E) interest rate swaptions that hedge the risk of a low interest rate environment on in-force recurring premium products.

The Company may enter into replicated (synthetic asset) transactions used for purposes other than hedging by the following: (A) combining a written credit default swap with a highly rated cash instrument to synthetically create corporate debt; (B) combining a written credit default swap with a highly rated cash instrument to synthetically create sovereign debt; or (C) combining a

 

22


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

written credit default swap with a highly rated cash instrument to synthetically create a portfolio of commercial mortgage backed securities.

Securities Lending Assets and Liabilities

The Company loans securities to third parties under agent-managed securities lending programs accounted for as secured borrowings. Cash collateral received which may be sold or repledged by the Company is reflected as a one-line entry on the Balance Sheets (Securities lending reinvested collateral assets) and a corresponding liability is established to record the obligation to return the cash collateral. Non-cash collateral received which may not be sold or repledged is not recorded on the Company’s Balance Sheets. Under GAAP, the reinvested collateral is included within invested assets and is not reported as a single line item.

Repurchase Agreements

For dollar repurchase agreements accounted for as secured borrowings, the Company receives cash collateral in an amount at least equal to the fair value of the securities transferred by the Company in the transaction as of the transaction date. The securities transferred are not removed from the Balance Sheets, and the cash received as collateral is invested as needed or used for general corporate purposes of the Company. A liability is established to record the obligation to return the cash collateral and included in borrowed money on the Balance Sheets.

Other Assets and Other Liabilities

Other assets consist primarily of cash surrender value of company owned life insurance, receivable from parent, subsidiaries and affiliates, general insurance accounts receivable, disallowed IMR and reinsurance receivable.

Other liabilities consist primarily of amounts withheld by the Company, accrued expenses, remittances, custody offset, and municipal repurchase agreements. Municipal repurchase agreements are investment contracts issued to municipalities that pay either a fixed or floating rate of interest on the guaranteed deposit balance. The floating interest rate is based on a market index. The related liabilities are equal to the policyholder deposit and accumulated interest. These municipal repurchase agreements require a minimum of 95% of the fair value of the securities transferred to be maintained as collateral.

Separate Accounts

The majority of separate accounts held by the Company, primarily for individual policyholders as well as for group pension plans, do not have any minimum guarantees, and the investment risks associated with fair value changes are borne by the policyholder. The assets in the accounts consist of underlying mutual fund shares, common stocks, long-term bonds and short-term investments.

 

23


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Assets held in trust for purchases of variable life, variable universal life, variable annuity and certain non-indexed guaranteed annuity contracts (which guarantee certain returns as specificed in the contracts) and the Company’s corresponding obligation to the contract owners are shown separately in the Balance Sheets. The assets and liabilities in the separate accounts are carried on a fair value basis. Income and gains and losses with respect to these assets accrue to the benefit of the policyholders and, accordingly, the operations of the separate accounts are not included in the accompanying financial statements. The investment risks associated with fair value changes of the separate accounts are borne entirely by the policyholders except in cases where minimum guarantees exist.

The individual variable life insurance policies typically provide a guaranteed minimum death benefit.

Certain other modified guaranteed annuity separate accounts represent funds invested by the Company for the benefit of contract holders who are guaranteed certain returns as specified in the contracts. These modified guaranteed annuity separate account assets and liabilities are carried at amortized cost. Income and gains and losses with respect to the assets in the separate accounts supporting modified guaranteed annuity contracts are included in the Company’s Statements of Operations as a component of net transfers from separate accounts.

Separate account asset performance different than the guaranteed requirements is either transferred to or received from the general account and reported in the Statements of Operations. These guarantees are included in the general account due to the nature of the guaranteed return.

Surplus funds transferred from the general account to the separate accounts, commonly referred to as seed money, and earnings accumulated on seed money are reported as surplus in the separate accounts until transferred or repatriated to the general account. The transfer of such funds between the separate account and the general account is reported as surplus contributed or withdrawn during the year.

Aggregate Reserves for Policies and Contracts

Life, annuity and accident and health benefit reserves are calculated by actuarial methods and are determined based on published tables using statutorily specified interest rates and valuation methods that will provide, in the aggregate, reserves that are greater than or equal to the minimum or guaranteed cash value, or the amount required by law. For direct business issued after October 1964, the Company waives deduction of deferred fractional premiums upon death of the insured and returns any portion of the final premium for periods beyond the month of death. For policies assumed during 1992 from former affiliates, Monumental General Insurance Company and Monumental Life Insurance Group, Inc., and for all business from company mergers occurring in 1998, the Company waives deduction of deferred fractional premium upon death of the insured and returns any portion of the final premium paid beyond the month of death. For fixed premium life insurance business resulting from company mergers occurring in 2004 and 2007, the Company waives deduction of deferred fractional premiums upon death of the insured and refunds portions of premiums unearned after the date of death. Where appropriate, the Company holds a non-deduction and/or refund reserve. The reserve for these benefits is computed using aggregate methods. The reserves are equal to the greater of the cash surrender value and the legally computed reserve.

 

24


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

For GAAP, policy reserves are calculated based on estimated expected experience or actual account balances.

Surrender values are not promised in excess of the legally computed reserves. For annual premium variable life insurance there is an extra premium charged to the policyholder before the premium is transferred to the Separate Accounts. An additional reserve for this policy is held in the General Account that is a multiple of the reserve that would otherwise be held. For interest sensitive whole life, the reserves held in the General Account are equal to the cash surrender value.

In accordance with SSAP No. 51, Life Contracts, and No. 54, Individual and Group Accident and Health Contracts, the Company reports the amount of insurance, if any, for which the gross premiums are less than the net premiums according to the valuation standards and any related premium deficiency reserve established. Anticipated investment income is not included as a factor in the health contract premium deficiency calculation.

Policy and Contract Claim Reserves

Claim reserves represent the estimated accrued liability for claims reported to the Company and claims incurred but not yet reported through the Balance Sheets date. These reserves are estimated using either individual case-basis valuations or statistical analysis techniques. These estimates are subject to the effects of trends in claim severity and frequency. The estimates are continually reviewed and adjusted as necessary as experience develops or new information becomes available.

Deposit-Type Contracts

Deposit-type contracts do not incorporate risk from the death or disability of policyholders. These types of contracts may include guaranteed investment contracts (GICs), funding agreements and other annuity contracts. Deposits and withdrawals on these contracts are recorded as a direct increase or decrease, respectively, to the liability balance and are not reported as premiums, benefits or changes in reserves in the Statements of Operations. Interest on these policies is reflected in other benefits.

Premiums and Annuity Considerations

Revenues for life and annuity policies with mortality or morbidity risk (including annuities with purchase rate guarantees) consist of the entire premium received. Benefits incurred represent surrenders and death benefits paid and the change in policy reserves. Under GAAP, for universal life policies, premiums received in excess of policy charges would not be recognized as premium revenue and benefits would represent interest credited to the account values and the excess of benefits paid over the policy account value. Under GAAP, for all annuity policies without significant mortality risk, premiums received and benefits paid would be recorded directly to the reserve liability using deposit accounting.

 

25


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Policyholder Dividends

Policyholder dividends are recognized when declared rather than over the term of the related policies as would be required under GAAP.

Reinsurance

Coinsurance premiums, commissions, expense reimbursements and reserves related to reinsured business are accounted for on bases consistent with those used in accounting for the original policies and the terms of the reinsurance contracts. Gains associated with reinsurance of in force blocks of business are included in unassigned surplus and amortized into income as earnings emerge on the reinsured block of business. Premiums ceded and recoverable losses have been reported as a reduction of premium income and benefits, respectively. Policy liabilities and accruals are reported in the accompanying financial statements net of reinsurance ceded.

Any reinsurance amounts deemed to be uncollectible have been written off through a charge to operations. In addition, a liability for reinsurance balances would be established for unsecured policy reserves ceded to reinsurers not authorized to assume such business. Changes to the liability are credited or charged directly to unassigned surplus. Under GAAP, an allowance for amounts deemed uncollectible has been established through a charge to earnings.

Losses associated with an indemnity reinsurance transaction are reported within income when incurred rather than being deferred and amortized over the remaining life of the underlying reinsured contracts as would be required under GAAP.

Policy and contract liabilities ceded to reinsurers have been reported as reductions of the related reserves rather than as assets as would be required under GAAP.

Commissions allowed by reinsurers on business ceded are reported as income when incurred rather than being deferred and amortized with deferred policy acquisition costs as required under GAAP.

Under GAAP, for certain reinsurance agreements whereby assets are retained by the ceding insurer (such as funds withheld or modified coinsurance) and a return is paid based on the performance of underlying investments, the assets and liabilities for these reinsurance arrangements must be adjusted to reflect the fair value of the invested assets. The NAIC SAP does not contain a similar requirement.

 

26


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Deferred Income Taxes

The Company computes deferred income taxes in accordance with SSAP No. 101, Income Taxes. Unlike GAAP, SSAP No. 101 does not consider state income taxes in the measurement of deferred taxes. SSAP No. 101 also requires additional testing to measure gross deferred tax assets. The additional testing limits gross deferred tax asset admission to 1) the amount of federal income taxes paid in prior years recoverable through hypothetical loss carrybacks of existing temporary differences expected to reverse during a timeframe corresponding with the Internal Revenue Service tax loss carryback provisions, not to exceed three years, plus 2) the amount of remaining gross deferred tax assets expected to be realized within three years limited to an amount that is no greater than 15% of current period’s adjusted statutory capital and surplus, plus 3) the amount of remaining gross deferred tax assets that can be offset against existing gross deferred tax liabilities after considering character (i.e. ordinary versus capital) and reversal patterns. The Company’s reported deferred tax asset or liability is the sum of gross deferred tax assets admitted through this three-part test plus the sum of all deferred tax liabilities.

Policy Acquisition Costs

The costs of acquiring and renewing business are expensed when incurred. Under GAAP, incremental costs directly related to the successful acquisition of insurance and investment contracts are deferred.

Value of Business Acquired

Under GAAP, value of business acquired (VOBA) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future contracts and contract changes, premiums, mortality and morbidity, separate account performance, surrenders, operation expenses, investment returns, nonperformance risk adjustment and other factors. VOBA is not recognized under the NAIC SAP.

Subsidiaries and Affiliated Companies

Investments in SCA are stated in accordance with the Purposes and Procedures Manual of the NAIC SVO, as well as SSAP No. 97.

The accounts and operations of the Company’s subsidiaries are not consolidated with the accounts and operations of the Company as would be required under GAAP. Dividends or distributions received from an investee are recognized in investment income when declared to the extent that they are not in excess of the undistributed accumulated earnings attributable to an investee. Changes in investments in SCA’s are recorded as a change to the carrying value of the investment with a corresponding amount recorded directly to unrealized gain/loss (capital and surplus).

 

27


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Nonadmitted Assets

Certain assets designated as “nonadmitted”, primarily net deferred tax assets, reinsurance receivables, agent’s balances and other assets not specifically identified as an admitted asset within the NAIC SAP, are excluded from the accompanying Balance Sheets and are charged directly to unassigned surplus. Under GAAP, such assets are included in the Balance Sheets to the extent that they are not impaired.

Statements of Cash Flow

Cash, cash equivalents and short-term investments in the Statements of Cash Flow represent cash balances and investments with initial maturities of one year or less and money market mutual funds. Under GAAP, the corresponding caption of cash and cash equivalents includes cash balances and investments with initial maturities of three months or less.

 

3.

Accounting Changes and Correction of Errors

The Company’s policy is to disclose recently adopted accounting pronouncements that have been classified by the NAIC as a new statutory accounting principle (SAP) concept change, as well as items classified by the NAIC as SAP clarification changes that have been adopted and have had a material impact on the financial position or results of operations of the Company.

Recent Accounting Pronouncements

On January 10, 2024, the Statutory Accounting Principles Working Group (SAPWG) adopted INT 23-04, Scottish Re Life Reinsurance Liquidation Questions, effective for reporting periods on or after December 31, 2023. INT 23-04 provides clarity that the Scottish Re liquidation should be accounted for as a commutation or recapture and reported as such, including all relevant disclosures. An impairment analysis shall be conducted and any remaining receivables in dispute or not secured by a trust shall be non-admitted. Refer to Note 7 for further detail.

On August 13, 2023, the SAPWG adopted INT 23-01, Net Negative (Disallowed) Interest Maintenance Reserve, effective immediately. INT 23-01 provides optional, limited-time guidance, which allows the admittance of net negative (disallowed) IMR if certain conditions are met, up to 10% of adjusted general account capital and surplus. Refer to Note 5 for further detail.

Change in Estimates

During 2023, the Company received approval from the IID, pursuant to SSAP No. 97 to change the valuation methodology under which it values its investments in Transamerica Pacific Reinsurance, Inc. (TPRe) and LIICA Re II, Inc. (LIICA Re II). Effective December 31, 2023, TPRe and LIICA Re II are valued at audited statutory equity, including the impacts of permitted practices, and consolidated in the Company’s Risk-Based Capital. This resulted in a $619 increase in affiliated common stock with a corresponding increase in Change in net unrealized capital gains/losses.

 

28


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Correction of Error

During 2022, the Company identified an error in the way in which it recognized the receipt of certain affiliated distributions in prior years. This error resulted in prior periods’ net investment income being understated by a total of $145, with a corresponding overstatement of the change in unrealized gains/losses. This was corrected as of December 31, 2022 in accordance with SSAP No. 3, Accounting Changes and Corrections of Errors, with the correction reflected in the Statements of Changes in Capital and Surplus in other changes, offset by a corresponding change in net unrealized capital gains/losses. There was no net impact to ending capital or surplus as a result of this error in any period.

There were additional errors identified in prior year financial statements that have been corrected in the years presented in the financial statements in accordance with SSAP No. 3. These errors do not have a material impact on the financial statements, individually or in aggregate, and therefore have not been separately disclosed.

4. Fair Values of Financial Instruments

The fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

Determination of Fair Value

The fair values of financial instruments are determined by management after taking into consideration several sources of data. When available, the Company uses quoted market prices in active markets to determine the fair value of its investments. The Company’s valuation policy utilizes a pricing hierarchy which dictates that publicly available prices are initially sought from indices and third-party pricing services. In the event that pricing is not available from these sources, those securities are submitted to brokers to obtain quotes. Lastly, securities are priced using internal cash flow modeling techniques. These valuation methodologies commonly use reported trades, bids, offers, issuer spreads, benchmark yields, estimated prepayment speeds, and/ or estimated cash flows.

To understand the valuation methodologies used by third-party pricing services, the Company reviews and monitors their applicable methodology documents. Any changes to their methodologies are noted and reviewed for reasonableness. In addition, the Company performs in- depth reviews of prices received from third-party pricing services on a sample basis. The objective for such reviews is to demonstrate the Company can corroborate detailed information such as assumptions, inputs and methodologies used in pricing individual securities against documented pricing methodologies. Only third-party pricing services and brokers with a substantial presence in the market and with appropriate experience and expertise are used.

Each month, the Company performs an analysis of the information obtained from indices, third- party services, and brokers to ensure the information is reasonable and produces a reasonable estimate of fair value. The Company considers both qualitative and quantitative factors as part of this analysis, including but not limited to, recent transactional activity for similar securities, review of pricing statistics and trends, and consideration of recent relevant market events. Other

 

29


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

controls and procedures over pricing received from indices, third-party pricing services, or brokers include validation checks such as exception reports which highlight significant price changes, stale prices or un-priced securities.

Fair Value Hierarchy

The Company’s financial assets and liabilities carried at fair value are classified, for disclosure purposes, based on a hierarchy defined by SSAP No. 100, Fair Value. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1), and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset’s or a liability’s classification is based on the lowest level input that is significant to its measurement. For example, a Level 3 fair value measurement may include inputs that are both observable (Levels 1 and 2) and unobservable (Level 3). The levels of the fair value hierarchy are as follows:

 

Level 1

 

-

 

Unadjusted quoted prices for identical assets or liabilities in active markets accessible at the measurement date.

Level 2

 

-

 

Quoted prices in markets that are not active or inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:

   

 a)  Quoted prices for similar assets or liabilities in active markets

 b)  Quoted prices for identical or similar assets or liabilities in non-active markets

 c)  Inputs other than quoted market prices that are observable

 d)  Inputs that are derived principally from or corroborated by observable market data through correlation or other means

Level 3

 

-

 

Prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. They reflect the Company’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments:

Cash Equivalents and Short-Term Investments: The carrying amounts reported in the accompanying Balance Sheets for these financial instruments is either reported at fair value or amortized cost (which approximates fair value). Cash is not included in the below tables.

Short-Term Notes Receivable from Affiliates: The carrying amounts reported in the accompanying Balance Sheets for these financial instruments approximate their fair value.

Bonds and Stocks: The NAIC allows insurance companies to report the fair value determined by the SVO or to determine the fair value by using a permitted valuation method. The fair values of

 

30


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

bonds and stocks are reported or determined using the following pricing sources: indices, third- party pricing services, brokers, external fund managers and internal models.

Fair values for fixed maturity securities (including redeemable preferred stock) actively traded are determined from third-party pricing services, which are determined as discussed above in the description of Level 1 and Level 2 values within the fair value hierarchy. For fixed maturity securities (including redeemable preferred stock) not actively traded, fair values are estimated using values obtained from third-party pricing services, or are based on non-binding broker quotes or internal models. In the case of private placements, fair values are estimated by discounting the expected future cash flows using current market rates applicable to the coupon rate, credit and maturity of the investments.

Mortgage Loans on Real Estate: The fair values for mortgage loans on real estate are estimated utilizing discounted cash flow analyses, using interest rates reflective of current market conditions and the risk characteristics of the loans.

Real Estate: Real estate held for sale is typically valued utilizing independent external appraisers in conjunction with reviews by qualified internal appraisers. Valuations are primarily based on active market prices, adjusted for any difference in the nature, location or condition of the specific property. If such information is not available, other valuation methods are applied, considering the value that the property’s net earning power will support, the value indicated by recent sales of comparable properties and the current cost of reproducing or replacing the property.

Other Invested Assets: The fair values for other invested assets, which include investments in surplus notes issued by other insurance companies and fixed or variable rate investments with underlying characteristics of bonds, are determined primarily by using indices, third-party pricing services and internal models.

Derivative Financial Instruments: The fair value of futures and forwards are based upon the latest quoted market price and spot rates at the Balance Sheets date. The estimated fair values of equity and interest rate options (calls, puts, caps) are based upon the latest quoted market price at the Balance Sheets date. The estimated fair values of swaps, including equity, interest rate and currency swaps, are based on pricing models or formulas using current assumptions. The estimated fair values of credit default swaps are based upon active market data, including interest rate quotes, credit spreads, and recovery rates, which are then used to calculate probabilities of default for the fair value calculation. The Company accounts for derivatives that receive and pass hedge accounting in the same manner as the underlying hedged instrument. If that instrument is held at amortized cost, then the derivative is also held at amortized cost.

Policy Loans: The book value of policy loans is considered to approximate the fair value of the loan, which is stated at unpaid principal balance.

Securities Lending Reinvested Collateral: The cash collateral from securities lending is reinvested in various short-term and long-term debt instruments. The fair values of these investments are determined using the methods described above under Cash Equivalents and Short-Term Investments and Bonds and Stocks.

 

31


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Separate Account Assets and Annuity Liabilities: The fair value of separate account assets are based on quoted market prices when available. When not available, they are primarily valued either using third-party pricing services or are valued in the same manner as the general account assets as further described in this note. However, some separate account assets are valued using non-binding broker quotes, which cannot be corroborated by other market observable data, or internal modeling which utilizes input that are not market observable. The fair value of separate account annuity liabilities is based on the account value for separate accounts business without guarantees. For separate accounts with guarantees, fair value is based on discounted cash flows.

Investment Contract Liabilities: Fair value for the Company’s liabilities under investment contracts, which include deferred annuities and GICs, are estimated using discounted cash flow calculations. For those liabilities that are short in duration, carrying amount approximates fair value. For investment contracts with no defined maturity, fair value is estimated to be the present surrender value.

Deposit-Type Contracts: The carrying amounts of deposit-type contracts reported in the accompanying Balance Sheets approximate their fair values. These are included in the investment contract liabilities.

Fair values for the Company’s insurance contracts other than investment-type contracts (including separate account universal life liabilities) are not required to be disclosed. However, the fair values of liabilities under all insurance contracts are taken into consideration in the Company’s overall management of interest rate risk, such that the Company’s exposure to changing interest rates is minimized through the matching of investment maturities with amounts due under insurance contracts.

The Company accounts for its investments in affiliated common stock in accordance with SSAP No. 97, as such, they are not included in the following disclosures.

 

32


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following tables set forth a comparison of the estimated fair values and carrying amounts of the Company’s financial instruments, including those not measured at fair value in the Balance Sheets, as of December 31, 2024 and 2023, respectively:

 

     December 31, 2024  
     Aggregate
Fair Value
    Admitted
Value
     (Level 1)      (Level 2)     (Level 3)  

Admitted assets

            

Cash equivalents and short-term investments, other than affiliates

   $ 1,370     $ 1,370      $ 1,367      $ 3     $  

Short-term notes receivable from affiliates

     450       450               450        

Bonds

     44,540       49,516        4,327        39,382       831  

Preferred stocks, other than affiliates

     44       44               44        

Common stocks, other than affiliates

     90       90        4              86  

Mortgage loans on real estate

     7,752       8,885                     7,752  

Other invested assets

     285       321               270       15  

Derivative assets:

            

Options

     63       63               63        

Interest rate swaps

     105       105               105        

Currency swaps

     110       70               110        

Credit default swaps

     62       38               62        

Equity swaps

     119       119               119        

Interest rate futures

     2       2        2               

Equity futures

     2       2        2               

Derivative assets total

     463       399        4        459        

Policy loans

     2,239       2,239               2,239        

Securities lending reinvested collateral

     1,537       1,537        1,537               

Separate account assets

   $ 102,011     $ 102,098      $ 95,458      $ 5,955     $ 598  

Liabilities

            

Investment contract liabilities

   $ 10,097     $ 9,763      $      $ 204     $ 9,893  

Derivative liabilities:

            

Options

     5       5               5        

Interest rate swaps

     1,849       1,417               1,849        

Currency swaps

     1       2               1        

Credit default swaps

     (2     5               (2      

Equity swaps

     37       37               37        

Interest rate futures

     1       1        1               

Equity futures

     14       14        14               

Derivative liabilities total

     1,905       1,481        15        1,890        

Payable for securities lending

     1,667       1,667               1,667        

Payable for derivative cash collateral

     96       96               96        

Separate account liabilities

   $ 91,620     $ 91,698      $ 2      $ 91,609     $ 9  

 

33


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

     December 31, 2023  
    

Aggregate

Fair Value

    

Admitted

Value

     (Level 1)      (Level 2)      (Level 3)  

Admitted assets

              

Cash equivalents and short-term investments, other than affiliates

   $ 3,077      $ 3,077      $ 3,075      $ 2      $  

Short-term notes receivable from affiliates

     250        250               250         

Bonds

     42,641        46,351        5,022        37,028        591  

Preferred stocks, other than affiliates

     59        59               59         

Common stocks, other than affiliates

     113        113        11               102  

Mortgage loans on real estate

     8,323        9,409                      8,323  

Other invested assets

     345        376               329        16  

Derivative assets:

              

Options

     100        100               100         

Interest rate swaps

     950        951               950         

Currency swaps

     83        38               83         

Credit default swaps

     63        38               63         

Equity swaps

     9        9               9         

Interest rate futures

     2        2        2                

Equity futures

     5        5        5                

Derivative assets total

     1,212        1,143        7        1,205         

Policy loans

     2,109        2,109               2,109         

Securities lending reinvested collateral

     1,974        1,974        1,974                

Separate account assets

   $ 97,308      $ 97,358      $ 91,472      $ 5,731      $ 105  

Liabilities

              

Investment contract liabilities

   $ 10,224      $ 9,878      $      $ 216      $ 10,008  

Derivative liabilities:

              

Options

     44        44               44         

Interest rate swaps

     1,075        688               1,075         

Currency swaps

     10        6               10         

Credit default swaps

     20        30               20         

Equity swaps

     435        435               435         

Interest rate futures

     2        2        2                

Equity futures

     9        9        9                

Derivative liabilities total

     1,595        1,214        11        1,584         

Dollar repurchase agreements

     11        11               11         

Payable for securities lending

     2,292        2,292               2,292         

Payable for derivative cash collateral

     806        806               806         

Separate account liabilities

   $ 87,871      $ 87,873      $ 2      $ 87,802      $ 67  

 

34


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following tables provide information about the Company’s financial assets and liabilities measured at fair value as of December 31, 2024 and 2023:

 

     2024  
     Level 1      Level 2      Level 3      Total  

Assets:

           

Bonds

           

Government

   $      $ 2      $      $ 2  

Industrial and miscellaneous

            26        2        28  
                                   

Total bonds

            28        2        30  
                                   

Preferred stock

           

Industrial and miscellaneous

            44               44  
                                   

Total preferred stock

            44               44  
                                   

Common stock

           

Industrial and miscellaneous

     4               86        90  
                                   

Total common stock

     4               86        90  
                                   

Cash equivalents and short-term investments

           

Money market mutual funds

     1,081                      1,081  
                                   

Total cash equivalents and short-term investments

     1,081                      1,081  
                                   

Other long term

            5               5  

Derivative assets

     4        281               285  

Separate account assets

     95,290        4,021               99,311  
                                   

Total assets

   $  96,379      $  4,379      $   88      $  100,846  
                                   
                                   

Liabilities:

           

Derivative liabilities

   $ 15      $ 799      $      $ 814  

Separate account liabilities

     2                      2  
                                   

Total liabilities

   $ 17      $ 799      $      $ 816  
                                   
                                   

 

35


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

    2023  
     Level 1      Level 2      Level 3      Total  

Assets:

          

Bonds

          

Government

  $      $ 2      $      $ 2  

Industrial and miscellaneous

           22        1        23  

Hybrid securities

           5               5  
                                  

Total bonds

           29        1        30  
                                  

Preferred stock

          

Industrial and miscellaneous

           58               58  
                                  

Total preferred stock

           58               58  
                                  

Common stock

          

Industrial and miscellaneous

    11               100        111  
                                  

Total common stock

    11               100        111  
                                  

Cash equivalents and short-term investments

          

Industrial and miscellaneous

           2               2  

Money market mutual funds

    2,466                      2,466  
                                  

Total cash equivalents and short-term investments

    2,466        2               2,468  
                                  

Derivative assets

    7        1,031               1,038  

Other long term

           5               5  

Separate account assets

    91,312        4,701               96,013  
                                  

Total assets

  $  93,796      $  5,826      $  101      $  99,723  
                                  
                                  

Liabilities:

          

Derivative liabilities

  $ 11      $ 604      $      $ 615  

Separate account liabilities

    2                      2  
                                  

Total liabilities

  $ 13      $ 604      $      $ 617  
                                  
                                  

Bonds classified as Level 2 are valued using inputs from third party pricing services or broker quotes. Bonds classified as Level 3 are primarily those valued using non-binding broker quotes, which cannot be corroborated by other market observable data, or internal modeling which utilize significant inputs that are not market observable.

Preferred stock classified as Level 2 are valued using inputs from third party pricing services or broker quotes.

Common stock classified as Level 3 are comprised primarily of shares in the FHLB of Des Moines, which are valued at par as a proxy for fair value as a result of restrictions that allow redemptions only by FHLB.

Cash or cash equivalents classified as Level 2 are valued using inputs from third party pricing services or broker quotes.

Derivatives classified as Level 2 represent over-the-counter (OTC) contracts valued using pricing models based on the net present value of estimated future cash flows, directly observed prices from exchange-traded derivatives, other OTC trades, or external pricing services.

Other long-term classified as Level 2 are comprised of surplus debentures, which are valued using inputs from third party pricing services or broker quotes.

 

36


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Separate account assets and liabilities are valued and classified in the same way as general account assets and liabilities (described above).

The following tables summarize the changes in assets classified as Level 3 for 2024 and 2023:

 

     Beginning
Balance at
January 1, 2024
     Transfers in
(Level 3)
     Transfers
out (Level 3)
     Total Gains
(Losses) Included
in Net income (a)
    Total Gains
(Losses) Included
in Surplus (b)
 
    

 

 

Bonds

             

Other

    $ 1      $ 20      $ 1      $ (1   $ (17)  

Common stock

     100                      1       (4)  
    

 

 

Total

    $ 101      $ 20      $ 1      $     $ (21)  
    

 

 
    

 

 
     Purchases      Issuances      Sales      Settlements     Ending Balance at
December 31, 2024
 
    

 

 

Bonds

             

Other

    $      $      $      $     $ 2  

Common stock

     16               27              86  
    

 

 

Total

    $ 16      $      $ 27      $     $ 88  
    

 

 
    

 

 

 

(a)

Recorded as a component of Net Realized Capital Gains (Losses) on Investments in the Statements of Operations

(b)

Recorded as a component of Change in Net Unrealized Capital Gains (Losses) in the Statements of Changes in Capital and Surplus

 

     Beginning
Balance at
January 1, 2023
    

Transfers in

(Level 3)

     Transfers
out (Level 3)
     Total Gains
(Losses) Included
in Net income (a)
    Total Gains
(Losses) Included
in Surplus (b)
 
    

 

 

Bonds

             

Other

   $ 1      $ 1      $      $ (3   $ 2  

Common stock

     132        1               (6     9  
    

 

 

Total

   $ 133      $ 2      $      $ (9   $ 11  
    

 

 
    

 

 
     Purchases      Issuances      Sales      Settlements     Ending Balance at
December 31, 2023
 
    

 

 

Bonds

             

Other

   $      $      $      $     $ 1  

Common stock

     15               51              100  
    

 

 

Total

   $ 15      $      $ 51      $     $ 101  
    

 

 
    

 

 

 

(a)

Recorded as a component of Net Realized Capital Gains (Losses) on Investments in the Statements of Operations

(b)

Recorded as a component of Change in Net Unrealized Capital Gains (Losses) in the Statements of Changes in Capital and Surplus

Transfers between fair value hierarchy levels are recognized at the beginning of the reporting period.

 

37


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Nonrecurring Fair Value Measurements

As indicated in Note 2, real estate held for sale is measured at the lower of carrying amount or fair value less encumbrances and estimated costs to sell. At December 31, 2024 and 2023, the Company held no properties classified as held-for-sale.

5. Investments

 

Bonds

and Stocks

The carrying amounts and estimated fair value of investments in bonds and stocks are as follows:

 

   

Book Adjusted
Carrying Value

     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated Fair
Value
 

December 31, 2024

             

Bonds:

             

United States Government and agencies

  $      5,182      $      $ 1,284      $ 3,898  

State, municipal and other government

       3,123        9        535        2,597  

Hybrid securities

       230        8        8        230  

Industrial and miscellaneous

       33,567        471        3,357        30,681  

Mortgage and other asset-backed securities

       7,414        162        442        7,134  
                                     

Total unaffiliated bonds

       49,516        650        5,626        44,540  

Unaffiliated preferred stocks

       44                      44  
                                     
 

$ 

     49,560      $ 650      $ 5,626      $ 44,584  
                                     
                                     
         Cost      Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated Fair
Value
 
 

 

 

Unaffiliated common stocks

  $      88      $ 2      $      $ 90  
 

 

 

 

38


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

     Book Adjusted
Carrying Value
    

Gross

Unrealized
Gains

    

Gross

Unrealized
Losses

     Estimated Fair
Value
 
    

 

 

December 31, 2023

           

Bonds:

           

United States Government and agencies

    $ 5,477      $ 54      $ 941      $ 4,590   

State, municipal and other government

     3,055        19        438        2,636   

Hybrid securities

     270        10        17        263   

Industrial and miscellaneous

     31,333        671        2,731        29,273   

Mortgage and other asset-backed securities

     6,216        203        540        5,879   
  

 

 

 

Total unaffiliated bonds

     46,351        957        4,667        42,641   

Unaffiliated preferred stocks

     59                      59   
  

 

 

 
    $   46,410      $   957      $   4,667      $   42,700   
  

 

 

 
     Cost      Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated Fair
Value
 
    

 

 

Unaffiliated common stocks

    $ 105      $ 8      $      $ 113   
  

 

 

 

The carrying amount and estimated fair value of long and short-term bonds at December 31, 2024, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because certain borrowers have the right to call or prepay obligations with or without call or prepayment penalties.

 

     2024  
December 31:    Carrying Value      Fair Value   
 

 

 

Due in one year or less

    $   1,261      $   1,261   

Due after one year through five years

     7,353        7,321   

Due after five years through ten years

     9,313        8,908   

Due after ten years

     24,567        20,309   
  

 

 

 

Subtotal

     42,494        37,799   

Mortgage and other asset-backed securities

     7,599        7,318   
  

 

 

 

Total

    $ 50,093      $ 45,117   
  

 

 

 

 

39


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The estimated fair value of bonds, preferred stocks and common stocks with gross unrealized losses at December 31, 2024 and 2023 is as follows:

 

     2024  
     Equal to or Greater
than 12 Months
     Less than 12 Months  
    

 

 
     Estimated
Fair Value
     Gross
Unrealized
Losses
     Estimated
Fair Value
     Gross
Unrealized 
Losses
 
    

 

 

United States Government and agencies

    $ 1,518      $ 649      $ 2,307      $ 635   

State, municipal and other government

     1,843        511        556        24   

Hybrid securities

     72        7        41        1   

Industrial and miscellaneous

     13,685        3,063        7,666        294   

Mortgage and other asset-backed securities

     3,310        414        1,356        28   
  

 

 

 

Total bonds

     20,428        4,644        11,926        982   
  

 

 

 

Common stocks-unaffiliated

                   1        —   
  

 

 

 
    $  20,428      $  4,644      $  11,927      $  982   
  

 

 

 
     2023  
    

 

 

 
     Equal to or Greater
than 12 Months
     Less than 12 Months  
    

 

 

 
     Estimated
Fair Value
     Gross
Unrealized
Losses
     Estimated
Fair Value
     Gross
Unrealized
Losses
 
    

 

 

United States Government and agencies

    $ 1,582      $ 487      $ 2,155      $ 454   

State, municipal and other government

     2,051        433        214        5   

Hybrid securities

     130        16        37        1   

Industrial and miscellaneous

     15,644        2,605        3,381        125   

Mortgage and other asset-backed securities

     3,866        521        635        20   
  

 

 

 

Total bonds

     23,273        4,062        6,422        605   
  

 

 

 

Preferred stocks-unaffiliated

     23               35        —   

Common stocks-unaffiliated

                   92        —   
  

 

 

 
    $ 23,296      $ 4,062      $ 6,549      $ 605   
  

 

 

 

During 2024, 2023 and 2022, respectively, there were $7, $13 and $2, of loan-backed or structured securities with a recognized OTTI due to intent to sell or lack of intent and ability to hold for a period of time to recover the amortized cost basis.

For loan-backed and structured securities with a recognized OTTI due to the Company’s cash flow analysis, in which the security is written down to estimated future cash flows discounted at the security’s effective yield, in 2024, 2023 and 2022, the Company recognized OTTI of $0, $25 and $1, respectively.

 

40


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following loan-backed and structured securities were held at December 31, 2024, for which an OTTI was recognized during the current reporting period:

 

CUSIP    Amortized
Cost Before
Current
Period OTTI
     Present
Value of
Projected
Cash Flows
    

Recognized

OTTI

    

Amortized

Cost After
OTTI

    

Fair Value
at Time of

OTTI

    

Date of
Financial

Statement
Where
Reported

 

22944BCX4

   $       1      $       1       $       —       $       1      $       1        6/30/2024  

89169DAA9

                   —                       6/30/2024  

BAE3K7RU3-TA

                   —                       6/30/2024  

86745QAA9

     1        1        —         1               6/30/2024  

89175MAA1

                   —                       6/30/2024  

38237GAA7

                   —                       6/30/2024  

3133KMY58

     1        1        —         1        1        6/30/2024  

3140XHCP0

     1        1        —         1        1        6/30/2024  

3133B3PM3

     1        1        —         1        1        6/30/2024  

3140QM5A8

     1        1        —         1        1        6/30/2024  

3140MA2S2

     1        1        —         1        1        6/30/2024  

89181JAA0

     1        1        —         1        1        6/30/2024  

3132DWFM0

     1        1        —         1        1        6/30/2024  

059494AA2

     4        4        —         4        4        9/30/2024  

026930AA5

                   —                       12/31/2024  

059494AA2

     4        3        1         3        3        12/31/2024  

05948KV63

                   —                       12/31/2024  

761118AH1

                   —                       12/31/2024  
        

 

 

          
          $ 1            
        

 

 

          

The unrealized losses of loan-backed and structured securities where fair value is less than cost or amortized cost for which an OTTI has not been recognized in earnings as of December 31, 2024 and 2023 is as follows:

 

     2024      2023  
     Losses 12
Months or
More
     Losses Less
Than 12
Months
     Losses 12
Months or
More
     Losses Less
Than 12
Months
 
    

 

 

Year ended December 31:

           

The aggregate amount of unrealized losses

   $ 425      $ 28      $ 532      $ 20  
The aggregate related fair value of securities with unrealized losses      3,325        1,448        3,866        863  

At December 31, 2024 and 2023, respectively, for bonds and preferred stocks that have been in a continuous loss position for greater than or equal to twelve months, the Company held 2,662 and 3,297 securities with a carrying amount of $25,071 and $27,359, and an unrealized loss of $4,644 and $4,062. Of this portfolio, at December 31, 2024 and 2023, 96.8% and 95.6% were investment grade with associated unrealized losses of $4,488 and $3,899, respectively.

 

41


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

At December 31, 2024 and 2023, respectively, for bonds and preferred stocks that have been in a continuous loss position for less than twelve months, the Company held 1,442 and 856 securities with a carrying amount of $12,908 and $7,061, and an unrealized loss of $982 and $605. Of this portfolio, at December 31, 2024 and 2023, 97.3% and 97.8% were investment grade with associated unrealized losses of $966 and $597, respectively.

At December 31, 2024 and 2023, for common stocks that have been in a continuous loss position for greater than or equal to twelve months, the Company held 0 and 4 securities, respectively, with an insignificant cost and unrealized loss.

At December 31, 2024 and 2023, for common stocks that have been in a continuous loss position for less than twelve months, the Company held 5 and 16 securities, respectively, with a cost of $1 and $92 and an insignificant unrealized loss.

The following table provides the number of 5GI securities, aggregate book adjusted carrying value and aggregate fair value by investment type:

 

    

Number of

 5GI Securities

    

Book / Adjusted

Carrying Value

     Fair Value   
    

 

 

December 31, 2024

        

Bond, amortized cost

     9      $   42      $ 24   
  

 

 

 

Total

     9      $ 42      $ 24   
  

 

 

 

December 31, 2023

        

Bond, amortized cost

     7      $ 46      $ 46   
  

 

 

 

Total

     7      $ 46      $ 46   
  

 

 

 

The Company did not have any offsetting assets and liabilities at December 31, 2024 and 2023.

During 2024 and 2023, respectively, the Company sold, redeemed or otherwise disposed of 68 and 21 securities as a result of a callable feature which generated investment income of $16 and $1 as a result of a prepayment penalty and/or acceleration fee.

Proceeds from sales and other disposals of bonds and preferred stock and related gross realized capital gains and losses are reflected in the following table. The amounts exclude maturities and include transfers associated with reinsurance agreements, if applicable.

 

     Year Ended December 31  
     2024      2023      2022  
    

 

 

Proceeds

     $  4,241        $  7,301        $  8,218  
  

 

 

 

Gross realized gains

     $85        $   184        $69  

Gross realized losses

     (139      (747      (624
  

 

 

 

Net realized capital gains (losses)

     $   (54      $   (563      $  (555
  

 

 

 

 

42


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The Company had gross realized losses, which relate to losses recognized on other-than- temporary declines in the fair value of bonds and preferred stocks, for the years ended December 31, 2024, 2023 and 2022 of $42, $106 and $54, respectively.

At December 31, 2024 and 2023, the Company had recorded investments in restructured securities of $2 and $14.

Mortgage Loans

The credit quality of mortgage loans by type of property for the years ended December 31, 2024 and 2023 were as follows:

 

December 31, 2024                     
     Farm      Commercial      Total  
           

 

 

AAA - AA

   $    —      $ 4,553      $   4,553   

A

     30        3,643        3,673   

BBB

     3        591        594   

BB

            1        1   

B

            79        79   
  

 

 

 
    $ 33      $ 8,867      $ 8,900   
  

 

 

 
December 31, 2023                     
     Farm      Commercial      Total  
           

 

 

AAA - AA

   $      $   4,454      $   4,454   

A

     30        4,090        4,120   

BBB

     7        791        798   

BB

            37        37   
  

 

 

 
    $    37      $   9,372      $   9,409   
  

 

 

 

The above tables exclude residential mortgage loans.

The credit quality for commercial and farm mortgage loans was determined based on an internal credit rating model which assigns a letter rating to each mortgage loan in the portfolio as an indicator of the credit quality of the mortgage loan. The internal credit rating model was designed based on rating agency methodology, then modified for credit risk associated with the Company’s mortgage lending process, taking into account such factors as projected future cash flows, net operating income and collateral value. The model produces a credit rating score and an associated letter rating which is intended to align with S&P ratings as closely as possible. Information supporting the credit risk rating process is updated at least annually.

During 2024, the Company issued mortgage loans with a maximum interest rate of 7.26% and a minimum interest rate of 5.66% for commercial loans. The maximum percentage of any one admitted loan to the value of the security (exclusive of insured or guaranteed or purchase money mortgages) originated or acquired during the year ending December 31, 2024 at the time of origination was 68%. During 2023, the Company issued mortgage loans with a maximum interest rate of 7.01% and a minimum interest rate of 5.13% for commercial loans. The maximum

 

43


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

percentage of any one admitted loan to the value of the security (exclusive of insured or guaranteed or purchase money mortgages) originated or acquired during the year ending December 31, 2023 at the time of origination was 72%.

During 2024, the Company issued agricultural loans with both a maximum and minimum interest rate of 6.55%. During 2023, the Company did not issue any agricultural loans.

During 2024 and 2023, the Company did not reduce the interest rate on any outstanding mortgage loans.

The age analysis of mortgage loans and identification in which the Company is a participant or co-lender in a mortgage loan agreement is as follows for December 31, 2024 and 2023:

 

            Commercial         
     Farm      All Other      Total  

December 31, 2024

        

Recorded Investment (All)

        

Current

   $   29      $   8,848      $   8,877  

30-59 Days Past Due

     4               4  

60-89 Days Past Due

            12        12  

180+ Days Past Due

            7        7  

Accruing interest 180+ days past due

        

Recorded investment

            7        7  

Participant or Co-lender in Mortgage Loan Agreement

        

Recorded Investment

   $ 29      $ 795      $ 824  
            Commercial         
     Farm      All Other      Total  

December 31, 2023

        

Recorded Investment (All) Current

   $ 37      $ 9,372      $ 9,409  

Participant or Co-lender in Mortgage Loan Agreement

        

Recorded Investment

   $ 33      $ 842      $ 875  

 

44


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

At December 31, 2024 and 2023, the Company held $7 of mortgage loans that were non-income producing for the previous 180 days. There was an insignificant amount of accrued interest related to these mortgage loans at December 31, 2024 and no amount at December 31, 2023. The Company has a mortgage or deed of trust on the property thereby creating a lien which gives it the right to take possession of the property (among other things) if the borrower fails to perform according to the terms of the loan documents. The Company requires all mortgaged properties to carry fire insurance equal to the value of the underlying property. At December 31, 2024 and 2023, there were no taxes, assessments and other amounts advanced and not included in the mortgage loan total.

At December 31, 2024 and 2023, the Company held 2 impaired loans with or without a related allowance for credit losses. There were no impaired mortgage loans held without an allowance for credit losses as of December 31, 2024 and 2023, respectively, that were subject to participant or co-lender mortgage loan agreement for which the Company is restricted from unilaterally foreclosing on the mortgage loans. There were no average recorded investments in impaired loans during 2024 and 2023.

The Company had an allowance for credit losses on mortgage loans of $15, $0 and $0 at December 31, 2024, 2023, and 2022.

As of December 31, 2024 and 2023, the Company had no mortgage loans derecognized as a result of foreclosure.

The Company accrues interest income on impaired loans to the extent deemed collectible (delinquent less than 91 days) and the loan continues to perform under its original or restructured contractual terms. Interest income on nonperforming loans generally is recognized on a cash basis. For the years ended December 31, 2024, 2023 and 2022, the Company has recognized no interest income on impaired loans.

At December 31, 2024 and 2023, the Company held a mortgage loan loss reserve in the AVR of $97 and $105, respectively.

 

45


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The Company’s mortgage loan portfolio is diversified by geographic region and specific collateral property type as follows:

 

Geographic Distribution

      

Property Type Distribution

 
       December 31               December 31  
       2024        2023                2024        2023  

Pacific

       29 %          28 %         Apartment        52 %          53 %  

South Atlantic

       21             22            Industrial        22             14     

Middle Atlantic

       12             13            Office        14             13     

E. North Central

       11             11            Retail        12             20     

W. South Central

       8             8                    

Mountain

       9             8                    

W. North Central

       5             4                    

New England

       3             3                    

E. South Central

       2             3                    

At December 31, 2024 and 2023, the Company had no mortgage loans with a total net admitted asset value that had been restructured in accordance with SSAP No. 36, Troubled Debt Restructuring. There were no realized losses during the years ended December 31, 2024, 2023 and 2022 related to such restructurings. At December 31, 2024 and 2023, there were no commitments to lend additional funds to debtors owing receivables.

Real Estate

The fair value of property is determined based on an appraisal from a third-party appraiser, along with information obtained from discussions with internal asset managers and a listing broker regarding recent comparable sales data and other relevant property information. Impairment losses of $0, $0 and $1 were taken on real estate in 2024, 2023 and 2022, respectively, to write the book value down to the current fair value, and included in net realized capital gains (losses), within the Statements of Operations, for the year ended December 31, 2024.

As of December 31, 2024 and 2023, there was no property classified as held for sale. During 2024, four property classified as held for sale were disposed, resulting in an insignificant net realized gain. During 2023, one property classified as held for sale was disposed, resulting in an insignificant net realized gain. Any associated gains and losses from these held for sale disposals were included in net realized capital gains (losses) within the Statements of Operations.

The Company disposed of other properties during 2024, 2023 and 2022 resulting in an insignificant amount of net realized gains, respectively. These gains and losses were included in net realized capital gains (losses) within the Statements of Operations.

 

46


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The carrying value of the Company’s real estate assets at December 31, 2024 and 2023 was as follows:

 

     2024      2023  
  

 

 

 

Home office properties

    $        39       $        41   
  

 

 

 
    $ 39       $ 41   
  

 

 

 

Accumulated depreciation on real estate at December 31, 2024 and 2023, was $33 and $29, respectively.

Other Invested Assets

The Company recorded impairments of $4, $0 and $4 throughout years 2024, 2023 and 2022, respectively. These impairments were primarily related to private equity funds. The impairments were taken because the decline in fair value of the funds were deemed to be other than temporary and a recovery in value from the remaining underlying investments in the funds were not anticipated. These write-downs are included in net realized capital gains (losses) within the Statements of Operations.

Tax Credits

At December 31, 2024, the Company had ownership interests in 45 LIHTC investments with a carrying value of $58. The remaining years of unexpired tax credits ranged from one to ten, and none of the properties were subject to regulatory review. The length of time remaining for holding periods ranged from one to fifteen years. The amount of contingent equity commitments expected to be paid during the years 2025 to 2029 is $2. Tax credit benefits recognized in 2024 were $18 and other tax benefits recognized in 2024 were $3. There were no impairment losses, write-downs or reclassifications during the year related to any of these credits.

At December 31, 2023, the Company had ownership interests in 52 LIHTC investments with a carrying value of $75. The remaining years of unexpired tax credits ranged from one to eleven, and the properties were not subject to regulatory review. The length of time remaining for holding periods ranged from one to fourteen years. The amount of contingent equity commitments expected to be paid during the years 2024 to 2029 is $2. Tax credits expenses recognized in 2023 were $49 and other tax benefits recognized in 2023 were $3. There were no impairment losses, write-downs or reclassifications during the year related to any of these credits.

 

47


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following tables provide the carrying value of transferable state tax credits gross of any related tax liabilities and total unused transferable tax credits by state and in total as of December 31, 2024 and 2023:

 

       December 31, 2024  
    

 

 

 

Description of State Transferable and Non-

      
transferable Tax Credits    State     Carrying Value     Unused Amount*  

 

 

Economic Redevelopment and Growth Tax Credits

     NJ       1       16   

Low-Income Housing Tax Credits

     CA             15   
    

 

 

 

Total

       $                   1        $                 31   
    

 

 

 
       December 31, 2023  
    

 

 

 

Description of State Transferable and Non-

      
transferable Tax Credits    State     Carrying Value     Unused Amount  

 

 

Economic Redevelopment and Growth Tax Credits

     NJ       13       19   

LIHTC

     CA             15   
    

 

 

 

Total

       $                  13        $                 34   
    

 

 

 

The Company did not have any non-transferable state tax credits.

The Company estimated the utilization of the remaining state transferable tax credits by projecting a future tax liability based on projected premium, tax rates and tax credits, and comparing the projected future tax liability to the availability of remaining state transferable tax credits. The Company had no impairment losses related to state transferable tax credits.

Derivatives

Amounts disclosed in this Derivatives section do not include derivatives utilized in the hedging of variable annuity guarantees in accordance with SSAP No. 108, Derivatives Hedging Variable Annuity Guarantees. Please see the subsequent section “Derivatives Hedging Variable Annuity Guarantees” for results associated with those derivatives.

 

48


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The Company has entered into collateral agreements with certain counterparties wherein the counterparty is required to post assets (cash or securities) on the Company’s behalf in an amount equal to the difference between the net positive fair value of the contracts and an agreed upon threshold based on the credit rating of the counterparty. If the net fair value of all contracts with this counterparty is negative, then the Company is required to post similar assets (cash or securities). Fair value of derivative contracts, aggregated at a counterparty level at December 31, 2024 and 2023 was as follows:

 

     2024      2023  
  

 

 

 

Fair value - positive

     $          484         $         322   

Fair value - negative

     (1,926)        (1,562)  

At December 31, 2024, 2023 and 2022, the Company has recorded unrealized gains (losses) of $132, ($433) and ($23), respectively, for the component of derivative instruments utilized for hedging purposes that did not qualify for hedge accounting. This has been recorded directly to unassigned surplus as an unrealized gain (loss). The Company did not recognize any unrealized gains or losses during 2024, 2023 and 2022 that represented the component of derivative instruments gain or loss that was excluded from the assessment of hedge effectiveness.

The maximum term over which the Company is hedging its exposure to the variability of future cash flows is approximately 19 years for forecasted hedge transactions. At December 31, 2024 and 2023, none of the Company’s cash flow hedges have been discontinued as it was probable that the original forecasted transactions would occur by the end of the originally specified time period documented at inception of the hedging relationship. As of December 31, 2024 and 2023, the Company has no accumulated deferred gains related to the termination of swaps that were hedging forecasted transactions. It is expected that these gains will be used as basis adjustments on future asset purchases expected to transpire throughout 2025.

Summary of realized gains (losses) by derivative type for the years ended December 31, 2024, 2023 and 2022:

 

     2024     2023     2022  
  

 

 

 

Options:

      

Calls

    $ 5     $ 13     $ —   

Puts

     1       (1     —   
  

 

 

 

Total options

    $ 6     $ 12     $ —   
  

 

 

 

Swaps:

      

Interest rate

    $ (6   $     $ (1)   

Total return

     (1,570     (1,092     1,054   
  

 

 

 

Total swaps

    $ (1,576   $ (1,092   $         1,053   
  

 

 

 

Futures - net positions

                442                  41       (376)   
  

 

 

 

Total realized gains (losses)

    $ (1,128   $ (1,039   $ 677   
  

 

 

 

 

49


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The average estimated fair value of derivatives held for other than hedging purposes is presented in the following table for the years ended December 31, 2024 and 2023:

 

     Asset(1)      Liability(1)  
  

 

 

    

 

 

 
     2024      2023      2024      2023  
  

 

 

    

 

 

 

Derivative component of RSATs

           

Credit default swaps

     $       63        $      43         $      (5)        $      (4)   

Interest rate swaps

     8        7                —   

 

(1) 

Asset and liability classification is based on the positive (asset) or negative

(liability) book/adjusted carrying value (BACV) of each derivative.

The estimated fair value of derivatives held for other than hedging purposes is presented in the following table for the years ended December 31, 2024 and 2023:

 

     Asset(1)      Liability(1)  
  

 

 

    

 

 

 
     2024      2023      2024      2023  
  

 

 

    

 

 

 

Derivative component of RSATs

           

Credit default swaps

      $       59        $       63         $       4        $       6   

Interest rate swaps

     9        8                —   
  

 

 

 

Total

      $       68        $       71         $       4        $       6   
  

 

 

 

 

(1) 

Asset and liability classification is based on the positive (asset) or negative

(liability) BACV of each derivative.

The Company did not have net realized gains (losses) on derivatives held for other than hedging purposes for the years ended December 31, 2024, 2023 and 2022.

As stated in Note 2, the Company replicates investment grade corporate bonds, sovereign debt, or commercial mortgage backed securities by writing credit default swaps. As a writer of credit swaps, the Company actively monitors the underlying asset, being careful to note any events (default or similar credit event) that would require the Company to perform on the credit swap. If such events would take place, a payment equal to the notional amount of the contract, less any potential recoveries as determined by the underlying agreement, will be made by the Company to the counterparty to the swap.

 

50


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following tables present the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at December 31, 2024 and 2023:

 

              2024  
       

 

 

 

Rating Agency Designation of

Referenced Credit Obligations (1)

  

NAIC

Designation

      

Estimated

Fair Value of

Credit

Default

Swaps

   

Maximum

Amount of

Future

Payments

under Credit

Default

Swaps

    

Weighted

Average

Years to

Maturity (2)

 

 

 

AAA/AA/A

     1            

Single name credit default swaps (3)

          $         12       $         978        2.2   

Credit default swaps referencing indices

                32        40.4   
       

 

 

    

 Subtotal

          12       1,010        3.4   
       

 

 

    

BBB

     2            

Single name credit default swaps (3)

          35       1,461        1.9   

Credit default swaps referencing indices

          16       992        2.6   
       

 

 

    

 Subtotal

          51       2,453        2.2   
       

 

 

    

BB

     3            

Single name credit default swaps (3)

                85        0.9   
       

 

 

    

 Subtotal

                85        0.9   
       

 

 

    

 Total

          $         63       $         3,548        2.5   
       

 

 

    

 

(1) 

The rating agency designations are based on availability and the blending of the applicable ratings among Moody’s Investors Service, S&P, and Fitch Ratings. If no rating is available from a rating agency, then an internally derived rating is used.

 

(2) 

The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts.

 

(3) 

Includes corporate, foreign government and state entities.

 

51


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

     2023  
       

 

 

 

Rating Agency Designation of

Referenced Credit Obligations (1)

  

NAIC

Designation

      

Estimated

Fair Value of

Credit

Default

Swaps

   

Maximum

Amount of

Future

Payments

under Credit

Default

Swaps

    

Weighted

Average

Years to

Maturity (2)

 

 

 

AAA/AA/A

     1            

Single name credit default swaps (3)

          $         16       $         973        3.0   

Credit default swaps referencing indices

                32        41.4   
       

 

 

    

 Subtotal

          16       1,005        4.2   
       

 

 

    

BBB

     2            

Single name credit default swaps (3)

          33       1,466        2.6   

Credit default swaps referencing indices

          19       1,402        2.3   
       

 

 

    

 Subtotal

          52       2,868        2.5   
       

 

 

    

BB

     3            

Single name credit default swaps (3)

          1       90        1.8   
       

 

 

    

 Subtotal

          1       90        1.8   
       

 

 

    

 Total

          $         69       $         3,963        2.9   
       

 

 

    

 

(1) 

The rating agency designations are based on availability and the blending of the applicable ratings among Moody’s Investors Service, S&P, and Fitch Ratings. If no rating is available from a rating agency, then an internally derived rating is used.

 

(2) 

The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts.

 

(3) 

Includes corporate, foreign government and state entities.

The Company may enter into credit default swaps to purchase credit protection on certain of the referenced credit obligations in the table above. At December 31, 2024 and 2023, there were not any potential future recoveries available to offset the $3,548 and $3,963, respectively, from the table above.

 

52


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

At December 31, 2024 and 2023, the Company’s outstanding derivative instruments, shown in notional or contract amounts and fair value, are summarized as follows:

 

     Contract or Notional Amount*      Fair Value  
  

 

 

 
     2024      2023      2024      2023  
  

 

 

 

Derivative assets:

           

Credit default swaps

   $ 3,343      $ 3,316      $ 62      $ 63  

Currency swaps

     905        699        110        83  

Equity futures

                   2        5  

Equity swaps

     3,770        448        120        9  

Interest rate swaps

     1,367        45        29        7  

Options

     314        2,102        63        100  

Derivative liabilities:

           

Credit default swaps

     715        1,183        (2      20  

Currency swaps

     135        213        1        10  

Equity futures

                   13        9  

Equity swaps

     2,494        5,690        37        435  

Interest rate swaps

       6,719          6,379            1,101            988  

Options

     (597      (2,641      5        44  

 

  *Futures

are presented in contract format. Swaps and options are presented in notional format.

Derivatives Hedging Variable Annuity Guarantees

The hedged obligation consists of guaranteed benefits on variable annuity contracts and resembles a long dated put option where claim payment is made whenever account value is less than a guaranteed amount, adjusted for applicable fees. Changes in interest rates impact the present value of future product cash flows (discount rate) as well as the value of investments comprising the account value to be assessed against the guarantee. Under this VM-21 compliant clearly defined hedging strategy, interest rate risk may be hedged by a duration matched portfolio of interest sensitive derivatives such as treasury bond forwards, treasury futures, interest rate swaps, interest rate swaptions or treasury future options. With approval of the IID, the guaranteed benefits included are variable annuity contracts with Guaranteed Minimum Death Benefit and Guaranteed Minimum Income Benefit riders, excluding contracts assumed via reinsurance. Total return on the designated portfolio of derivatives remains highly effective in covering the interest rate risk (rho) of the hedged obligation. Hedge effectiveness is measured in accordance with the requirements outlined under SSAP No. 108 and entails assessment of the total return on the designated portfolio of derivatives against changes in the fair value of the hedged obligation due to interest rate movements on a cumulative basis.

 

53


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Scheduled amortization for SSAP No. 108 derivatives as of December 31, 2024 is as follows:

 

 Amortization Year    Deferred Assets      Deferred Liabilities  

 

 

2025

    $ (133    $ 32   

2026

     (133      32   

2027

     (133      32   

2028

     (133      32   

2029

     (133      32   

2030

     (133      32   

2031

     (133      32   

2032

     (113      32   

2033

     (82      26   

2034

     (50      11   
  

 

 

 

Total

    $ (1,176    $ 293   
  

 

 

 

The following table is a reconciliation of the total deferred balance (net of tax) of SSAP No. 108 derivatives:

 

     Total Deferred
Balance
 
  

 

 

 

1. Balance at January 1, 2023

    $ 380  

2. Amortization

     44  

3. Deferred Recognition

     (109
  

 

 

 

4. Balance at December 31, 2023 [1-(2+3)]

    $ 445  

5. Amortization

     63  

6. Deferred Recognition

     (501
  

 

 

 

7. Balance at December 31, 2024 [4-(5+6)]

    $ 883  
  

 

 

 

The following tables provide information regarding SSAP No. 108 hedging instruments:

 

     2024      2023  
  

 

 

 

Amortized cost

     $  (3)       

$  —

 

Fair value

     (672      855  

 

54


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

 

December 31, 2024

 

     Net Investment
Income
    Realized Gain
(Loss)
    Unrealized
Gain (Loss)
     Total*  
  

 

 

 

Derivative performance

   $  (1)     $  409     $  (1,524)      $  (1,116)  

SSAP No. 108 Adjustments  

         

Portion of the derivative performance attributed to natural offset

     15       (148     615        482  

Deferred

     (14     (261     909        634  

 

*Totals

shown are pre-tax

 

December 31, 2023

        
     Net Investment
Income
    Realized Gain
(Loss)
    Unrealized
Gain (Loss)
    Total*  
  

 

 

 

Derivative performance

   $ (13   $ (1,725   $ 1,606     $ (132

SSAP No. 108 Adjustments  

        

Portion of the derivative performance attributed to natural offset

     5       717       (722      

Deferred

     8       1,008       (884     132  

 

*Totals

shown are pre-tax

 

     Year Ended December 31  
     2024      2023  
  

 

 

 

Prior year fair value of hedged item

    $ 630      $ 539   

Current year fair value of hedged item

     1,663        630   
  

 

 

 

Change in fair value attributable to interest rates

    $ 1,033      $ 91   
  

 

 

 

Portion of the fair value change attributed to the hedged risk

    $ 1,032      $ 91   
  

 

 

 

 

55


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Restricted Assets

The following tables show the pledged or restricted assets as of December 31, 2024 and 2023, respectively:

 

     Gross (Admitted & Nonadmitted) Restricted  
     2024  
  

 

 

 
Restricted Asset Category    Total General
Account (G/A)
    

G/A Supporting
Separate
Account (S/A)

Activity

     Total S/A
Restricted
Assets
     S/A Assets
Supporting
G/A Activity
     Total  

 

 
Collateral held under security lending agreements     $ 1,667      $      $      $      $ 1,667   

Subject to repurchase agreements

     306                             306   

Subject to dollar repurchase agreements

                                 —   

FHLB capital stock

     77                             77   

On deposit with states

     57                             57   
Pledged as collateral to FHLB (including assets backing funding agreements)      3,956                             3,956   
Pledged as collateral not captured in other categories      3,085                             3,085   

Other restricted assets

     6,586                             6,586   
  

 

 

 

Total restricted assets

    $ 15,734      $      $      $      $   15,734   
  

 

 

 

 

     Gross (Admitted & Nonadmitted) Restricted      Percentage  
  

 

 

 
Restricted Asset Category    Total From
Prior Year
(2023)
     Increase/
(Decrease)
    Total
Nonadmitted
Restricted
    

Total

Admitted

Restricted

    

Gross
(Admitted &
Nonadmitted)
Restricted

to Total
Assets

    Admitted
Restricted to
Total
Admitted
Assets
 

 

 
Collateral held under security lending agreements     $ 2,292      $ (625   $      $ 1,667        0.92     0.93%  

Subject to repurchase agreements

     157        149              306        0.17       0.17   
Subject to dollar repurchase agreements      11        (11                   0.00       0.00   

FHLB capital stock

     88        (11            77        0.04       0.04   

On deposit with states

     38        19              57        0.03       0.03   
Pledged as collateral to FHLB (including assets backing funding agreements)      3,937        19              3,956        2.19       2.21   
Pledged as collateral not captured in other categories      2,230        855              3,085        1.71       1.72   

Other restricted assets

     7,337        (751            6,586        3.64       3.68   
  

 

 

 

Total restricted assets

    $ 16,090      $ (356   $      $ 15,734        8.70     8.78%  
  

 

 

 

The amounts reported as other restricted assets in the table above represent assets held in trust related to reinsurance.

 

56


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following tables show the pledged or restricted assets in other categories as of December 31, 2024 and 2023, respectively:

 

            Gross Restricted (Admitted & Nonadmitted)         
                   2024                
  

 

 

 
Description of Assets    Total General
Account (G/A)
     G/A
Supporting
Separate
Account (S/A)
Activity
     Total S/A
Restricted
Assets
     S/A Assets
Supporting G/A
Activity
     Total  

Derivatives

    $ 3,052      $ —       $ —       $ —       $ 3,052   

Secured funding agreements

     1        —         —         —         1   

AMBAC

     32        —         —         —         32   
  

 

 

 

Total

    $ 3,085      $ —       $ —       $ —       $ 3,085   
  

 

 

 

 

     Gross (Admitted & Nonadmitted) Restricted      Percentage  
Description of Assets    Total From
Prior Year
(2023)
     Increase/
(Decrease)
     Total
Nonadmitted
Restricted
     Total
Admitted
Restricted
    

Gross
(Admitted &
Nonadmitted)
Restricted

to Total
Assets

    Admitted
Restricted
to Total
Admitted
Assets
 

Derivatives

    $ 2,229      $ 823      $ —       $ 3,052        1.69     1.70%  

Secured funding agreements

     1        —         —         1        0.00       0.00   

AMBAC

     —         32        —         32        0.02     0.02%  
  

 

 

 

Total

    $ 2,230      $ 855      $ —       $ 3,085        1.71     1.72%  
  

 

 

 

 

57


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following tables show the collateral received and reflected as assets within the financial statements as of December 31, 2024 and 2023:

 

2024  
Collateral Assets    Carrying Value      Fair Value      % of CV to
Total Assets
(Admitted and
Nonadmitted)
    % of CV to
Total Admitted
Assets
 

Cash

    $ 94      $ 94        0.12      0.12 %  

Securities lending collateral assets

     1,667        1,667        2.16       2.20    

Other

     2        2              —    
  

 

 

 

Total collateral assets

    $ 1,763      $ 1,763        2.28      2.32 %  
  

 

 

 

 

     Amount      % of Liability
to Total
Liabilities
 
  

 

 

 

Recognized obligation to return collateral asset

   $ 1,763        2.53%   

 

2023  
Collateral Assets    Carrying Value      Fair Value      % of CV to
Total Assets
(Admitted
and
Nonadmitted)
    % of CV to
Total
Admitted
Assets
 

Cash

    $ 787      $ 787        1.01  %      1.04 %  

Securities lending collateral assets

     2,292        2,292        2.95       3.02    

Other

     30        30        0.04       0.04    
  

 

 

 

Total collateral assets

    $ 3,109      $ 3,109        4.00  %      4.10 %  
  

 

 

 

 

     Amount      % of Liability
to Total
Liabilities
 
  

 

 

 

Recognized obligation to return collateral asset

   $ 3,110        4.44 %   

 

58


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Net Investment Income

Detail of net investment income is presented below:

 

     Year Ended December 31  
     2024     2023      2022  
  

 

 

   

 

 

    

 

 

 

Income:

       

Bonds

    $ 2,178     $ 2,170      $ 2,029   

Preferred stocks

     4       5        3   

Common stocks

     481       392        343   

Mortgage loans on real estate

     384       383        415   

Real estate

     9       9        13   

Policy loans

     112       110        108   

Cash, cash equivalents and short-term investments

     107       95        26   

Derivatives

     421       403        273   

Other invested assets

     174       200        180   
  

 

 

 

Gross investment income

     3,870       3,767        3,390   

Less: investment expenses

     178       198        178   
  

 

 

 

Net investment income before amortization of IMR

     3,692       3,569        3,212   

Amortization of IMR

     (9     28        85   
  

 

 

 

Net investment income

    $   3,683     $   3,597      $   3,297   
  

 

 

 

At December 31, 2024 and 2023, the Company excluded investment income due and accrued of $5 and $10, respectively. There were no amounts excluded for mortgage loans or real estate for either 2024 and 2023.

The gross, nonadmitted and admitted amounts for interest income due and accrued are presented in the following table:

 

     Year Ended December 31  
     2024      2023  
  

 

 

    

 

 

 

Gross

   $ 658      $ 636  

Nonadmitted

   $ 5      $ 10  

Admitted

   $ 653      $ 626  

At December 31, 2024 and 2023, the Company had cumulative amounts for paid-in-kind interest of $1 and $1, respectively, included in the principle balance.

 

59


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Realized Capital Gains (Losses)

Net realized capital gains (losses) on investments, including OTTI, are summarized below:

 

     Realized  
     Year Ended December 31  
     2024     2023     2022  
  

 

 

 

Bonds

   $ (97 )   $ (669   $ (614

Preferred stocks

     1              

Common stocks

     2       (8     56  

Mortgage loans on real estate

     (21     (1      

Real estate

                 1  

Cash, cash equivalents and short-term investments

           (1      

Derivatives

     (1,471     (2,043     (4,555

Variable annuity reserve hedge offset

           (44     229  

Other invested assets

     45       27       169  
                        

Net realized capital gains (losses), before taxes

     (1,541     (2,739     (4,714

Federal income tax effect

           106       45  

Transfer from (to) IMR

     102       634       458  
                        

Net realized capital gains (losses) on investments

   $  (1,439   $  (1,999)     $  (4,211)  
                        
                        

Unrealized Capital Gains (Losses)

The changes in net unrealized capital gains and losses on investments, including the changes in net unrealized foreign capital gains and losses were as follows:

 

     Change in Unrealized  
     Year Ended December 31  
     2024     2023     2022  
                        

Bonds

   $ 42     $ 10     $ 197  

Preferred stocks

           1       (11

Common stocks

     (6     1       (40

Affiliated entities

     (384     443       (278

Mortgage loans on real estate

     (15            

Derivatives

     268       600       1,142  

Other invested assets

     (104     327       51  
                        

Change in unrealized capital gains (losses), before taxes

     (199     1,382       1,061  

Taxes on unrealized capital gains (losses)

     13       (98     (47
                        

Change in unrealized capital gains (losses), net of tax*

   $   (186   $   1,284     $   1,014  
                        
                        

*2024 variance to Statement of Changes in Capital and Surplus related to an immaterial prior period correction included within the “Other changes - net” line.

 

60


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Admitted Disallowed IMR

The Company has admitted net negative (disallowed) IMR in accordance with the following criteria:

 

  A.

Fixed income investments generating IMR losses comply with the reporting entity’s documented investment or liability management policies.

  B.

IMR losses for fixed income related derivatives are all in accordance with prudent and documented risk management procedures, in accordance with a reporting entity’s derivative use plans and reflect symmetry with historical treatment in which unrealized derivative gains were reversed to IMR and amortized in lieu of being recognized as realized gains upon derivative termination.

  C.

Any deviation to (a) was either because of a temporary and transitory timing issue or related to a specific event, such as a reinsurance transaction, that mechanically made the cause of IMR losses not reflective of reinvestment activities.

  D.

Asset sales that were generating admitted negative IMR were not compelled by liquidity pressures (e.g., to fund significant cash outflows including, but not limited to excess withdrawals and collateral calls).

The aggregate net negative (disallowed) IMR allocation is presented in the following table for the years ended December 31, 2024 and 2023:

 

     Total     

General

Account

    

Insulated

Separate

Account

    

Non-Insulated

Separate

Account

 
                                   

2024 

   $    100      $    100      $    —      $    —  

2023 

     7        7                

The allocation of the admitted negative (disallowed) IMR is presented in the following table for the years ended December 31, 2024 and 2023:

 

     Total      General
Account
     Insulated
Separate
Account
     Non-Insulated
Separate
Account
 
                                   

2024 

   $    100      $    100      $    —      $    —  

2023 

     7        7                

 

61


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The calculation of adjusted capital and surplus with consideration of the negative (disallowed) IMR is presented in the following table for the years ended December 31, 2024 and 2023:

 

     2024      2023  
                 
Prior period, as of September 30, the most recent statement filed with the IID, general account capital and surplus    $ 5,912      $ 5,731  

From prior period SAP financials:

                         

Net positive goodwill (admitted)

             

EDP equipment & operating system software (admitted)

             

Net DTAs (admitted)

     771        748  

Net negative (disallowed) IMR (admitted)

     81         
                 

Adjusted capital and surplus

   $ 5,060      $ 4,983  
                 
                 

The admitted net negative (disallowed) IMR represents 1.98% and 0.14% of adjusted capital and surplus for 2024 and 2023.

The Company did not have gains/losses associated with derivatives sold allocated to IMR during 2024 and 2023.

6.  Policy and Contract Attributes

Insurance Liabilities

Policy reserves, deposit-type contracts and policy claims at December 31, 2024 and 2023 were as follows:

 

     Year Ended December 31  
     2024      2023  
                 
Life insurance reserves    $ 31,616      $ 32,027  

Annuity reserves and supplementary contracts with life contingencies

     14,816        13,368  

Accident and health reserves (including long term care)

     7,252        7,101  
                 

Total policy reserves

   $ 53,684      $ 52,496  
                       

Deposit-type contracts

     693        717  

Policy claims

     1,048        983  
                 

Total policy reserves, deposit-type contracts and claim liabilities

   $ 55,425      $ 54,196  
                 
                 

 

62


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Life Insurance Reserves

The aggregate policy reserves for life insurance policies are based upon the 1941, 1958, 1980, 2001 and 2017 Commissioner’s Standard Ordinary Mortality Tables, the 1912, 1941 and 1961 Standard Industrial Mortality Tables, the 1960 Commissioner’s Standard Group Mortality Table, the American Men, Actuaries and American Experience Mortality Tables. The reserves are calculated using interest rates ranging from 0.75 to 6.50 percent and are computed principally on the Net Level Premium Valuation and the Commissioner’s Reserve Valuation Method. Reserves for universal life policies are based on account balances adjusted for the Commissioner’s Reserve Valuation Method or Actuarial Guideline XXXVIII. Term insurance issued after July 1, 2017 and Indexed Universal life Insurance issued after January 1, 2020 follow Valuation Manual section 20 (VM-20) reserve requirements.

Tabular interest, tabular less actual reserves released and tabular cost have been determined by formula.

The Company waives deduction of deferred fractional premiums upon death of the insured and returns any portion of the final premium for periods beyond the date of death.

Additional premiums are charged or additional mortality charges are assessed for policies issued on substandard lives according to underwriting classification. Generally, reserves are determined by computing the regular reserve for the plan at the true age and holding, in addition, the unearned portion of the extra premium charge for the year. Effective July 1, 2017, for substandard term insurance policies, per VM-20 requirements, the substandard rating is applied to the reserve mortality. For certain flexible premium and fixed premium universal life insurance products, reserves are calculated utilizing the Commissioner’s Reserve Valuation Method for universal life policies and recognizing any substandard ratings.

As of December 31, 2024 and 2023, the Company had insurance in force aggregating $31,676 and $33,976, respectively, in which the gross premiums are less than the net premiums required by the valuation standards established by the IID. The Company established policy reserves of $1,478 and $1,463 to cover these deficiencies as of December 31, 2024 and 2023, respectively.

Participating life insurance policies were issued by the Company in prior years which entitle policyholders to a share in the earnings of the participating policies, provided that a dividend distribution, which is determined annually based on mortality and persistency experience of the participating policies, is authorized by the Company. Participating insurance constituted less than 0.05% of ordinary life insurance in force at December 31, 2024 and 2023.

Annuity Reserves and Supplementary Contracts Involving Life Contingencies

Deferred annuity reserves are calculated according to the Commissioner’s Annuity Reserve Valuation Method including excess interest reserves to cover situations where the future interest guarantees plus the decrease in surrender charges are in excess of the maximum valuation rates of interest.

 

63


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Reserves for immediate annuities and supplementary contracts with and without life contingencies are equal to the present value of future payments assuming interest rates ranging from 1.25 to 11.75 percent and mortality rates, where appropriate, from a variety of tables.

Annuity reserves also include GICs and funding agreements classified as life-type contracts as defined in SSAP No. 50, Classifications of Insurance or Managed Care Contracts. These liabilities have annuitization options at guaranteed rates and consist of floating interest rate and fixed interest rate contracts. The contract reserves are carried at the greater of the account balance or the value as determined for an annuity with cash settlement option, on a change in fund basis, according to the Commissioner’s Annuity Reserve Valuation Method.

For variable annuities with guaranteed living benefits and variable annuities with minimum guaranteed death benefits the Company complies with VM-21. VM-21 specifies statutory reserve requirements for variable annuity contracts with benefit guarantees (VACARVM) and without benefit guarantees and related products. The VM-21 reserve calculation covers all variable annuity products. Examples of covered guaranteed benefits include guaranteed minimum accumulation benefits, return of premium death benefits, guaranteed minimum income benefits, guaranteed minimum withdrawal benefits and guaranteed payout annuity floors. The aggregate reserve for contracts falling within the scope of VM-21 is equal to the stochastic reserves plus the additional standard projection amount. During 2022, the Company established a voluntary reserve in addition to the reserve required under VM-21 to help manage volatility associated with unhedged base contract cashflows. The VA voluntary reserve totaled $0 and $505 as of December 31, 2024 and 2023, respectively.

Both the stochastic reserves and the standard projection are determined as the conditional tail expectation (CTE)-70 of the scenario reserves. To determine the CTE-70 values, the Company used 1,000 of the pre-packaged scenarios developed by the American Academy of Actuaries (AAA) and Society of Actuaries. The stochastic reserves uses prudent estimate assumptions based on Company experience, while the standard projection uses the assumptions prescribed in VM-21 for determining the additional standard projection amount.

Accident and Health Liabilities

Accident and health policy reserves are equal to the greater of the gross unearned premiums or any required mid-terminal reserves plus net unearned premiums and the present value of amounts not yet due on both reported and unreported claims.

At December 31, 2024 and 2023, the Company had no premium deficiency reserve related to accident and health policies.

The Company’s primary method utilized to estimate premium adjustments for contracts subject to redetermination is to review experience periodically and to adjust premiums for differences between the experience anticipated at the time of redetermination and that underlying the original premiums. The Company has not limited its degree of discretion contractually; however, in some states it has agreed not to raise premiums in order to recoup past losses. The Company forgoes premium changes on existing policies at its option if the administrative cost and other business issues associated with the change outweigh the direct financial impact of the change. Also, the Company has extra-contractually guaranteed the current premium scale for certain policies.

 

64


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

For indeterminate premium products, a full schedule of current and anticipated premium rates is developed at the point of issue. Premium rate adjustments are considered when anticipated future experience foretells deviations from the original profit standards. The source of deviation (mortality, persistency, expense, etc.) is an important consideration in the re-rating decision as well as the potential effect of a rate change on the future experience of the existing block of business.

The Company does not write any accident and health business that is subject to the Affordable Care Act risk sharing provisions.

Liabilities for losses and loss/claim adjustment expenses for accident and health contracts are estimated using statistical claim development models to develop best estimates of liabilities for medical expense business and using tabular reserves employing mortality/morbidity tables and discount rates meeting minimum regulatory requirements for other business. Unpaid claims include amounts for losses and related adjustment expenses and are estimates of the ultimate net costs of all losses, reported and unreported. These estimates are subject to the impact of future changes in claim severity, frequency and other factors.

Activity in the liability for unpaid claims and related processing costs net of reinsurance is summarized as follows:

 

    Unpaid Claims
Liability Beginning
of Year
     Claims
Incurred
   

Claims

Paid

    

Unpaid Claims

Liability End of

Year

 
                                 

Year ended December 31, 2024

         

2024

  $      $ 1,233     $ 470      $ 763  

2023 and prior

    2,000        54       641        1,413  
                                 
    2,000      $    1,287     $    1,111        2,176  
    

 

 

    

Active life reserve

  $ 5,508           $ 5,476  
 

 

 

         

 

 

 

Total accident and health reserves

  $   7,508           $   7,652  
 

 

 

         

 

 

 
    Unpaid Claims
Liability Beginning
of Year
     Claims
Incurred
   

Claims

Paid

    

Unpaid Claims

Liability End of

Year

 
                                 

Year ended December 31, 2023

         

2023

  $      $ 1,148     $ 435      $ 713  

2022 and prior

    1,991        (82     622        1,287  
                                 
    1,991      $ 1,066     $ 1,057        2,000  
                     
                     

Active life reserve

  $ 5,476           $ 5,508  
 

 

 

         

 

 

 

Total accident and health reserves

  $      7,467           $      7,508  
 

 

 

         

 

 

 

The change in the Company’s unpaid claims reserve was $54 and ($82) for the years ended December 31, 2024 and 2023, respectively, for health claims that were incurred prior to those Balance Sheets date. The change in 2024 was due to worse than expected experience primarily due to higher medical claims. The change in 2023 was due to better than expected experience primarily due to reduced medical claims and accidental deaths.

 

65


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Activity in the liability for unpaid claims adjustment expense is summarized as follows:

 

    

Liability

Beginning of
Year

     Incurred      Paid     

Liability

End of
Year

 
  

 

 

 

Year ended December 31, 2024

                                                   

2024

    $      $ 38      $ 22      $ 16   

2023 and prior

     42        (12      2        28   
  

 

 

 
    $ 42      $ 26      $ 24      $ 44   
  

 

 

 

Year ended December 31, 2023

           

2023

    $      $ 38      $ 23      $ 15   

2022 and prior

     42        (12      3        27   
  

 

 

 
    $ 42      $ 26      $ 26      $ 42   
  

 

 

 

There was no significant change in the claim adjustment expense provision for insured events of prior years during 2024.

Premium and Annuity Considerations Deferred and Uncollected

Reserves on the Company’s traditional life insurance products are computed using mean and interpolated or mid-terminal reserving methodologies. The mean methodologies result in the establishment of assets for the amount of the net valuation premiums that are anticipated to be received between the policy’s paid-through date to the policy’s next anniversary date. The interpolated methodologies do not require the establishment of such assets, however, it is required to hold unearned premium liabilities. At December 31, 2024 and 2023, the gross premiums and net of loading amounts related to these assets (which are reported as premiums deferred and uncollected), are as follows:

 

     2024             2023  
  

 

 

 
     Gross      Net of Loading             Gross      Net of Loading   
  

 

 

 

Life and annuity:

                                                      

Ordinary first-year business

    $ 1      $         $ 1      $ —   

Ordinary renewal business

     24        19           122        96   

Group life direct business

     10        6           14        10   
  

 

 

 
    $ 35      $ 25         $ 137      $ 106   
  

 

 

 

Deposit-type Contracts

Tabular interest on funds not involving life contingencies has been determined primarily by formula.

The Company issues certain funding agreements with well-defined class-based annuity purchase rates defining either specific or maximum purchase rate guarantees. However, these funding agreements are not issued to or for the benefit of an identifiable individual or group of individuals. These contracts are classified as deposit-type contracts in accordance with SSAP No. 50.

 

66


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Included in the liability for deposit-type contracts at December 31, 2024 and 2023 are approximately $10 and $11, respectively, of funding agreements issued to special purpose entities in conjunction with non-recourse medium-term note programs. Under these programs, the proceeds from each note series issuance are used to purchase a funding agreement from an affiliated Company which secures that particular series of notes. The funding agreement is reinsured to the Company. In general, the payment terms of the note series match the payment terms of the funding agreement that secures that series. Claims for the principal and interest for these funding agreements are afforded equal priority as other policyholders. As of December 31, 2024 and 2023, there were no contractual maturities.

Withdrawal Characteristics of Annuity Reserves and Deposit Funds

A portion of the Company’s policy reserves and other policyholders’ funds (including separate account liabilities) relates to liabilities established on a variety of the Company’s annuity, deposit fund and life products. There may be certain restrictions placed upon the amount of funds that can be withdrawn without penalty. The amount of reserves on annuity and deposit fund products, by withdrawal characteristics, is summarized as follows:

 

    

December 31

2024

 
  

 

 

 
Individual Annuities:    General
Account
     Separate
Account
with
Guarantees
     Separate
Account
Non-
Guaranteed
     Total      Percent  
  

 

 

 

Subject to discretionary withdrawal
with adjustment:

              

With fair value adjustment

   $ 286      $ 2,208      $      $ 2,494        4 %  

At book value less surrender charge of 5% or more

     880                      880        1    

At fair value

     6               58,835        58,841        84    
  

 

 

 

Total with adjustment or at fair value

     1,172        2,208        58,835        62,215        89    

At book value without adjustment
(minimal or no charge or adjustment)

     6,024                      6,024        9    

Not subject to discretionary withdrawal provision

     1,043               569        1,612        2    
  

 

 

 

Total individual annuity reserves

     8,239        2,208        59,404        69,851        100 %  
              

 

 

 

Less reinsurance ceded

     5,303                      5,303     
  

 

 

    

Net individual annuities reserves

   $ 2,936      $ 2,208      $ 59,404      $ 64,548     
  

 

 

    

Amount included in book value less surrender charge above that will move to book value without adjustment in the year after the statement date

   $ 160      $      $      $ 160     
  

 

 

    

 

67


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

    

December 31

2024

 
  

 

 

 
Group Annuities:    General
Account
     Separate
Account
with
Guarantees
     Separate
Account
Non-
Guaranteed
     Total      Percent  
  

 

 

 

Subject to discretionary withdrawal with adjustment:

              

With fair value adjustment

   $ 4,842      $ 10      $      $ 4,852        12 %  

At book value less surrender charge of 5% or more

     17                      17        —    

At fair value

                   29,901        29,901        70    
  

 

 

 

Total with adjustment or at fair value

     4,859        10        29,901        34,770        82    

At book value without adjustment (minimal or no charge or adjustment)

     2,299                      2,299        5    

Not subject to discretionary withdrawal provision

     5,516               68        5,584        13    
  

 

 

 

Total group annuities reserves

     12,674        10        29,969        42,653        100 %  
              

 

 

 

Less reinsurance ceded

     794                      794     
  

 

 

    

Net group annuities reserves

   $ 11,880      $ 10      $ 29,969      $ 41,859     
  

 

 

    
    

December 31

2024

 
  

 

 

 
Deposit-type contracts (no life contingencies):    General
Account
     Separate
Account
with
Guarantees
     Separate
Account
Non-
Guaranteed
     Total      Percent  
  

 

 

 

Subject to discretionary withdrawal with adjustment:

              

With fair value adjustment

   $      $      $      $        0 %  
  

 

 

 

Total with adjustment or at fair value

                                 0    

At book value without adjustment (minimal or no charge or adjustment)

     207                      207        26    

Not subject to discretionary withdrawal provision

     492        87        18        597        74    
  

 

 

 

Total deposit-type contracts

     699        87        18        804        100 %  
              

 

 

 

Less reinsurance ceded

     6                      6     
  

 

 

    

Net deposit-type contracts

   $ 693      $ 87      $ 18      $ 798     
  

 

 

    

 

68


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Reconciliation to the Annual Statement:    Amount  
  

 

 

 

Life & Accident & Health Annual Statement:

  

Exhibit 5, Annuities section, total (net)

   $ 13,876  

Exhibit 5, Supp contracts with life contingencies section, total (net)

     940  

Exhibit 7, Deposit-type contracts, net balance at the end of the current year after reinsurance

     693  
  

 

 

 

Subtotal

     15,509  

Separate Accounts Annual Statement:

  

Exhibit 3, Annuities section, total

     90,994  

Exhibit 3, Supp contracts with life contingencies section, total

     597  

Other contract deposit funds

     105  
  

 

 

 

Subtotal

     91,696  
  

 

 

 

Combined total

   $ 107,205  
  

 

 

 

 

    

December 31

2023

 
  

 

 

 
Individual Annuities:    General
Account
     Separate
Account
with
Guarantees
     Separate
Account
Non-
Guaranteed
     Total      Percent  
  

 

 

 

Subject to discretionary withdrawal with adjustment:

              

With fair value adjustment

   $ 316      $  714      $      $ 1,030        2 %  

At book value less surrender charge of 5% or more

     919                      919        1    

At fair value

     6               58,435        58,441        84    
  

 

 

 

Total with adjustment or at fair value

     1,241        714        58,435        60,390        87    

At book value without adjustment (minimal or no charge or adjustment)

     6,679                      6,679        10    

Not subject to discretionary withdrawal provision

     1,723               488        2,211        3    
  

 

 

 

Total individual annuity reserves

     9,643        714        58,923        69,280        100 %  
              

 

 

 

Less reinsurance ceded

     6,228                      6,228     
  

 

 

    

Net individual annuity reserves

   $ 3,415      $ 714      $ 58,923      $  63,052     

Amount included in book value less surrender charge above that will move to book value without adjustment in the year after the statement date

   $ 235      $      $      $ 235     
  

 

 

    

 

69


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

    

December 31

2023

 
  

 

 

 
Group Annuities:    General
Account
     Separate
Account
with
Guarantees
     Separate
Account
Non-
Guaranteed
     Total      Percent  
  

 

 

 

Subject to discretionary withdrawal with adjustment:

              

With fair value adjustment

   $ 4,104      $ 13      $      $  4,117        11 %  

At book value less surrender charge of 5% or more

     20                      20        —    

At fair value

                   28,070        28,070        72    
  

 

 

 

Total with adjustment or at fair value

     4,124        13        28,070        32,207        83    

At book value without adjustment (minimal or no charge or adjustment)

     4,848                      4,848        12    

Not subject to discretionary withdrawal provision

     1,846               64        1,910        5    
  

 

 

 

Total group annuity reserves

     10,818        13        28,134        38,965        100 %  
              

 

 

 

Less reinsurance ceded

     864                      864     
  

 

 

    

Net group annuity reserves

   $ 9,954      $ 13      $ 28,134      $ 38,101     
  

 

 

    
    

December 31

2023

 
  

 

 

 
Deposit-type contracts (no life contingencies):    General
Account
     Separate
Account
with
Guarantees
     Separate
Account
Non-
Guaranteed
     Total      Percent  
  

 

 

 

Subject to discretionary withdrawal with adjustment:

              

With fair value adjustment

   $      $      $      $        0 %  
  

 

 

 

Total with adjustment or at fair value

                                 0   

At book value without adjustment (minimal or no charge or adjustment)

     220                      220        27   

Not subject to discretionary withdrawal provision

     504        68        19        591        73   
  

 

 

 

Total deposit-type contracts

     724        68        19        811        100 %  
              

 

 

 

Less reinsurance ceded

     8                      8     
  

 

 

    

Net deposit-type contracts

   $ 716      $ 68      $ 19      $ 803     
  

 

 

    

 

70


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Reconciliation to the Annual Statement:    Amount  

Life & Accident & Health Annual Statement:

  

Exhibit 5, Annuities section, total (net)

   $ 12,438  

Exhibit 5, Supp contracts with life contingencies section, total (net)

     931  

Exhibit 7, Deposit-type contracts, net balance at the end of the

current year after reinsurance

     716  
  

 

 

 

Subtotal

     14,085  

Separate Accounts Annual Statement:

  

Exhibit 3, Annuities section, total

     87,269  

Exhibit 3, Supp contracts with life contingencies section, total

     515  

Other contract deposit funds

     87  
  

 

 

 

Subtotal

     87,871  
  

 

 

 

Combined total

   $ 101,956  
  

 

 

 

The amount of reserves on life products, by withdrawal characteristics, is summarized as follows:

 

    

December 31

2024

 
  

 

 

 
     General Account  
  

 

 

 
     Account Value      Cash Value      Reserve  
  

 

 

 

Subject to discretionary withdrawal, surrender values, or policy loans:

        

Term policies with cash value

   $      $ 296      $ 430  

Universal life

     12,610        12,060        14,295  

Universal life with secondary guarantees

     5,479        5,360        12,528  

Indexed universal life with secondary guarantees

     9,239        6,513        7,572  

Other permanent cash value life insurance

     2        4,797        7,142  

Variable universal life

     709        708        1,025  

Not subject to discretionary withdrawal or no cash values

        

Term policies without cash value

                   8,007  

Accidental death benefits

                   46  

Disability - active lives

                   36  

Disability - disabled lives

                   159  

Miscellaneous reserves

                   1,578  
  

 

 

 

Total (gross)

     28,039        29,734        52,818  

Reinsurance ceded

     5,048        4,909        21,202  
  

 

 

 

Total (net)

   $   22,991      $   24,825      $   31,616  
  

 

 

 

 

71


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

    

December 31

2024

 
  

 

 

 
     Separate Account - Guaranteed  
  

 

 

 
     Account Value      Cash Value      Reserve  
  

 

 

 

Subject to discretionary withdrawal, surrender values, or policy loans:

        

Variable universal life

   $    690      $    690      $    690  
  

 

 

 

Total (net)

   $ 690      $ 690      $ 690  
  

 

 

 
    

December 31

2024

 
  

 

 

 
     Separate Account - Nonguaranteed  
  

 

 

 
     Account Value      Cash Value      Reserve  
  

 

 

 

Subject to discretionary withdrawal, surrender values, or policy loans:

        

Variable universal life

   $ 8,906      $ 8,904      $ 10,198  
  

 

 

 

Total (net)

   $ 8,906      $ 8,904      $ 10,198  
  

 

 

 

 

Reconciliation to the Annual Statement:    Amount  

Life & Accident & Health Annual Statement:

  

Exhibit 5, Life insurance section, total (net)

   $    30,839  

Exhibit 5, Accidental death benefits section total (net)

     25  

Exhibit 5, Disability - active lives section, total (net)

     17  

Exhibit 5, Disability - disabled lives section, total (net)

     136  

Exhibit 5, Miscellaneous reserves section, total (net)

     599  
  

 

 

 

Subtotal

     31,616  

Separate Accounts Annual Statement:

  

Exhibit 3, Life insurance section, total

     10,888  
  

 

 

 

Subtotal

     10,888  
  

 

 

 

Combined total

   $ 42,504  
  

 

 

 

 

72


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

    

December 31

2023

 
  

 

 

 
     General Account  
  

 

 

 
     Account Value      Cash Value      Reserve  
  

 

 

 

Subject to discretionary withdrawal, surrender values, or policy loans:

        

Term policies with cash value

   $      $ 319      $ 462   

Universal life

     13,359        12,668        15,050   

Universal life with secondary guarantees

     5,929        5,819        12,845   

Indexed universal life with secondary guarantees

     7,773        5,385        6,486   

Other permanent cash value life insurance

     2        4,755        7,192   

Variable universal life

     681        680        1,002   

Not subject to discretionary withdrawal or no cash values Term policies without cash value

                   8,024   

Accidental death benefits

                   48   

Disability - active lives

                   37   

Disability - disabled lives

                   160   

Miscellaneous reserves

                   1,604   
  

 

 

 

Total (gross)

     27,744        29,626        52,910   

Reinsurance ceded

     5,065        4,914        21,387   
  

 

 

 

Total (net)

   $    22,679      $    24,712      $    31,523   
  

 

 

 

 

    

December 31

2023

 
  

 

 

 
     Separate Account - Guaranteed  
  

 

 

 
     Account Value      Cash Value      Reserve  
  

 

 

 

Subject to discretionary withdrawal, surrender values, or policy loans:

        

Variable universal life

   $ 684      $ 684      $ 684   
  

 

 

 

Total (net)

   $ 684      $ 684      $ 684   
  

 

 

 
    

December 31

2023

 
  

 

 

 
     Separate Account - Nonguaranteed  
  

 

 

 
     Account Value      Cash Value      Reserve  
  

 

 

 

Subject to discretionary withdrawal, surrender values, or policy loans:

        

Variable universal life

   $ 8,003      $ 8,000      $ 9,208   
  

 

 

 

Total (net)

   $     8,003      $     8,000      $     9,208   
  

 

 

 

 

73


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

 

Reconciliation to the Annual Statement:    Amount

Life & Accident & Health Annual Statement:

  

Exhibit 5, Life insurance section, total (net)

    $ 30,751   

Exhibit 5, Accidental death benefits section total (net)

     25  

Exhibit 5, Disability – active lives section, total (net)

     16  

Exhibit 5, Disability – disabled lives section, total (net)

     137  

Exhibit 5, Miscellaneous reserves section, total (net)

     594  
  

 

 

 

Subtotal

     31,523  

Separate Accounts Annual Statement:

  

Exhibit 3, Life insurance section, total

     9,892  
  

 

 

 

Subtotal

     9,892  
  

 

 

 

Combined total

    $    41,415  
  

 

 

 

Separate Accounts

Information regarding the separate accounts of the Company as of and for the years ended December 31, 2024, 2023 and 2022 is as follows:

 

     Guaranteed
Indexed
     Nonindexed
Guarantee
Less Than or
Equal to 4%
     Nonindexed
Guarantee
Greater
Than 4%
     Nonguaranteed
Separate
Accounts
     Total  
  

 

 

 

Premiums, deposits and other considerations for the year ended December 31, 2024

    $      $      $ 10      $ 7,999      $ 8,009   
  

 

 

 

Reserves for separate accounts as of December 31, 2024 with assets at:

              

Fair value

    $      $ 100      $      $ 99,374      $ 99,474   

Amortized cost

     2,419        690                      3,109   
  

 

 

 

Total as of December 31, 2024

    $ 2,419      $ 790      $      $ 99,374      $ 102,583   
  

 

 

 

Reserves for separate accounts by withdrawal characteristics as of
December 31, 2024:

              

With fair value adjustment

    $ 2,419      $ 14      $      $      $ 2,433   

At fair value

                          98,719        98,719   

At book value without fair value adjustment and with current surrender charge of less than 5%

            690                      690   
  

 

 

 

Subtotal

     2,419        704               98,719        101,842   

Not subject to discretionary withdrawal

            86               655        741   
  

 

 

 

Total separate account reserve liabilities at December 31, 2024

    $   2,419      $   790      $   —      $   99,374      $   102,583   
  

 

 

 

 

74


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

 

     Guaranteed
Indexed
     Nonindexed
Guarantee
Less Than or
Equal to 4%
     Nonindexed
Guarantee
Greater
Than 4%
     Nonguaranteed
Separate
Accounts
     Total  
  

 

 

 

Premiums, deposits and other considerations for the year ended December 31, 2023

    $      $      $ 10      $ 6,075      $ 6,085   
  

 

 

 

Reserves for separate accounts as of December 31, 2023 with assets at:

              

Fair value

    $ 710      $ 85      $      $ 96,283      $ 97,078   

Amortized cost

            684                      684   
  

 

 

 

Total as of December 31, 2023

    $ 710      $ 769      $      $ 96,283      $ 97,762   
  

 

 

 

Reserves for separate accounts by withdrawal characteristics as of
December 31, 2023:

              

With fair value adjustment

    $ 710      $ 18      $      $      $ 728   

At fair value

                          95,712        95,712   

At book value without fair value adjustment and with current surrender charge of less than 5%

            684                      684   
  

 

 

 

Subtotal

     710        702               95,712        97,124   

Not subject to discretionary withdrawal

            68               571        639   
  

 

 

 

Total separate account reserve liabilities at December 31, 2023

    $ 710      $ 770      $      $ 96,283      $   97,763   
  

 

 

 

 

75


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

 

     Guaranteed
Indexed
    

Nonindexed
Guarantee

Less Than or
Equal to 4%

     Nonindexed
Guarantee
Greater
Than 4%
     Nonguaranteed
Separate
Accounts
     Total  
  

 

 

 

Premiums, deposits and other considerations for the year ended December 31, 2022

    $      $      $ 10      $ 7,663      $ 7,673   
  

 

 

 

Reserves for separate accounts as of December 31, 2022 with assets at:

              

Fair value

    $ 132      $ 75      $      $ 89,360      $ 89,567   

Amortized cost

            677                      677   
  

 

 

 

Total as of December 31, 2022

    $ 132      $ 752      $      $ 89,360      $ 90,244   
  

 

 

 

Reserves for separate accounts by withdrawal characteristics as of December 31, 2022:

              

With fair value adjustment

    $ 132      $ 22      $      $      $ 154   

At fair value

                          88,880        88,880   

At book value without fair value adjustment and with current surrender charge of less than 5%

            677                      677   
  

 

 

 

Subtotal

     132        699               88,880        89,711   

Not subject to discretionary withdrawal

            53               479        532   
  

 

 

 

Total separate account reserve liabilities at December 31, 2022

    $ 132      $ 752      $      $ 89,359      $   90,243   
  

 

 

 

A reconciliation of the amounts transferred to and from the Company’s separate accounts is presented below:

 

     Year Ended December 31  
     2024      2023      2022  
  

 

 

 

Transfer as reported in the Summary of Operations of the separate accounts statement:

        

Transfers to separate accounts

    $   8,100      $   6,167      $   7,757  

Transfers from separate accounts

     (14,225      (10,944      (18,692
  

 

 

 

Net transfers from separate accounts

     (6,125      (4,777      (10,935

Miscellaneous reconciling adjustments

     (38      (24      (17
  

 

 

 

Net transfers as reported in the Summary of Operations of the life, accident and health annual statement

    $ (6,163    $ (4,801    $ (10,952
  

 

 

 

 

76


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The legal insulation of separate account assets prevents such assets from being generally available to satisfy claims resulting from the general account. At December 31, 2024 and 2023, the Company’s separate account statement included legally insulated assets of $101,121 and $98,092, respectively. The assets legally insulated from general account claims at December 31, 2024 and 2023 are attributed to the following products:

 

     2024      2023  
  

 

 

 

Group annuities

    $ 28,064       $ 25,977   

Variable annuities

     61,483        61,550   

Fixed universal life

     727        725   

Variable universal life

     9,365        8,484   

Variable life

     1,367        1,277   

Modified separate accounts

     114        78   

Registered market value annuity product - SPL

     1        1   
  

 

 

 

Total separate account assets

    $   101,121       $   98,092   
  

 

 

 

At December 31, 2024 and 2023, the Company held separate account assets not legally insulated from the general account in the amount of $2,373 and $760, respectively.

Some separate account liabilities are guaranteed by the general account. In accordance with the guarantees provided, if the investment proceeds are insufficient to cover the rate of return guaranteed for the product, the policyholder proceeds will be remitted by the general account. To compensate the general account for the risk taken, the separate account paid risk charges of $551, $570, $584, $579 and $565, to the general account in 2024, 2023, 2022, 2021 and 2020, respectively. During the years ended December 31, 2024, 2023, 2022, 2021 and 2020, the general account of the Company had paid $41, $63, $56, $45 and $75, respectively, toward separate account guarantees.

At December 31, 2024 and 2023, the Company reported guaranteed separate account assets at amortized cost in the amount of $2,784 and $710, respectively, based upon the prescribed practice granted by the State of Iowa as described in Note 2. These assets had a fair value of $2,699 and $649 at December 31, 2024 and 2023, respectively, which would have resulted in an unrealized gain/(loss) of ($86) and ($61), respectively, had these assets been reported at fair value.

The Company does not participate in securities lending transactions within the separate account.

 

7.

Reinsurance

Certain premiums and benefits are assumed from and ceded to other insurance companies under various reinsurance agreements. The Company coinsures up to 100% of select policies or reinsures portions of the risk on certain insurance policies which exceed its established limits, thereby providing a greater diversification of risk and minimizing exposure on larger risks. The Company remains contingently liable with respect to any insurance ceded, and this would become an actual liability in the event that the assuming insurance company became unable to meet its obligation under the reinsurance treaty.

 

77


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

Premiums and annuity considerations include the following reinsurance amounts:

 

     Year Ended December 31  
     2024      2023      2022  
  

 

 

 

Direct premiums

    $ 19,907      $ 16,262      $ 15,957   

Reinsurance assumed - non affiliates

     886        866        1,017   

Reinsurance assumed - affiliates

     (15      (10      5,366   

Reinsurance ceded - non affiliates

     (1,503      (2,547      (1,819)  

Reinsurance ceded - affiliates

     (591      (5,055      (708)  
  

 

 

 

Net premiums earned

    $   18,684      $   9,516      $   19,813   
  

 

 

 

The Company received reinsurance recoveries in the amount of $3,294, $3,327 and $3,764 during 2024, 2023 and 2022, respectively. At December 31, 2024 and 2023, estimated amounts recoverable from reinsurers that have been deducted from policy and contract claim reserves totaled $858 and $853, respectively. The aggregate reserves for policies and contracts were reduced for reserve credits for reinsurance ceded at December 31, 2024 and 2023 of $37,420 and $39,004, respectively, of which $16,315 and $16,868 were ceded to affiliates, respectively.

During 2024, 2023 and 2022, amortization of deferred gains associated with previously transacted reinsurance agreements was released into income in the amount of $387 ($255 after tax), $684 ($429 after tax) and $869 ($574 after tax), respectively.

Effective December 31, 2023, the Company entered into a reinsurance agreement whereby the Company ceded fixed deferred annuity business to an affiliated entity, Transamerica Bermuda Re, Ltd. (TBRe). The Company paid a ceding commission of $138 in addition to reinsurance premiums of $4,394 in the form of a funds withheld payable and ceded $4,394 of statutory reserves. The transaction resulted in a pre-tax loss of $138, which has been included in the Statements of Operations.

Effective July 1, 2023, the Company ceded universal life with secondary guarantee (SGUL) insurance business to an unaffiliated entity. The Company paid considerations of $1,057 in assets and cash, ceded $1,436 of reserves and $555 of policy loans. After a $199 realized loss, the transaction resulted in a pre-tax gain of $179.

Effective July 1, 2023, the Company recaptured a specific list of policies from an affiliate, LIICA Re II. As a result, the Company received $5 in cash and $114 in policyholder reserves. The transaction resulted in a pre-tax loss of $109 which has been included in the Statements of Operations.

Effective July 1, 2023, the Company recaptured a specific list of policies from an affiliate, Transamerica Pacific Re. As a result, the Company received $12 in cash and $33 in policyholder reserves. The transaction resulted in a pre-tax loss of $21 which has been included in the Statements of Operations.

On October 31, 2022, the Company executed an affiliated coinsurance arrangement, effective July 1, 2022, under which it assumes the remaining in force universal life business from TLB net of third-party reinsurance. The Company received consideration of $4,974 in the form of cash and

 

78


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

invested assets and assumed $5,543 in policy and contract reserves along with $6 in policy loans. After establishing a $432 IMR deferral related to the asset transfers, this transaction resulted in a pre-tax loss of $131 which was included in the Summary of Operations. This transaction is secured by a comfort trust equal to 100% of the Company’s U.S. statutory reserves.

Effective April 1, 2022, LIICA Re II, an affiliate, executed a recapture of a specific list of policies to the Company. The Company received consideration of $186 in the form of cash and recaptured policyholder reserves of $838. The transaction resulted in a pre-tax loss of $652 which was included in the Statements of Operations.

In January 2018, Scottish Re Group announced a sale and restructuring plan and commenced Chapter 11 (reorganization) procedures for some of its subsidiaries. In December 2018, the Delaware Department of Insurance began oversight procedures of Scottish Re (U.S.), Inc. (SRUS), with whom the Company is a counterparty for some of its reinsurance activities. SRUS was ordered into receivership for the purposes of rehabilitation on March 6, 2019. On May 16, 2019, the IID suspended the certificate of authority for SRUS but later clarified that reserve credit could be taken on reinsurance agreements entered into prior to the revocation date if a recovery analysis could be illustrated. The Company concluded it could not support a favorable recovery analysis and therefore did not take statutory reserve credit in its year-end 2022 financial statements. A loss contingency allowance was also established for the doubtful recoveries of billed and unbilled claims in the amount of $125 as of December 31, 2022. On July 19, 2023, a Motion for Liquidation of SRUS was granted, resulting in any related treaty coverage ending on September 30, 2023. The Company does not believe sufficient information is available at this time to be able to reasonably estimate any potential loss and has therefore reversed the previously established loss contingency allowance and reported gross receivables on billed and unbilled claims of $158 and $260 as of December 31, 2024, respectively, all of which have been fully non- admitted.

 

79


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

8.

Income Taxes

The net deferred income tax asset at December 31, 2024 and 2023 and the change from the prior year are comprised of the following components:

 

     December 31, 2024  
     Ordinary      Capital      Total  
  

 

 

 

Gross Deferred Tax Assets

    $   2,399      $   209      $   2,608  

Statutory Valuation Allowance Adjustment

                    
  

 

 

 

Adjusted Gross Deferred Tax Assets

     2,399        209        2,608  

Deferred Tax Assets Nonadmitted

     1,037               1,037  
  

 

 

 

Subtotal (Net Deferred Tax Assets)

     1,362        209        1,571  

Deferred Tax Liabilities

     527        271        798  
  

 

 

 

Net Admitted Deferred Tax Assets (Liabilities)

    $ 835      $ (62    $ 773  
  

 

 

 
     December 31, 2023  
     Ordinary      Capital      Total  
  

 

 

 

Gross Deferred Tax Assets

    $    2,492      $   202      $   2,694  

Statutory Valuation Allowance Adjustment

                    
  

 

 

 

Adjusted Gross Deferred Tax Assets

     2,492        202        2,694  

Deferred Tax Assets Nonadmitted

     1,023               1,023  
  

 

 

 

Subtotal (Net Deferred Tax Assets)

     1,469        202        1,671  

Deferred Tax Liabilities

     628        271        899  
  

 

 

 

Net Admitted Deferred Tax Assets (Liabilities)

    $ 841      $ (69    $ 772  
  

 

 

 
     Ordinary     

Change

Capital

     Total  
  

 

 

 

Gross Deferred Tax Assets

    $ (93    $    7      $ (86

Statutory Valuation Allowance Adjustment

                    
  

 

 

 

Adjusted Gross Deferred Tax Assets

     (93      7        (86

Deferred Tax Assets Nonadmitted

        14                  14  
  

 

 

 

Subtotal (Net Deferred Tax Assets)

     (107      7        (100

Deferred Tax Liabilities

     (101             (101
  

 

 

 

Net Admitted Deferred Tax Assets (Liabilities)

    $ (6    $ 7      $ 1  
  

 

 

 

The Company recognized all of its deferred tax liabilities as of December 31, 2024 and 2023.

 

80


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The main components of deferred income tax amounts are as follows:

 

     Year Ended December 31         
     2024      2023      Change  
                          

Deferred Tax Assets:

        

Ordinary

        

Policyholder reserves

   $ 515      $ 777      $ (262

Investments

     226        237        (11

Deferred acquisition costs

     721        699        22  

Policyholder dividends accrual

     6        5        1  

Compensation and benefits accrual

     43        42        1  

Receivables - nonadmitted

     136        143        (7

Net operating loss carry-forward

     331        171        160  

Tax credit carry-forward

     340        319        21  

Other

     81        99        (18
                          

Subtotal

     2,399        2,492        (93

Statutory valuation allowance adjustment

                    

Nonadmitted

     1,037        1,023        14  
                          

Admitted ordinary deferred tax assets

     1,362        1,469        (107

Capital

        

Investments

     187        202        (15

Net capital loss carry-forward

     22               22  

Other

                    
                          

Subtotal

     209        202        7  

Statutory valuation allowance adjustment

                    

Nonadmitted

                    
                          

Admitted capital deferred tax assets

     209        202        7  
                          

Admitted deferred tax assets

   $   1,571      $   1,671      $   (100
                          
                          
     Year Ended December 31         
     2024      2023      Change  
                          

Deferred Tax Liabilities:

        

Ordinary

        

Investments

   $ 444      $ 463      $ (19

Policyholder reserves

     68        146        (78

Other

     15        19        (4
                          

Subtotal

     527        628        (101

Capital

        

Investments

     271        271         

Other

                    
                          

Subtotal

     271        271         
                          

Deferred tax liabilities

     798        899        (101
                          

Net admitted deferred tax assets (liabilities)

   $ 773      $ 772      $ 1  
                          
                          

 

81


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

As a result of the 2017 Tax Cuts and Jobs Act, the Company’s tax reserve deductible temporary difference decreased by ($396). This change results in an offsetting $396 deductible temporary difference that will be amortized into taxable income evenly over the eight years subsequent to 2017. The remaining amortizable balance is included within the Policyholder Reserves line items above.

The Inflation Reduction Act was enacted during the third quarter 2022 reporting period on August 16, 2022. The act included a provision which subjects high earning corporate taxpayers to the Corporate Alternative Minimum Tax (CAMT). The Company is part of an affiliated group that determined it was a nonapplicable reporting entity for CAMT in 2024 or 2023. The Company has not included any impacts of the CAMT in the financial statements as of December 31, 2024.

As discussed in Note 2, for the years ended December 31, 2024 and 2023, the Company admits deferred income tax assets pursuant to SSAP No. 101. The amount of admitted adjusted gross deferred income tax assets under each component of SSAP No. 101 is as follows:

 

     December 31, 2024  
     Ordinary      Capital      Total  
                          

Admission Calculation Components SSAP No. 101

        

2(a)  Federal Income Taxes Paid in Prior Years Recoverable Through Loss Carrybacks

   $      $      $  

2(b)  Adjusted Gross Deferred Tax Assets Expected to be Realized (Excluding The Amount of Deferred Tax Assets From 2(a) above) After Application of the Threshold Limitation (the Lesser of 2(b)1 and 2(b)2 below)

     749        24        773  

1. Adjusted Gross Deferred Tax Assets Expected to be Realized Following the Balance Sheet Date

     1,008        32        1,040  

2. Adjusted Gross Deferred Tax Assets Allowed per Limitation Threshold

     XXX        XXX        773  

2(c)  Adjusted Gross Deferred Tax Assets (Excluding The Amount Of Deferred Tax Assets From 2(a) and 2(b) above) Offset by Gross Deferred Tax Liabilities

     613        185        798  
                          

2(d)  Deferred Tax Assets Admitted as the result of application of SSAP No. 101, Total (2(a) + 2(b) + 2(c))

   $   1,362      $   209      $   1,571  
                          
                          

 

82


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

 

     December 31, 2023  
     Ordinary     Capital     Total  
                        

Admission Calculation Components SSAP No. 101

      

2(a)  Federal Income Taxes Paid in Prior Years Recoverable Through Loss Carrybacks

   $     $     $  

2(b)  Adjusted Gross Deferred Tax Assets Expected to be Realized (Excluding The Amount of Deferred Tax Assets From 2(a) above) After Application of the Threshold Limitation (the Lesser of 2(b)1 and 2(b)2 below)

     736       36       772  

1. Adjusted Gross Deferred Tax Assets Expected to be Realized Following the Balance Sheet Date

     986       48       1,034  

2. Adjusted Gross Deferred Tax Assets Allowed per Limitation Threshold

     XXX       XXX       772  

2(c)  Adjusted Gross Deferred Tax Assets (Excluding The Amount Of Deferred Tax Assets From 2(a) and 2(b) above) Offset by Gross Deferred Tax Liabilities

     733       166       899  
                        

2(d)  Deferred Tax Assets Admitted as the result of application of SSAP No. 101, Total (2(a) + 2(b) + 2(c))

   $   1,469     $   202     $   1,671  
                        
                        
           Change        
     Ordinary     Capital     Total  
                        

Admission Calculation Components SSAP No. 101

      

2(a)  Federal Income Taxes Paid in Prior Years Recoverable Through Loss Carrybacks

   $     $     $  

2(b)  Adjusted Gross Deferred Tax Assets Expected to be Realized (Excluding The Amount of Deferred Tax Assets From 2(a) above) After Application of the Threshold Limitation (the Lesser of 2(b)1 and 2(b)2 below)

     13       (12     1  

1. Adjusted Gross Deferred Tax Assets Expected to be Realized Following the Balance Sheet Date

     22       (16     6  

2. Adjusted Gross Deferred Tax Assets Allowed per Limitation Threshold

     XXX       XXX       1  

2(c)  Adjusted Gross Deferred Tax Assets (Excluding The Amount Of Deferred Tax Assets From 2(a) and 2(b) above) Offset by Gross Deferred Tax Liabilities

     (120     19       (101
                        

2(d)  Deferred Tax Assets Admitted as the result of application of SSAP No. 101, Total (2(a) + 2(b) + 2(c))

   $ (107   $ 7     $  (100
                        
                        

 

83


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

     December 31  
     2024     2023  
  

 

 

 

Ratio Percentage Used To Determine Recovery

    
  

 

 

 

Period and Threshold Limitation Amount

     744     722%  
  

 

 

 

 

Amount of Adjusted Capital and Surplus Used To

    

Determine Recovery Period and Threshold

    
  

 

 

 

Limitation in 2(b)2 Above

    $   5,152     $   5,146   
  

 

 

 

The impact of tax planning strategies at December 31, 2024 and 2023 was as follows:

 

     December 31, 2024  
     Ordinary     Capital     Total  
     Percent     Percent     Percent  
        

Impact of Tax Planning Strategies:

      

(% of Total Adjusted Gross DTAs)

     0     0     0
        
        

(% of Total Net Admitted Adjusted Gross DTAs)

     2     0     2
        
        
     December 31, 2023  
     Ordinary     Capital     Total  
     Percent     Percent     Percent  
        

Impact of Tax Planning Strategies:

      

(% of Total Adjusted Gross DTAs)

     0     0     0
        
        

(% of Total Net Admitted Adjusted Gross DTAs)

     13     0     13
        
        

The Company’s tax planning strategies include the use of reinsurance-related tax planning strategies.

Current income taxes incurred consist of the following major components:

 

     Year Ended December 31         
     2024      2023      Change  
        

Current Income Tax

        

Federal

   $ (59)      $ 75       $  (134)  
        

Subtotal

     (59)        75         (134)  

Federal income tax on net capital gains

     —         (106)        106   
        

Federal and foreign income taxes incurred

   $    (59)      $    (31)      $    (28)  
        
        

 

84


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

 

     Year Ended December 31        
     2023     2022     Change  
        

Current Income Tax

      

Federal

   $ 75     $ (80   $ 155  
        

Subtotal

     75       (80     155  

Federal income tax on net capital gains

     (106     (45     (61
        

Federal and foreign income taxes incurred

   $    (31   $    (125   $    94  
        
        

The Company’s current income tax incurred and change in deferred income tax differs from the amount obtained by applying the federal statutory rate to income before tax as follows:

 

     Year Ended December 31  
     2024     2023     2022  
        

Current income taxes incurred

   $ (59   $ (31   $ (125

Change in deferred income taxes

     5       (149     (702

(without tax on unrealized gains and losses)

      
        

Total income tax reported

   $ (54   $ (180   $ (827
        
        

Income before taxes

   $ 751     $ 312     $ (3,207

Federal statutory tax rate

     21.00     21.00     21.00
        

Expected income tax expense (benefit) at statutory rate

   $ 158     $ 66     $ (673

Increase (decrease) in actual tax reported resulting from:

      

Pre-tax income of disregarded subsidiaries

   $ 11     $ 6     $ 24  

Dividends received deduction

     (128     (127     (98

Tax-exempt income

     (4     (4     (3

Nondeductible expenses

     5       3       5  

Pre-tax items reported net of tax

     (52     (97     (201

Tax credits

     (27     (21     (29

Prior period tax return adjustment

     24       (18     22  

Change in statutory valuation allowance

                 (11

Deferred tax change on other items in surplus

     (38     13       140  

Other

     (3     (1     (3
        

Total income tax reported

   $   (54   $   (180   $   (827
        
        

The Company’s federal income tax return is consolidated with other includible affiliated companies. Please see the listing of companies in Appendix A. The method of allocation between the companies is subject to a written tax allocation agreement. Under the terms of the tax allocation agreement, allocations are based on separate income tax return calculations. The Company is entitled to recoup federal income taxes paid in the event the future losses and credits reduce the greater of the Company’s separately computed income tax liability or the consolidated group’s income tax liability in the year generated. The Company is also entitled to recoup federal income taxes paid in the event the losses and credits reduce the greater of the Company’s

 

85


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

separately computed income tax liability or the consolidated group’s income tax liability in any carryback or carryforward year when so applied. Intercompany income tax balances are settled within thirty days of payment to or filing with the Internal Revenue Service (IRS). A tax return has not been filed for 2024.

The amounts, origination dates and expiration dates of operating loss and tax credit carryforwards available for tax purposes:

 

Description    Amount      Origination Dates    Expiration Dates

 

Operating Loss

   $ 637      12/31/2022    N/A

Operating Loss

     940      12/31/2024    N/A
  

 

 

       

Operating Loss Total

   $ 1,577        
  

 

 

       

Foreign Tax Credit

   $ 5      12/31/2021    12/31/2031

Foreign Tax Credit

     13      12/31/2022    12/31/2032

Foreign Tax Credit

     13      12/31/2024    12/31/2034
  

 

 

       

Foreign Tax Credit Total

   $ 31        
  

 

 

       

General Business Credit

   $ 20      12/31/2009    12/31/2029

General Business Credit

     26      12/31/2011    12/31/2031

General Business Credit

     32      12/31/2012    12/31/2032

General Business Credit

     40      12/31/2013    12/31/2033

General Business Credit

     25      12/31/2014    12/31/2034

General Business Credit

     56      12/31/2015    12/31/2035

General Business Credit

     7      12/31/2016    12/31/2036

General Business Credit

     9      12/31/2017    12/31/2037

General Business Credit

     6      12/31/2018    12/31/2038

General Business Credit

     8      12/31/2019    12/31/2039

General Business Credit

     14      12/31/2020    12/31/2040

General Business Credit

     17      12/31/2021    12/31/2041

General Business Credit

     19      12/31/2022    12/31/2042

General Business Credit

     16      12/31/2023    12/31/2043

General Business Credit

     14      12/31/2024    12/31/2044
  

 

 

       

General Business Credit Total

   $   309        
  

 

 

       

The Company has net capital loss carryforwards which expire as follows: 2029, $103.

The Company did not have any income tax expense available for recoupment in the event of future losses for December 31, 2024, 2023 and 2022.

The Company did not have any deposits admitted under Internal Revenue Code Section 6603 for December 31, 2024 and 2023.

 

86


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The total amount of the unrecognized tax benefits that if recognized would affect the effective income tax rate:

 

     Unrecognized
Tax Benefits
 

Balance at January 1, 2023

    $ 18  

Tax positions taken during prior period

      
  

 

 

 

Balance at December 31, 2023

    $ 18  

Tax positions taken during prior period

      
  

 

 

 

Balance at December 31, 2024

    $ 18  
  

 

 

 

The Company is not subject to the repatriation transition tax.

The Company did not have any alternative minimum tax credit carryovers as of December 31, 2024 and 2023.

The Company classifies interest and penalties related to income taxes as income tax expense. The amount of interest and penalties accrued on the Balance Sheets as income taxes includes the following:

 

     Interest      Penalties     

Total payable

(receivable)

 
  

 

 

 

Balance at January 1, 2022

    $ 1      $      $ 1    

Interest expense (benefit)

     1               1    

Cash received (paid)

                   —    
  

 

 

 

Balance at December 31, 2022

    $ 2      $      $ 2    

Interest expense (benefit)

     2               2    

Cash received (paid)

     (1             (1)   
  

 

 

 

Balance at December 31, 2023

    $ 3      $      $ 3    

Interest expense (benefit)

     1               1    

Cash received (paid)

     (2             (2)   
  

 

 

 

Balance at December 31, 2024

    $    2      $      $ 2    
  

 

 

 

The IRS completed its examination for 2009 through 2013 for which is currently at appeals with a refund pending Joint Committee on Taxation approval. The IRS opened an exam for the 2014 through 2018 amended tax returns. Federal income tax returns filed in 2019, 2021 through 2023 remain open, subject to potential future examination. The statute of limitations for all other tax years have been closed. The Company believes there are adequate defenses against, or sufficient provisions established related to any open or contested tax positions.

 

9.

Capital and Surplus

The Company has authorized 1,000,000 common stock shares at $10 per share par value, of which 676,190 shares were issued and outstanding at December 31, 2024 and 2023.

The Company is subject to limitations, imposed by the State of Iowa, on the payment of dividends and other distributions to its parent companies. Total distributions, within the preceding 12-month period, are generally limited to the greater of (a) 10 percent of surplus as regards to policyholders as of the preceding December 31, or (b) statutory net gain from operations for the

 

87


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

preceding year. Dividend payments are further limited by the availability of unassigned funds at the time of the payment. Iowa law grants the Commissioner authority to approve, or in some cases non-disapprove, distributions requested in excess of these limitations.

On December 21, 2022, the Company purchased 250,000 shares of TBRe to become its sole shareholder. TBRe received additional capital contributions from the Company of $490 and $10 on December 29, 2023 and December 21, 2022, respectively.

On December 19, 2024, the Company paid an ordinary common stock dividend of $150 to CGC.

On June 20, 2024, the Company paid an ordinary common stock dividend of $265 to CGC.

On December 14, 2023, the Company paid an ordinary common stock dividend of $300 to CGC.

On November 9, 2023, the Company received a return of capital of $267 from TLB.

On September 29, 2023, the Company paid an ordinary common stock dividend of $200 to CGC.

On June 21, 2023, the Company paid an ordinary common stock dividend of $300 to CGC.

On March 30, 2023, the Company paid an ordinary common stock dividend of $58 to CGC.

On December 15, 2022, the Company paid an ordinary common stock dividend of $275 to CGC.

On June 30, 2022, the Company received a return of contributed surplus of $165 from LIICA Re II.

On June 21, 2022, the Company paid an ordinary common stock dividend of $150 to CGC.

On March 29 2022, the Company received a capital contribution of $100 from CGC.

Life and health insurance companies are subject to certain RBC requirements as specified by the NAIC. Under those requirements, the amount of capital and surplus maintained by a life or health insurance company is to be determined based on various risk factors. At December 31, 2024 and 2023, the Company met the minimum RBC requirements.

The Company held special surplus funds in the amount of $883 and $445, as of December 31, 2024 and 2023, respectively, for derivatives hedging variable annuity guarantees as required under SSAP No. 108.

The Company held special surplus funds in the amount of $160 and $71, as of December 31, 2024 and 2023, respectively, for admitted disallowed IMR as required under INT 23-01.

 

88


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

10.

Securities Lending

The Company participates in an agent-managed securities lending program in which the Company primarily loans out US Treasuries and other bonds. The Company receives collateral equal to 102% of the fair value of the loaned government or other domestic securities as of the transaction date. If the fair value of the collateral is at any time less than 102% of the fair value of the loaned securities, the counterparty is mandated to deliver additional collateral, the fair value of which, together with the collateral already held in connection with the lending transaction, is at least equal to 102% of the fair value of the loaned government or other domestic securities. In the event the Company loans a foreign security and the denomination of the currency of the collateral is other than the denomination of the currency of the loaned foreign security, the Company receives and maintains collateral equal to 105% of the fair value of the loaned security.

At December 31, 2024 and 2023, respectively, securities with a fair value of $1,394 and $1,967 were on loan under securities lending agreements. At December 31, 2024 and 2023, the collateral the Company received from securities lending activities was in the form of cash and on open terms. This cash collateral is reinvested and is not available for general corporate purposes. The reinvested cash collateral has a fair value of $1,667 and $2,292 at December 31, 2024 and 2023, respectively.

The contractual maturities of the securities lending collateral positions are as follows:

 

    Fair Value  
    2024      2023  
 

 

 

 

Open

  $    1,667      $   2,292  
 

 

 

 

Total collateral received

  $ 1,667      $ 2,292  
 

 

 

 

The Company receives primarily cash collateral in an amount in excess of the fair value of the securities lent. The Company reinvests the cash collateral into higher yielding securities than the securities which the Company has lent to other entities under the arrangement.

The maturity dates of the reinvested securities lending collateral are as follows:

 

         2024           2023  
   

Amortized

Cost

    

Fair

Value

     Amortized
Cost
    

Fair

Value

 
 

 

 

    

 

 

 

Open

  $ 130      $ 130      $ 105      $ 105  

30 days or less

    658        658        938        938  

31 to 60 days

    263        263        562        562  

61 to 90 days

    318        318        84        84  

91 to 120 days

    105        105        296        296  

121 to 180 days

    150        150        307        307  

181 to 365 days

    43        43                
       

Total

    1,667        1,667        2,292        2,292  

Securities received

                          
       

Total collateral reinvested

  $    1,667      $   1,667      $   2,292      $   2,292  
       
       

 

89


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

For securities lending, the Company’s source of cash used to return the cash collateral is dependent upon the liquidity of the current market conditions. Under current conditions, the Company has securities with a par value of $1,671 (fair value of $1,667) that are currently tradable securities that could be sold and used to pay for the $1,667 in collateral calls that could come due under a worst-case scenario.

 

11.

Retirement and Compensation Plans

 

Defined

Contribution Plans

The Company’s employees participate in a contributory defined contribution plan sponsored by Transamerica Corporation (TA Corp) which is qualified under Section 401(k) of the Internal Revenue Code. Generally, employees of the Company who customarily work at least 20 hours per week and meet the other eligibility requirements are participants of the plan. Participants may elect to contribute up to 100% of eligible earnings, subject to government or other plan restrictions for certain key employees. The Company will contribute an amount up to four percent of the participant’s eligible earnings per the plan’s matching formula. Participants may direct all of their contributions and plan balances to be invested in a variety of investment options. The plan is subject to the reporting and disclosure requirements of the Employee Retirement Income Security Act of 1974 (ERISA), as amended. Benefits expense of $21, $18 and $18 was allocated to the Company for the years ended December 31, 2024, 2023 and 2022, respectively.

Defined Benefit Plans

The Company’s employees participate in a qualified defined benefit pension plan sponsored by TA Corp. Generally, employees of the Company who customarily work at least 20 hours per week and complete six months of continuous service and meet the other eligibility requirements are participants of the plan. The Company has no legal obligation for the plan. The benefits are based on the employee’s eligible compensation. The plan provides benefits based on a cash balance formula. The plan is subject to the reporting and disclosure requirements of the ERISA.

TA Corp sponsors supplemental retirement plans to provide the Company’s senior management with benefits in excess of normal pension benefits. The Company has no legal obligation for the plan. The plans are noncontributory. The benefits are based on the employee’s eligible compensation. The plans provide benefits based on a cash balance formula. The plans are unfunded and nonqualified under the IRS Code.

The Company recognizes pension expense equal to its allocation from TA Corp. The pension expense related to both the qualified defined pension plan and the supplemental retirement plans is allocated among the participating companies based on International Accounting Standards 19 (IAS 19), Accounting for Employee Benefits, and based upon actuarial participant benefit calculations, which is within the guidelines of SSAP No. 102, Pensions. Pension expenses were $13, $11 and $17 for the years ended December 31, 2024, 2023 and 2022, respectively.

In addition to pension benefits, TA Corp sponsors unfunded plans that provide health care and life insurance benefits to retired Company employees meeting certain eligibility requirements. The Company has no legal obligation for the plans. Portions of the medical and dental plans are contributory. The expenses of the postretirement plans are allocated among the participating

 

90


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

companies based on IAS 19 and based upon actuarial participant benefit calculations, which is within the guidelines of SSAP No. 92, Postretirement Benefits Other Than Pensions. The Company’s allocation of postretirement expenses was $2, $4 and $4 for the years ended December 31, 2024, 2023 and 2022, respectively.

Other Plans

TA Corp has established deferred compensation plans for certain key employees of the Company. The Company’s allocation of expense for these plans for each of the years ended December 31, 2024, 2023 and 2022 was insignificant.

 

12.

Related Party Transactions

The Company shares certain officers, employees and general expenses with affiliated companies.

The Company is party to a shared services and cost sharing agreement among and between the Transamerica companies, under which various affiliated companies may perform specified administrative functions in connection with the operation of the Company, in consideration of reimbursement of actual costs of services rendered. Effective August 1, 2020, the Company, and an affiliate, Transamerica Financial Life Insurance Company (TFLIC), entered into a Shared Services and Cost Sharing Agreement for both parties to provide accounting, administrative, and other advisory services in accordance with the agreement. The agreement, filed and approved by the IID, replaces prior agreements between the entities. The amount received by the Company as a result of being a party to these agreements was $1,083, $621 and $564 during 2024, 2023 and 2022, respectively. The amount paid as a result of being a party to these agreements was $647, $619 and $605 during 2024, 2023 and 2022, respectively. Fees charged between affiliates approximate their cost.

The Company is party to a Management and Administrative and Advisory agreement with AEGON USA Realty Advisors (AURA), LLC whereby AURA serves as the administrator and advisor for the Company’s mortgage loan operations. The Company paid $29, $30 and $31 for these services during 2024, 2023 and 2022, respectively.

The Company is party to an Investment Management Agreement with AEGON USA Investment Management (AUIM), LLC whereby AUIM acts as a discretionary investment manager for the Company. The Company paid $98, $98 and $89 for these services during 2024, 2023 and 2022, respectively.

The Company has an administration service agreement with Transamerica Asset Management to provide administrative services to the Transamerica Series Trust. The Company received $119, $115 and $130 for these services during 2024, 2023 and 2022, respectively.

Transamerica Capital, Inc. provides wholesaling distribution services for the Company under a distribution agreement. The Company incurred expenses under this agreement of $23, $10 and $6 for the years ended December 31, 2024, 2023 and 2022, respectively.

Receivables from (payables to) affiliates and intercompany borrowings bear interest at the thirty- day commercial paper rate. During 2024, 2023 and 2022, the Company received (paid) net

 

91


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

interest of ($28), ($21) and ($5) from (to) affiliates, respectively. At December 31, 2024 and 2023, respectively, the Company reported net receivables (payables) from (to) affiliates of $239 and $629. Terms of settlement require that these amounts are settled within 90 days of quarter- end per the requirements of SSAP No. 25, Affiliates and Other Related Parties.

At December 31, 2024, the Company had short-term intercompany notes receivables of $550 as follows:

 

Receivable from    Amount      Due By    Interest Rate      

TA Corp

   $ 275      March 27, 2025    5.33    %

TA Corp

     25      April 26, 2025    5.33   

TA Corp

     75      June 21, 2025    5.30   

TA Corp

     75      June 25, 2025    5.30   

ULI Funding LLC

     100      December 30, 2025    4.70   

At December 31, 2023, the Company had short-term intercompany notes receivables of $350 as follows:

 

Receivable from    Amount      Due By    Interest Rate      

TA Corp

   $ 175      March 27, 2024    4.61    %

TA Corp

     75      June 21, 2024    5.15   

ULI Funding LLC

     100      December 30, 2024    5.29   

At December 31, 2024 and 2023, the Company had no short-term intercompany notes payable.

 

92


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The Company utilizes the look-through approach in valuing its investment in the following entities.

 

     Book Adjusted
 Carrying Value 
 

Real Estate Alternatives Portfolio 2, LLC

   $  

Real Estate Alternatives Portfolio 3, LLC

     13  

Real Estate Alternatives Portfolio 4 HR, LLC

     221  

Real Estate Alternatives Portfolio 4 MR, LLC

     7  

Aegon Workforce Housing Fund 2, L.P.

     177  

Aegon Workforce Housing Fund 3, L.P.

     15  

Natural Resources Alternatives Portfolio I, LLC

     271  

Natural Resources Alternatives Portfolio II, LLC

     171  

Natural Resources Alternatives Portfolio 3, LLC

     246  

TA Private Equity Assets LLC

     329  

Zero Beta Fund, LLC

     5  

TA-APOP I, LLC

     206  

TA-APOP I-A, LLC

     66  

These entity’s financial statements are not audited and the Company has limited the value of its investment in these entities to the value contained in the audited financial statements of the underlying LP/LLC investments, including adjustments required by SSAP No. 97 entities and/or non-SCA SSAP No. 48, Joint Ventures, Partnerships and Limited Liability Companies, entities owned by these entities. All liabilities, commitments, contingencies, guarantees or obligations of these entities which are required to be recorded as liabilities, commitments, contingencies, guarantees or obligations under applicable accounting guidance, are reflected in the Company’s determination of the carrying value of the investment in these entities.

 

93


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following tables show the disclosures for all SCA investments, except 8bi entities, Balance Sheets value (admitted and nonadmitted) and the NAIC responses for the SCA filings as of December 31, 2024 and 2023:

 

December 31, 2024  
SCA Entity   

Percentage of
SCA

Ownership

    Gross
Amount
     Admitted
Amount
     Nonadmitted
Amount
 

SSAP No. 97 8a Entities

          

None

      %    $      $      $  
  

 

 

 

Total SSAP No. 97 8a Entities

     XXX     $      $      $  
  

 

 

 

SSAP No. 97 8b(ii) Entities

          

None

      %    $      $      $  
  

 

 

 

Total SSAP No. 97 8b(ii) Entities

     XXX     $      $      $  
  

 

 

 

SSAP No. 97 8b(iii) Entities

          

AEGON Direct Marketing Services, Inc.

     73  %    $      $      $  

AEGON Financial Services Group, Inc.

     100                      

Garnet Assurance Corporation

     100                      

Garnet Assurance Corporation III

     100                      

Life Investors Alliance LLC

     100                      

Real Estate Alternatives Portfolio 3A, Inc.

     91                      

Transamerica Asset Management, Inc.

     77       149        149         

Transamerica Fund Services, Inc.

     44                      
  

 

 

 

Total SSAP No. 97 8b(iii) Entities

     XXX     $ 149      $ 149      $  
  

 

 

 

SSAP No. 97 8b(iv) Entities

          

Transamerica Bermuda Re, Ltd.

     100  %    $ 434      $ 434      $  
  

 

 

 

Total SSAP No. 97 8b(iv) Entities

     XXX     $ 434      $ 434      $  
  

 

 

 

Total SSAP No. 97 8b Entities (except 8bi entities)

     XXX     $ 583      $ 583      $  
  

 

 

 

Aggregate Total

       XXX     $    583      $   583      $      —  
  

 

 

 

 

94


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

December 31, 2023  
SCA Entity    Percentage of
SCA
Ownership
    Gross
Amount
     Admitted
Amount
     Nonadmitted
Amount
 

SSAP No. 97 8a Entities

          

None

      %    $      $      $  
  

 

 

 

Total SSAP No. 97 8a Entities

     XXX     $      $      $  
  

 

 

 

SSAP No. 97 8b(ii) Entities

          

None

      %    $      $      $  
  

 

 

 

Total SSAP No. 97 8b(ii) Entities

     XXX     $      $      $  
  

 

 

 

SSAP No. 97 8b(iii) Entities

          

AEGON Direct Marketing Services, Inc.

     73  %    $      $      $  

AEGON Financial Services Group, Inc.

     100                      

Garnet Assurance Corporation

     100                      

Garnet Assurance Corporation III

     100                      

Life Investors Alliance LLC

     100                      

Real Estate Alternatives Portfolio 3A, Inc.

     91                      

Transamerica Asset Management, Inc.

     77       136        136         

Transamerica Fund Services, Inc.

     44                      
  

 

 

 

Total SSAP No. 97 8b(iii) Entities

     XXX     $ 136      $ 136      $  
  

 

 

 

SSAP No. 97 8b(iv) Entities

          

Transamerica Bermuda Re, Ltd.

     100  %    $ 415      $ 415      $  
  

 

 

 

Total SSAP No. 97 8b(iv) Entities

     XXX     $ 415      $ 415      $  
  

 

 

 

Total SSAP No. 97 8b Entities (except 8bi entities)

     XXX     $ 551      $ 551      $  
  

 

 

 

Aggregate Total

       XXX     $    551      $   551      $      —  
  

 

 

 

 

95


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following table shows the NAIC responses for the SCA filings (except 8bi entities):

December 31, 2024

 

SCA Entity    Type of
NAIC
Filing*
    

Date of
Filing to

the NAIC

     NAIC
Valuation
Amount 
(1)
     NAIC
Response
Received
Y/N
    

NAIC
Disallowed
Entities
Valuation
Method,

Submission
Required
Y/N

     Code**  

SSAP No. 97 8a Entities

                 

None

         $           
        

 

 

          

Total SSAP No. 97 8a Entities

                 $                       
        

 

 

          

SSAP No. 97 8b(ii) Entities

                 

None

         $           
        

 

 

          

Total SSAP No. 97 8b(ii) Entities

                 $                       
        

 

 

          

SSAP No. 97 8b(iii) Entities

                 

AEGON Direct Marketing Services, Inc.

     NA         $                      I  

AEGON Financial Services Group, Inc.

     NA                                I  

Garnet Assurance Corporation

     NA                                I  

Garnet Assurance Corporation III

     NA                                I  

Life Investors Alliance LLC

     NA                                I  

Real Estate Alternatives Portfolio 3A, Inc.

     NA                                I  

Transamerica Asset Management, Inc.

     S2        11/4/2024        136        Y        N        I  

Transamerica Fund Services, Inc.

     NA                            I  
        

 

 

          

Total SSAP No. 97 8b(iii) Entities

                 $ 136                       
        

 

 

          

SSAP No. 97 8b(iv) Entities

                 

Transamerica Bermuda Re, Ltd.

     S2        11/4/2024      $ 502        Y        N        I  
        

 

 

          

Total SSAP No. 97 8b(iv) Entities

                 $ 502                       
        

 

 

          

Total SSAP No. 97 8b Entities (except 8bi entities)

                 $ 638                       
        

 

 

          

Aggregate Total

                 $    638                       
        

 

 

          

*S1 - Sub1, S2 - Sub2 or RDF - Resubmission of Disallowed Filing

** I - Immaterial or M - Material

(1) NAIC Valuation Amount is as of the Filing Date to the NAIC

 

96


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

December 31, 2023

 

SCA Entity    Type of
NAIC
Filing*
   Date of
Filing to
the NAIC
   NAIC
Valuation
Received
Amount 
(1)
    

NAIC
Response

Received

Y/N

  

NAIC
Disallowed
Entities
Valuation
Method,

Submission
Required
Y/N

   Code
**
 

SSAP No. 97 8a Entities

                 

None

         $               
        

 

 

          

Total SSAP No. 97 8a Entities

         $               
        

 

 

          

SSAP No. 97 8b(ii) Entities

                 

None

         $               
        

 

 

          

Total SSAP No. 97 8b(ii) Entities

         $               
        

 

 

          

SSAP No. 97 8b(iii) Entities

                 

AEGON Direct Marketing Services, Inc.

   NA       $              I  

AEGON Financial Services Group, Inc.

   NA                      I  

Garnet Assurance Corporation

   NA                      I  

Garnet Assurance Corporation III

   NA                      I  

Life Investors Alliance LLC

   NA                      I  

Real Estate Alternatives Portfolio 3A, Inc.

   NA                      I  

Transamerica Asset Management, Inc.

   S2    10/25/2023      124      Y    N      I  

Transamerica Fund Services, Inc.

   NA                      I  
        

 

 

          

Total SSAP No. 97 8b(iii) Entities

         $ 124               
        

 

 

          

SSAP No. 97 8b(iv) Entities

                 

Transamerica Bermuda Re, Ltd.

   NA       $              I  
        

 

 

          

Total SSAP No. 97 8b(iv) Entities

         $               
        

 

 

          

Total SSAP No. 97 8b Entities (except 8bi entities)

         $ 124               
        

 

 

          

Aggregate Total

         $    124               
        

 

 

          

*S1 - Sub1, S2 - Sub2 or RDF - Resubmission of Disallowed Filing

** I - Immaterial or M - Material

(1) NAIC Valuation Amount is as of the Filing Date to the NAIC

The Company reports an investment in the following insurance SCAs for which the reported statutory equity reflects a departure from NAIC SAP. Each of the insurance SCAs listed in the table below reflects an admitted asset, equal to the value of the excess of loss reinsurance asset provided by an unaffiliated company, whereas this would not be an admitted asset recognized by SSAP No. 4, Assets and Non Admitted Assets.

 

LIICA Re II

  

Excess of loss reinsurance asset

TPRe

  

Excess of loss reinsurance asset

 

97


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The Company has two Limited Purpose Subsidiaries (LPS) with prescribed practices whereby under Iowa Administrative Code 191-99.11(3), the LPS are entitled to admit the following assets that would not be admissible under the NAIC SAP:

 

TORI

   Credit linked note   

TLIC Watertree Reinsurance, Inc. (TWRI)

  

Excess of loss reinsurance asset

  

The monetary effect on net income and surplus as a result of using an accounting practice that differed from NAIC SAP, the amount of the investment in the insurance SCA per reported statutory equity, and amount of the investment if the insurance SCA has completed statutory financial statements in accordance with the NAIC SAP. The SCAs are valued in the Company’s financial statements at zero in accordance with SSAP No. 97.

 

    

Monetary Effect on

NAIC SAP

      Amount of Investment    

SCA Entity

(Investments in Insurance SCA Entities)

   Net
Income
Increase
(Decrease)
     Surplus
Increase
(Decrease)
    Per
Reported
Statutory
Equity
     If the
Insurance
SCA Had
Completed
Statutory
Financial
Statements*
 

LIICA Re II

   $    —      $  (1,639   $   260      $      —  

TPRe

            (1,385     235         

TORI

            (3,257     1,032         

TWRI

            (1,359     665         

*Per AP&P Manual (without permitted or prescribed practices)

Had the above SCA entities not been permitted to recognize the excess of loss reinsurance assets or the credit linked note as admitted assets in the financial statements, the risk-based capital would have been below the control level which would have triggered a regulatory event.

Information regarding the Company’s affiliated reinsurance transactions is available in Note 7.

Information regarding the Company’s affiliated guarantees is available in Note 14.

13. Managing General Agents and Third-Party Administrators

The Company utilizes managing general agents (MGA) and third-party administrators (TPA) in its operation. There were no MGA’s/TPA’s that wrote premiums in excess of 5% of the Company’s surplus.

14. Commitments and Contingencies

At December 31, 2024 and 2023, the Company has mortgage loan commitments of $179 and $437, respectively.

 

98


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The Company has commitments of $812 and $904, as of December 31, 2024 and 2023, respectively, to provide additional funding for joint ventures, partnerships and limited liability companies, which includes LIHTC commitments of $2 and $2, respectively.

The Company leases office buildings and equipment under various non-cancelable operating lease agreements. Rental expense for the years 2024 and 2023 was $13 and $11, respectively.

Private placement commitments outstanding as of December 31, 2024 and 2023 were $238 and $90, respectively.

The Company did not sell any “to-be-announced” (TBA) securities as of December 31, 2024 and 2023.

The Company may pledge cash as collateral for derivative transactions. When cash is pledged as collateral, it is derecognized and a receivable is recorded to reflect the eventual return of that cash by the counterparty. The amount of cash collateral pledged by the Company as of December 31, 2024 and 2023, respectively, was $466 and $361.

At December 31, 2024 and 2023, securities in the amount of $114 and $87, respectively, were posted to the Company as collateral from derivative counterparties. The securities were not included on the Company’s Balance Sheets as the Company does not have the ability to sell or repledge the collateral.

 

99


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following table provides the nature and circumstances of guarantee as of December 31, 2024 and 2023:

 

Nature and Circumstances of Guarantee

  

Liability Recognition
of Guarantee

  

Ultimate Financial

Statement Impact if

Action Under the

Guarantee is
Required

  

Maximum Potential Amount of
Future Payments
(Undiscounted) the Guarantor
Could be Required to Make

Under the Guarantee

  

Current Status of
Payment or
Performance Risk of
Guarantees

The Company has provided back-stop guarantees for the performance of non-insurance affiliates or subsidiaries that are involved in the guaranteed sale of investments in low-income housing tax credit partnerships. The nature of the obligation is to provide third party investors with a minimum guaranteed annual and cumulative return on their contributed capital which is based on tax credits and tax losses generated from the low income housing tax credit partnerships. Guarantee payments arise if low income housing tax credit partnerships experience unexpected significant decreases in tax credits and tax losses or there are compliance issues with the partnerships. A significant portion of the remaining term of the guarantees is between 13-18 years.    $       —    Payment would impact Investment Expenses, which will ultimately roll up to Net investment income.    $             —    No payments required as of December 31, 2024. Current assessment of risk of making payments under guarantees is remote.
The Company has guaranteed to the Hong Kong Insurance Authority that it will provide the financial support to TLB for maintaining TLB’s solvency at all times so as to enable TLB to promptly meet its obligations and liabilities. If at any time the value of TLB’s assets do not exceed its liabilities by the prevailing acceptable level of solvency, the Company will increase the paid up share capital of TLB or provide financial assistance to TLB to maintain the acceptable level of solvency. An acceptable level of solvency is net assets at one hundred and fifty percent of the required margin of solvency as stipulated under the Insurance Companies (Margin of Solvency) Regulation.    Exempt. Guarantee is on behalf of a wholly owned subsidiary.    None. Capital contributions to wholly owned subsidiaries would not affect the Company’s financial position.    Unlimited    None pending as of December 31, 2024. The current assessment of risk of making payments under these guarantees is remote.
The Company has guaranteed that TLB will (1) maintain tangible net worth of at least equal to the greater of 165% of S&P’s Risk-Based Capital and the minimum required by regulatory authorities in all jurisdictions in which TLB operates, (2) have, at all times, sufficient cash to pay all contractual obligations in a timely manner and (3) have a maximum operating leverage ratio of 20 times. The Company can terminate this agreement upon thirty days written notice, but not until TLB attains a rating from S&P’s the same as without the support from this agreement, or the entire book of TLB business is transferred provided that it is transferred to an entity with a rating from S&P that is the same as or better than the Company’s then current rating or AA, whichever is lower.    Exempt. Guarantee is on behalf of a wholly owned subsidiary.    None. Capital contributions to wholly owned subsidiaries would not affect the Company’s financial position.    Unlimited    None pending as of December 31, 2024. The current assessment of risk of making payments under these guarantees is remote.
The Company has provided a guarantee to TLB’s Singapore Branch policyholders. If TLB fails to pay a valid claim solely by reason of it becoming insolvent as defined by Bermuda law, then the Company shall pay directly to the policy owner or named beneficiary the amount of the valid claim.    Exempt. Guarantee is on behalf of a wholly owned subsidiary.    None. Capital contributions to wholly owned subsidiaries would not affect the Company’s financial position.    140    None pending as of December 31, 2024. The current assessment of risk of making payments under these guarantees is remote.
The Company has provided a guarantee to TLB’s Hong Kong Branch policyholders. If TLB fails to pay a valid claim solely by reason of it becoming insolvent as defined by Bermuda law, then the Company shall pay directly to the policy owner or named beneficiary the amount of the valid claim.    Exempt. Guarantee is on behalf of a wholly owned subsidiary.    None. Capital contributions to wholly owned subsidiaries would not affect the Company’s financial position.    128    None pending as of December 31, 2024. The current assessment of risk of making payments under these guarantees is remote.
  

 

     

 

  

Total

   $         —        $              268   
  

 

     

 

  

 

100


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following table provides an aggregate compilation of guarantee obligations as of December 31, 2024 and 2023:

 

                  December 31  
            2024                  2023  
  

 

 

 

Aggregate maximum potential of future payments of all guarantees (undiscounted)

    $            268        $ 238   
  

 

 

 

Current liability recognized in financial statements:

            

Noncontingent liabilities

                   —   
  

 

 

 

Contingent liabilities

                   —   
  

 

 

 

Ultimate financial statement impact if action required:

            

Investments in SCA

          268          238   

Other

                   —   
  

 

 

 

Total impact if action required

    $            268        $     238   
  

 

 

 

During 2019, the Company entered into an agreement with AURA, LLC to commit to purchase certain tax credit investments up to a maximum of $100,000. Under the terms of the agreement, the Company provides certain commitments to purchase tax credit investments that are part of tax credit funds in the event certain conditions are met. The Company acquired one tax credit investments during 2024 or 2023 under this agreement. As of December 31, 2024 and 2023, there is $48 and $24 committed to these purchases.

The Company is a member of the FHLB of Des Moines. Through its membership, the Company establishes the option to access funds through secured borrowing arrangements with the FHLB. It is part of the Company’s strategy to utilize these funds for asset and liability management and other strategic initiatives. The Company has determined the actual/estimated long-term maximum borrowing capacity as $5,320 and $5,601 at December 31, 2024 and 2023, respectively. The Company calculated this amount in accordance with the terms and conditions of agreement with FHLB of Des Moines.

 

101


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

At December 31, 2024 and 2023, the Company purchased/owned the following FHLB stock as part of the agreement:

 

       Year Ended December 31  
       2024      2023  
    

 

 

 

Membership Stock:

       

Class A

      $      —       $     —   

Class B

       10        10   

Activity Stock

       68        78   

Excess Stock

              —   
    

 

 

 

Total

      $ 78       $ 88   
    

 

 

 

At December 31, 2024 and 2023, membership stock (Class A and B) eligible for redemption and the anticipated timeframe for redemption was as follows:

 

     Less Than 6
Months
     6 Months to
Less Than 1
Year
     1 to Less
Than 3
Years
     3 to 5 Years   
  

 

 

 

December 31, 2024

           

Membership Stock

           

Class A

    $      $      $      $ —   

Class B

                          10   
  

 

 

 

Total

    $    —       $    —      $    —      $    10   
  

 

 

 
    

Less Than 6

Months

    

6 Months to

Less Than 1
Year

     1 to Less
Than 3
Years
     3 to 5 Years   
  

 

 

 

December 31, 2023

           

Membership Stock

           

Class A

    $      $      $      $ —   

Class B

                          10   
  

 

 

 

Total

    $      $      $      $ 10   
  

 

 

 

At December 31, 2024 and 2023, the amount of collateral pledged and the maximum amount pledged to the FHLB was as follows:

 

       Fair Value      Carry Value   
    

 

 

 

December 31, 2024

       

Total Collateral Pledged

     $     3,433      $     3,956   

Maximum Collateral Pledged

       3,995        4,603   
       Fair Value      Carry Value   
    

 

 

 

December 31, 2023

       

Total Collateral Pledged

     $ 3,452      $ 3,937   

Maximum Collateral Pledged

       4,803        5,290   

 

102


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

At December 31, 2024 and 2023, the borrowings from the FHLB were as follows:

 

    December 31,  
    2024     2023  
 

 

 

   

 

 

 
    General     General  
    Account     Account  
 

 

 

   

 

 

 

Debt 1

   $    1,500     $    1,725   
 

 

 

 

Total

   $ 1,500     $ 1,725   
 

 

 

 

 

1 

The maximum amount of borrowing during 2024 and 2023 was $1,725 and $2,300, respectively.

As of December 31, 2024, the weighted average interest rate on FHLB advances was 4.415% with a weighted average term of 0.9 years. As of December 31, 2023, the weighted average interest rate on FHLB advances was 4.627% with a weighted average term of 2.0 years.

At December 31, 2024 and 2023, the borrowings from the FHLB were not subject to prepayment penalties.

The Company has issued synthetic GIC primarily to tax-qualified institutional entities such as 401(k) plans and other retirement plans and college savings plans with a book value totaling $32,000 and $50,150 as of December 31, 2024 and 2023, respectively. In a synthetic GIC, the Company generally guarantees book value withdrawals by plan participants from plan-owned assets by paying the difference between book value and the fair value of those assets in the event the book value exceeds fair value upon termination. The Company mitigates the related investment risk through certain contractual provisions and approval of the investment guidelines applicable to the plan-owned assets. Funding requirements to date have been minimal and management does not anticipate future funding requirements having a material financial impact. As of December 31, 2024 and 2023, the related reserves are $0 and $2, respectively.

The Company may be a party to legal proceedings involving a variety of issues incidental to its business, including class action lawsuits. Lawsuits may be brought in any federal or state court in the United States or in an arbitral forum. In addition, there continues to be significant federal and state regulatory activity relating to financial services companies. The Company’s legal proceedings are subject to many variables, and given their complexity and scope, outcomes cannot be predicted with certainty. Although legal proceedings sometimes include substantial demands for compensatory and punitive damages, and injunctive relief, damages arising from such demands are typically not material to the Company’s financial position.

The Company was named in two class actions relating to increases in monthly deduction rates (MDR) on universal life products in 2015 to 2016 and 2017 to 2018, respectively, as well as several individual lawsuits. The Company settled these two class actions, one in March 2019 and one in June 2021. All remaining exposures were settled during the first quarter of 2024, therefore the Company held no provision for this class action at December 31, 2024.

The Company is subject to insurance guaranty laws in the states in which it writes business. These laws provide for assessments against insurance companies for the benefit of policyholders

 

103


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

and claimants in the event of insolvency of other insurance companies. Assessments are charged to operations when received by the Company, except where right of offset against other taxes paid is allowed by law. Amounts available for future offsets are recorded as an asset on the Company’s Balance Sheets. The future obligation for known insolvencies has been accrued based on the most recent information available from the National Organization of Life and Health Insurance Guaranty Associations. Potential future obligations for unknown insolvencies are not determinable by the Company and are not required to be accrued for financial reporting purposes. The Company has established a reserve of $14 and $8 and an offsetting premium tax benefit $9 and $6 at December 31, 2024 and 2023, respectively, for its estimated share of future guaranty fund assessments related to several major insurer insolvencies. The guaranty fund (benefit) expense was $10, $0 and $3 for the years ended December 31, 2024, 2023 and 2022, respectively.

15.  Sales, Transfers, and Servicing of Financial Assets and Extinguishments of Liabilities

The Company is party to municipal repurchase agreements which were established via bilateral trades and accounted for as secured borrowings. For municipal repurchase agreements, the Company rigorously manages asset/liability risks via an integrated risk management framework. The Company’s liquidity position is monitored constantly, and factors heavily in the management of the asset portfolio. Projections comparing liquidity needs to available resources in both adverse and routine scenarios are refreshed monthly. The results of these projections on time horizons ranging from 16 months to 24 months are the basis for the near-term liquidity planning. This liquidity model excludes new business (non applicable for the spread business), renewals and other sources of cash and assumes all liabilities are paid off on the earliest dates required. Interest rate risk is carefully managed, in part through rigorously defined and monitored derivatives programs.

 

104


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

The following tables provide information on the securities sold under the municipal repurchase agreements for four quarters of 2024 and 2023:

December 31, 2024

 

     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth 
Quarter 
 
  

 

 

 

Maximum Amount

           

BACV

     XXX        XXX        XXX      $ 315   

Fair Value

   $   200      $   266      $   323      $   320   

Ending Balance

           

BACV

     XXX        XXX        XXX      $ 306   

Fair Value

   $ 200      $ 266      $ 323      $ 308   
December 31, 2023            
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
 
  

 

 

 

Maximum Amount

           

BACV

     XXX        XXX        XXX      $ 685   

Fair Value

   $ 273      $ 249      $ 662      $ 623   

Ending Balance

           

BACV

     XXX        XXX        XXX      $ 156   

Fair Value

   $ 198      $ 249      $ 662      $ 157   

 

            2024                    2023         
  

 

 

    

 

 

 
     NAIC 1      NAIC 2      Total      NAIC 1      NAIC 2      Total  
  

 

 

    

 

 

 

Bonds - BACV

     $ 257      $    49      $    306      $    143      $    13      $    156   

Bonds - FV

       259        50        309        144        13        157   

These securities have maturity dates that range from February 15, 2025 to November 1, 2066.

The following table provides information on the cash collateral received and liability to return collateral under the municipal repurchase agreements for four quarters of 2024 and 2023:

December 31, 2024

 

     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth 
Quarter 
 
  

 

 

 

Maximum Amount

           

Cash

   $ 154      $ 197      $   221      $   113  

Ending Balance (1)

           

Cash

   $   154      $   197      $ 80      $ 113  

 

(1) 

The remaining collateral held was greater than 90 days from contractual maturity.

 

105


Transamerica Life Insurance Company

Notes to Financial Statements – Statutory Basis

(Dollars in Millions, Except per Share amounts)

 

 

December 31, 2023                            
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
 
                                   

Maximum Amount
Cash

   $   147      $   186      $   536      $   508  

Ending Balance (1)
Cash

   $ 147      $ 186      $ 536      $ 110  

 

(1) 

The remaining collateral held was greater than 90 days from contractual maturity.

The Company enters into dollar repurchase agreements in which securities are delivered to the counterparty once adequate collateral has been received. At December 31, 2024, the Company had no dollar repurchase agreements. At December 31, 2023, the Company had dollar repurchase agreements outstanding in the amount of $11, which is included in borrowed money on the Balance Sheets. Those amounts included no accrued interest at December 31, 2023. At December 31, 2023, securities with a book value of $11 and a fair value of $11 were subject to dollar repurchase agreements. The Company does not have the legal right to recall or substitute the underlying assets prior to the transaction’s scheduled termination. Upon scheduled termination, the counterparty is obligated to return substantially similar assets.

The contractual maturities of the dollar repurchase agreement positions are as follows:

 

     Fair Value  
  

 

 

 
     2024      2023  
  

 

 

 

Open

    $       $ 11   

Securities received

                
  

 

 

 

Total collateral received

    $     —       $    11   
  

 

 

 

In the course of the Company’s asset management, securities are sold and reacquired within 30 days of the sale date to enhance the Company’s yield on its investment portfolio. The Company sold and reacquired one security with an NAIC designation 3 or below within 30 days of the sale date resulting in an insignificant amount during 2024.

 

16.

Subsequent Events

The financial statements are adjusted to reflect events that occurred between the Balance Sheets date and the date when the financial statements are available to be issued, provided they give evidence of conditions that existed at the Balance Sheets date (Type I). Events that are indicative of conditions that arose after the Balance Sheets date are disclosed, but do not result in an adjustment of the financial statements themselves (Type II). The Company has not identified any Type I or Type II subsequent events for the year ended December 31, 2024 through April 11, 2025.

 

106


Transamerica Life Insurance Company

Appendix A – Listing of Affiliated Companies

 

 

Transamerica Corporation

EIN: 42-1484983

AFFILIATIONS SCHEDULE

YEAR ENDED DECEMBER 31, 2024

 

 
Entity Name    FEIN  

Transamerica Corporation

     42-1484983  

AEGON Asset Management Services Inc

     39-1884868  

AEGON Direct Marketing Services Inc

     42-1470697  

AEGON Financial Services Group Inc

     41-1479568  

AEGON Institutional Markets Inc

     61-1085329  

AEGON Management Company

     35-1113520  

AEGON USA Real Estate Services Inc

     61-1098396  

AEGON USA Realty Advisors of CA

     20-5023693  

AUSA Properties Inc

     27-1275705  

Commonwealth General Corporation

     51-0108922  

Creditor Resources Inc

     42-1079584  

CRI Solutions Inc

     52-1363611  

Financial Planning Services Inc

     23-2130174  

Garnet Assurance Corporation

     11-3674132  

Garnet Assurance Corporation II

     14-1893533  

Garnet Assurance Corporation III

     01-0947856  

Ironwood Re Corp

     47-1703149  

LIICA RE II

     20-5927773  

Money Services Inc

     42-1079580  

Monumental General Administrators Inc

     52-1243288  

Pearl Holdings Inc I

     20-1063558  

Pearl Holdings Inc II

     20-1063571  

Real Estate Alternatives Portfolio 3A Inc

     20-1627078  

River Ridge Insurance Company

     20-0877184  

Stonebridge Benefit Services Inc

     75-2548428  

TLIC Oakbrook Reinsurance Inc.

     47-1026613  

TLIC Watertree Reinsurance, Inc.

     81-3715574  

Transamerica Affordable Housing Inc

     94-3252196  

Transamerica Asset Management

     59-3403585  

Transamerica Bermuda Re, Ltd

     98-1701849  

Transamerica Capital Inc

     95-3141953  

Transamerica Casualty Insurance Company

     31-4423946  

Transamerica Corporation (OREGON)

     98-6021219  

 

107


Transamerica Life Insurance Company

Appendix A – Listing of Affiliated Companies

 

 

Transamerica Corporation

EIN: 42-1484983

AFFILIATIONS SCHEDULE

YEAR ENDED DECEMBER 31, 2024

 

 
Entity Name    FEIN  

Transamerica Finance Corporation

     95-1077235  

Transamerica Financial Advisors

     59-2476008  

Transamerica Financial Life Insurance Company

     36-6071399  

Transamerica Fund Services Inc

     59-3403587  

Transamerica Investors Securities Corp

     13-3696753  

Transamerica Life Insurance Company

     39-0989781  

Transamerica Pacific Re, Inc.

     85-1028131  

Transamerica Resources Inc

     52-1525601  

Transamerica Stable Value Solutions Inc

     27-0648897  

Transamerica Trust Company

     42-0947998  

United Financial Services Inc

     52-1263786  

World Fin Group Ins Agency of Massachusetts Inc

     04-3182849  

World Financial Group Inc

     42-1518386  

World Financial Group Ins Agency of Hawaii Inc

     99-0277127  

World Financial Group Insurance Agency of WY Inc

     42-1519076  

Zahorik Company Inc

     95-2775959  

Zero Beta Fund LLC

     26-1298094  

 

108


 

Statutory-Basis Financial

Statement Schedules

 

 

 

109


LOGO

Report of Independent Auditors

The Board of Directors

Transamerica Life Insurance Company

We have audited the statutory-basis financial statements of Transamerica Life Insurance Company (the Company) as of December 31, 2024 and for the year then ended, and have issued our report thereon dated April 10, 2025. Our audit of the statutory-basis financial statements included the financial statement supplementary information, which includes Schedule I Summary of Investments – Other Than Investments in Related Parties, Schedule III – Supplementary Insurance Information, and Schedule IV - Reinsurance (the “supplementary information”). These schedules are the responsibility of Transamerica Life Insurance Company’s management. Our responsibility is to express an opinion on Transamerica Life Insurance Company’s supplementary information based on our audit.

In our opinion, the supplementary information present fairly, in all material respects, the information set forth therein when considered in conjunction with the statutory-basis financial statements.

/s/ Ernst & Young LLP

Philadelphia, PA

April 10, 2025

 

110


Transamerica Life Insurance Company

Summary of Investments – Other Than

Investments in Related Parties

(Dollars in Millions)

December 31, 2024

SCHEDULE I

 

Type of Investment    Cost (1)     

Fair

Value

   

Amount at

Which Shown

in the

Balance Sheet (2)

 

Fixed maturities

       

Bonds:

       

United States government and government agencies and authorities

     $          4,442         $          3,904       $          5,188   

States, municipalities and political subdivisions

     2,393         1,954       2,393   

Foreign governments

     808         710       808   

Hybrid securities

     230         230       230   

All other corporate bonds

     40,974         37,742       40,897   

Preferred stocks

     45         44       44   
  

 

 

 

Total fixed maturities

     48,892         44,584       49,560   

Equity securities

       

Common stocks:

       

Industrial, miscellaneous and all other

     88         90       90   
  

 

 

 

Total equity securities

     88         90       90   

Mortgage loans on real estate

     8,885           8,885   

Real estate

     39           39   

Policy loans

     2,239           2,239   

Other long-term investments

     1,201           1,201   

Receivable for securities

     10           10   

Receivable for derivative cash collateral posted to counterparty

     466           466   

Securities lending

     1,667           1,667   

Cash, cash equivalents and short-term investments

     1,394           1,394   
  

 

 

      

 

 

 

Total investments

     $          64,881           $          65,551   
  

 

 

      

 

 

 

 

(1)

Equity securities are reported at original cost. Fixed maturities are reported at original cost reduced by repayments and adjusted for amortization of premiums and accrual of discounts.

 

(2)

Bonds of $30 are held at fair value rather than amortized cost. Preferred stock of $43 are held at fair value.

 

111


Transamerica Life Insurance Company

Supplementary Insurance Information

(Dollars in Millions)

SCHEDULE III

 

    

Future Policy

Benefits and

Expenses

    

Unearned

Premiums

    

Policy and

Contract

Liabilities

    

Premium

Revenue

    

Net

Investment

Income*

    

Benefits,

Claims

Losses and

Settlement

Expenses

    

Other

Operating

Expenses*

 
  

 

 

 

Year ended December 31, 2024

 

Individual life

     $      30,043        $        —        $       576        $      3,384        $     1,923        $     4,860        $     1,410   

Individual health

     6,304        100        306        625        391        943        196   

Group life and health

     2,404        17        130        833        158        517        345   

Annuity

     14,816               36        13,842        1,211        19,311        (5,173)  
  

 

 

 
     $      53,567        $      117        $     1,048        $     18,684        $     3,683        $    25,631        $     (3,222)  
  

 

 

 

Year ended December 31, 2023

 

Individual life

     $      29,961        $        —        $493        $      2,410        $     1,882        $     2,870        $     1,808   

Individual health

     6,083        105        317        665        382        807        221   

Group life and health

     2,455        19        124        788        134        520        370   

Annuity

     13,873               49        5,653        1,199        10,215        (4,060)  
  

 

 

 
     $      52,372        $      124        $       983        $      9,516        $     3,597        $    14,412        $     (1,661)  
  

 

 

 

Year ended December 31, 2022

 

Individual life

     $      30,960        $        —        $580        $      8,576        $     1,626        $     9,716        $1,201   

Individual health

     5,993        112        327        710        406        822        226   

Group life and health

     2,469        21        128        806        170        509        360   

Annuity

     18,401               63        9,721        1,095        21,481        (10,034)  
  

 

 

 
     $      57,823        $      133        $     1,098        $     19,813        $     3,297        $    32,528        $     (8,247)  
  

 

 

 

*Allocations of net investment income and other operating expenses are based on a number of assumptions and estimates, and the results would change if different methods were applied.

 

112


Transamerica Life Insurance Company

Reinsurance

(Dollars in Millions)

SCHEDULE IV

    Gross
Amount
    

Ceded to

Other

Companies

    

Assumed

From Other

Companies

    

Net

Amount

    

Percentage of

Amount

Assumed to Net

 
 

 

 

 

Year ended December 31, 2024

             

Life insurance in force

    $ 805,576        $  494,708        $  234,794        $  545,662        43    %   
 

 

 

 

Premiums:

             

Individual life

    $   4,495        $    1,971        $      860        $    3,384        25    %   

Individual health

    673        53        5        625        1         

Group life and health

    886        54        1        833        0         

Annuity

    13,853        16        5        13,842        0         
 

 

 

 
    $   19,907        $    2,094        $     871        $   18,684        5    %   
 

 

 

 

Year ended December 31, 2023

             

Life insurance in force

    $  798,119        $  540,679        $  262,185        $  519,625        50    %   
 

 

 

 

Premiums:

             

Individual life

    $    4,598        $    3,029        $      841        $    2,410        35    %   

Individual health

    717        58        6        665        1         

Group life and health

    898        112        2        788        0         

Annuity

    10,049        4,403        7        5,653        0         
 

 

 

 
    $   16,262        $    7,602        $      856        $    9,516        9    %   
 

 

 

 

Year ended December 31, 2022

             

Life insurance in force

    $  776,124        $  616,800        $  319,443        $  478,767        67    %   
 

 

 

 

Premiums:

             

Individual life

    $    4,547        $     2,316        $    6,345        $    8,576        74    %   

Individual health

    758        60        12        710        2         

Group life and health

    927        135        14        806        2         

Annuity

    9,725        16        12        9,721        0         
 

 

 

 
    $   15,957        $     2,527        $    6,383        $   19,813        32    %   
 

 

 

 

 

113


FINANCIAL STATEMENTS

Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Years Ended December 31, 2024 and 2023


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Financial Statements

Years Ended December 31, 2024 and 2023

Contents

 

Report of Independent Registered Public Accounting Firm

   1

Financial Statements

  

Statements of Assets and Liabilities

   6

Statements of Operations and Changes in Net Assets

   7

Notes to Financial Statements

   17


LOGO

 

 

Ernst & Young LLP

155 North Wacker Drive

Chicago, IL 60606-1787

  

Tel: +1 312 879 2000

Fax: +1 312 879 4000

ey.com

  

 

Report of Independent Registered Public Accounting Firm

To the Board of Directors of Transamerica Life Insurance Company and

Contract Owners of Transamerica Life Insurance Co Separate Account VUL-6

Opinion on the Financial Statements

We have audited the accompanying statements of assets and liabilities of each of the subaccounts listed in the table below that comprise Transamerica Life Insurance Co Separate Account VUL-6 (the Separate Account), as of December 31, 2024, the related statements of operations and changes in net assets for each of the periods indicated in the table below, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each subaccount as of December 31, 2024, the results of its operations and changes in its net assets for each of the periods indicated in the table below, in conformity with U.S. generally accepted accounting principles.

 

 
Subaccounts
   
AB Large Cap Growth Class B Shares (1)   MS VIF Global Strategist Class I Shares (1)
   
AB Relative Value Class B Shares (1)   PIMCO Real Return Administrative Class (1)
   
Alger Growth & Income Class I-2 Shares (1)   TA Aegon Bond Initial Class (1)
   
BNY Mellon MidCap Stock Initial Shares (1)   TA Aegon Sustainable Equity Income Initial Class (1)
   
BNY Mellon Sustainable U.S. Equity Initial Shares (1)   TA Aegon U.S. Government Securities Initial Class (1)
   
BNY Mellon VIF Appreciation Initial Shares (1)   TA BlackRock Government Money Market Initial Class (1)
   
BNY Mellon VIF Opportunistic Small Cap Initial Shares (1)   TA BlackRock iShares Edge 40 Initial Class (1)
   
Fidelity® VIP Contrafund® Service Class 2 (1)   TA BlackRock Real Estate Securities Initial Class (1)

 

1


LOGO

 

 

Ernst & Young LLP

155 North Wacker Drive

Chicago, IL 60606-1787

  

Tel: +1 312 879 2000

Fax: +1 312 879 4000

ey.com

  

 

 

   

Fidelity® VIP Equity-Income Service Class 2 (1)

 

 

TA Janus Mid-Cap Growth Initial Class (1)

 

   

Fidelity® VIP Index 500 Service Class 2 (1)

 

TA JPMorgan Asset Allocation - Conservative Initial Class (1)

   

Franklin Small Cap Value Class 2 Shares (1)

 

TA JPMorgan Asset Allocation - Growth Initial Class (1)

   

Franklin Small-Mid Cap Growth Class 2 Shares (1)

 

TA JPMorgan Asset Allocation - Moderate Initial Class (1)

   

Invesco V.I. High Yield Series I Shares (1)

 

TA JPMorgan Asset Allocation - Moderate Growth Initial Class (1)

   

Janus Henderson - Balanced Service Shares (1)

 

 

TA JPMorgan Tactical Allocation Initial Class (1)

 

   

Janus Henderson - Global Research Service Shares (1)

 

TA Morgan Stanley Capital Growth Initial Class (1)

   

MFS® Growth Initial Class (1)

 

 

TA Small/Mid Cap Value Initial Class (1)

 

   

MFS® Investors Trust Initial Class (1)

 

TA TSW Mid Cap Value Opportunities Initial Class (1)

   

MFS® Research Initial Class (1)

 

 

TA WMC US Growth Initial Class (1)

 

   

MS VIF Emerging Markets Equity Class I Shares (1)

   
 

(1) Statements of operations and changes in net assets for the year ended December 31, 2024

 

Basis for Opinion

These financial statements are the responsibility of the Separate Account’s management. Our responsibility is to express an opinion on each of the subaccounts’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Separate Account in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2024, by correspondence with the fund companies or their transfer agents, as applicable. Our audits also included evaluating the accounting principles used and significant

 

2


LOGO

 

 

Ernst & Young LLP

155 North Wacker Drive

Chicago, IL 60606-1787

  

Tel: +1 312 879 2000

Fax: +1 312 879 4000

ey.com

  

 

estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Ernst & Young LLP

 

We have served as the auditor of the Separate Account since 2024.

Chicago, IL

April 18, 2025

 

3


Report of Independent Registered Public Accounting Firm

To the Board of Directors of Transamerica Life Insurance Company and the Contract Owners of Transamerica Life Insurance Co Separate Account VUL-6

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities of each of the subaccounts of Transamerica Life Insurance Co Separate Account VUL-6 indicated in the table below as of December 31, 2023, and the related statements of operations and changes in net assets for each of the two years in the period ended December 31, 2023, including the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the subaccounts of Transamerica Life Insurance Co Separate Account VUL-6 as of December 31, 2023, and the results of each of their operations and the changes in each of their net assets for each of the two years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

AB Large Cap Growth Class B Shares    MS VIF Global Strategist Class I Shares
AB Relative Value Class B Shares    PIMCO Real Return Administrative Class
Alger Growth & Income Class I-2 Shares    TA Aegon Bond Initial Class
BNY Mellon MidCap Stock Initial Shares    TA Aegon Sustainable Equity Income Initial Class
BNY Mellon Sustainable U.S. Equity Initial Shares    TA Aegon U.S. Government Securities Initial Class
BNY Mellon VIF Appreciation Initial Shares    TA BlackRock Government Money Market Initial Class
BNY Mellon VIF Opportunistic Small Cap Initial Shares    TA BlackRock iShares Edge 40 Initial Class
Fidelity® VIP Contrafund® Service Class 2    TA BlackRock Real Estate Securities Initial Class
Fidelity® VIP Equity-Income Service Class 2    TA Janus Mid-Cap Growth Initial Class
Fidelity® VIP Index 500 Service Class 2    TA JPMorgan Asset Allocation - Conservative Initial Class
Franklin Small Cap Value Class 2 Shares    TA JPMorgan Asset Allocation - Growth Initial Class
Franklin Small-Mid Cap Growth Class 2 Shares    TA JPMorgan Asset Allocation - Moderate Initial Class
Invesco V.I. High Yield Series I Shares    TA JPMorgan Asset Allocation - Moderate Growth Initial Class
Janus Henderson - Balanced Service Shares    TA JPMorgan Mid Cap Value Initial Class
Janus Henderson - Global Research Service Shares    TA JPMorgan Tactical Allocation Initial Class
MFS® Growth Initial Class    TA Morgan Stanley Capital Growth Initial Class
MFS® Investors Trust Initial Class    TA Small/Mid Cap Value Initial Class
MFS® Research Initial Class    TA WMC US Growth Initial Class
MS VIF Emerging Markets Equity Class I Shares     

 

4


Basis for Opinions

These financial statements are the responsibility of the Transamerica Life Insurance Company management. Our responsibility is to express an opinion on the financial statements of each of the subaccounts of Transamerica Life Insurance Co Separate Account VUL-6 based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to each of the subaccounts of Transamerica Life Insurance Co Separate Account VUL-6 in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of investments owned as of December 31, 2023 by correspondence with the custodian, the transfer agents, or the investee mutual funds. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Chicago, Illinois

April 19, 2024

We have served as the auditor of one or more of the subaccounts of Transamerica Life Insurance Co Separate Account VUL-6 since 2014.

 

5


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Assets and Liabilities

December 31, 2024

 

 Subaccount   Number of Shares         Cost         Assets at Market
Value
    Due (to)/from
General Account
      Net Assets       Units Outstanding          Range of Unit Values    

AB Large Cap Growth Class B Shares

    31,282.365     $ 2,070,404     $ 2,493,830     $ (1)     $ 2,493,829       28,728     $ 86.807160     $ 86.807160  

AB Relative Value Class B Shares

    62,306.772       1,783,199       1,923,410       -       1,923,410       35,307       54.477225       54.477225  

Alger Growth & Income Class I-2 Shares

    40,039.043       803,786       1,333,701       (5)       1,333,696       20,831       64.023755       64.023755  

BNY Mellon MidCap Stock Initial Shares

    76,214.086       1,410,534       1,568,486       (5)       1,568,481       25,797       60.800476       60.800476  

BNY Mellon Sustainable U.S. Equity Initial Shares

    4,298.219       170,722       238,594       1       238,595       3,877       61.545599       61.545599  

BNY Mellon VIF Appreciation Initial Shares

    38,027.670       1,395,453       1,387,630       -       1,387,630       21,331       65.052190       65.052190  

BNY Mellon VIF Opportunistic Small Cap Initial Shares

    25,202.731       1,084,342       1,097,831       1       1,097,832       31,403       34.959005       34.959005  

Fidelity® VIP Contrafund® Service Class 2

    85,401.058       3,345,636       4,739,759       (2)       4,739,757       45,772       103.550574       103.550574  

Fidelity® VIP Equity-Income Service Class 2

    57,698.240       1,284,575       1,471,305       1       1,471,306       28,753       51.170510       51.170510  

Fidelity® VIP Index 500 Service Class 2

    13,336.639       4,279,031       7,484,922       6       7,484,928       95,430       78.433695       78.433695  

Franklin Small Cap Value Class 2 Shares

    138,232.930       1,969,453       1,979,496       (8)       1,979,488       32,045       61.772973       61.772973  

Franklin Small-Mid Cap Growth Class 2 Shares

    160,521.953       2,506,827       2,374,120       1       2,374,121       41,345       57.421548       57.421548  

Invesco V.I. High Yield Series I Shares

    147,994.719       766,147       705,935       3       705,938       39,503       17.870647       17.870647  

Janus Henderson - Balanced Service Shares

    28,908.026       1,185,178       1,572,308       (1)       1,572,307       27,144       57.925192       57.925192  

Janus Henderson - Global Research Service Shares

    26,366.272       1,252,205       1,844,848       -       1,844,848       40,765       45.256215       45.256215  

MFS® Growth Initial Class

    36,850.181       2,147,226       2,701,487       1       2,701,488       25,734       104.978769       104.978769  

MFS® Investors Trust Initial Class

    13,957.339       430,770       554,665       (1)       554,664       8,148       68.072371       68.072371  

MFS® Research Initial Class

    10,857.539       317,136       386,420       -       386,420       5,104       75.712587       75.712587  

MS VIF Emerging Markets Equity Class I Shares

    92,162.768       1,282,773       1,265,395       (1)       1,265,394       27,387       46.203573       46.203573  

MS VIF Global Strategist Class I Shares

    98,976.410       955,615       911,573       (3)       911,570       28,189       32.337945       32.337945  

PIMCO Real Return Administrative Class

    42,724.951       550,306       491,764       (10)       491,754       26,224       18.751965       18.751965  

TA Aegon Bond Initial Class

    140,773.850       1,556,604       1,334,536       (1)       1,334,535       66,015       20.215641       20.215641  

TA Aegon Sustainable Equity Income Initial Class

    113,173.126       2,115,614       2,367,582       -       2,367,582       67,523       35.063524       35.063524  

TA Aegon U.S. Government Securities Initial
Class

    52,376.099       551,491       461,957       -       461,957       28,756       16.064462       16.064462  

TA BlackRock Government Money Market Initial Class

    2,297,812.230       2,297,812       2,297,812       (54)       2,297,758       1,652,695       1.390310       1.390310  

TA BlackRock iShares Edge 40 Initial Class

    17,084.335       161,118       151,026       (1)       151,025       6,335       23.839605       23.839605  

TA BlackRock Real Estate Securities Initial Class

    84,327.265       937,412       812,915       -       812,915       32,445       25.055173       25.055173  

TA Janus Mid-Cap Growth Initial Class

    59,504.025       1,939,110       1,957,087       (4)       1,957,083       34,407       56.880425       56.880425  

TA JPMorgan Asset Allocation - Conservative Initial Class

    56,482.317       576,422       504,387       -       504,387       21,169       23.826165       23.826165  

TA JPMorgan Asset Allocation - Growth Initial Class

    558,989.345       6,466,327       6,528,996       15       6,529,011       150,976       43.245281       43.245281  

TA JPMorgan Asset Allocation - Moderate Initial Class

    44,198.367       492,756       481,762       (1)       481,761       16,811       28.657862       28.657862  

TA JPMorgan Asset Allocation - Moderate Growth Initial Class

    476,311.713       5,449,439       5,268,008       (6)       5,268,002       154,834       34.023585       34.023585  

TA JPMorgan Tactical Allocation Initial Class

    116,613.352       1,659,322       1,454,168       3       1,454,171       59,110       24.601199       24.601199  

TA Morgan Stanley Capital Growth Initial Class

    172,345.811       1,375,857       1,382,213       1       1,382,214       69,078       20.009441       20.009441  

TA Small/Mid Cap Value Initial Class

    96,555.558       1,863,304       1,913,731       (2)       1,913,729       66,620       28.726108       28.726108  

TA TSW Mid Cap Value Opportunities Initial
Class

    28,372.824       413,537       370,265       -       370,265       7,020       52.743147       52.743147  

TA WMC US Growth Initial Class

    259,461.390       8,072,670       10,912,946       (13)       10,912,933       109,458       99.699544       99.699544  

 

See accompanying notes.   6


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

    AB Large Cap Growth Class B Shares
Subaccount
    AB Relative Value Class B Shares  
Subaccount
   

Alger Growth & Income Class I-2

Shares

Subaccount

   

BNY Mellon MidCap Stock Initial

Shares

Subaccount

 

Net Assets as of December 31, 2022:

   $ 1,511,353     $ 1,308,562     $ 1,186,967     $ 1,523,216  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    -       17,204       17,805       12,596  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    -       17,204       17,805       12,596  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    128,266       108,671       40,486       50,643  

Realized Gain (Loss) on Investments

    35,918       23,448       95,105       (5,374
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    164,184       132,119       135,591       45,269  

Net Change in Unrealized Appreciation (Depreciation)

    356,883       2,241       122,260       218,524  
 

 

 

 

Net Gain (Loss) on Investment

    521,067       134,360       257,851       263,793  

Net Increase (Decrease) in Net Assets Resulting from Operations

    521,067       151,564       275,656       276,389  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (44,227     (42,251     (145,434     (53,063
 

 

 

 

Total Increase (Decrease) in Net Assets

    476,840       109,313       130,222       223,326  
 

 

 

 

Net Assets as of December 31, 2023:

   $ 1,988,193     $ 1,417,875     $ 1,317,189     $ 1,746,542  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    -       24,504       8,229       15,252  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    -       24,504       8,229       15,252  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    105,326       68,949       4,497       26,086  

Realized Gain (Loss) on Investments

    96,306       66,697       184,417       12,897  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    201,632       135,646       188,914       38,983  

Net Change in Unrealized Appreciation (Depreciation)

    303,896       40,590       80,316       140,151  
 

 

 

 

Net Gain (Loss) on Investment

    505,528       176,236       269,230       179,134  

Net Increase (Decrease) in Net Assets Resulting from Operations

    505,528       200,740       277,459       194,386  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    108       304,795       (260,952     (372,447
 

 

 

 

Total Increase (Decrease) in Net Assets

    505,636       505,535       16,507       (178,061
 

 

 

 

Net Assets as of December 31, 2024:

   $ 2,493,829     $ 1,923,410     $ 1,333,696     $ 1,568,481  
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  7


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

   

BNY Mellon Sustainable U.S. Equity

Initial Shares

Subaccount

 

BNY Mellon VIF Appreciation Initial

Shares

Subaccount

   

BNY Mellon VIF Opportunistic Small

Cap Initial Shares

Subaccount

   

Fidelity® VIP Contrafund® Service
Class 2

Subaccount

 

Net Assets as of December 31, 2022:

   $ 160,653     $ 1,092,750     $ 1,043,533     $ 3,255,980  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    1,309       8,456       3,458       9,386  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    1,309       8,456       3,458       9,386  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    21,022       100,182       23,304       132,990  

Realized Gain (Loss) on Investments

    873       (23,657     13,622       122,840  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    21,895       76,525       36,926       255,830  

Net Change in Unrealized Appreciation (Depreciation)

    15,836       139,796       55,299       767,791  
 

 

 

 

Net Gain (Loss) on Investment

    37,731       216,321       92,225       1,023,621  

Net Increase (Decrease) in Net Assets Resulting from Operations

    39,040       224,777       95,683       1,033,007  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    1,372       (50,542     (28,598     (364,259
 

 

 

 

Total Increase (Decrease) in Net Assets

    40,412       174,235       67,085       668,748  
 

 

 

 

Net Assets as of December 31, 2023:

   $ 201,065     $ 1,266,985     $ 1,110,618     $ 3,924,728  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    1,193       5,768       7,648       1,506  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    1,193       5,768       7,648       1,506  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    1,420       96,340       -       551,111  

Realized Gain (Loss) on Investments

    10,396       (15,579     34,426       223,024  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    11,816       80,761       34,426       774,135  

Net Change in Unrealized Appreciation (Depreciation)

    35,293       74,414       7,835       476,997  
 

 

 

 

Net Gain (Loss) on Investment

    47,109       155,175       42,261       1,251,132  

Net Increase (Decrease) in Net Assets Resulting from Operations

    48,302       160,943       49,909       1,252,638  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (10,772     (40,298     (62,695     (437,609
 

 

 

 

Total Increase (Decrease) in Net Assets

    37,530       120,645       (12,786     815,029  
 

 

 

 

Net Assets as of December 31, 2024:

   $ 238,595     $ 1,387,630     $ 1,097,832     $ 4,739,757  
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  8


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

   

  Fidelity® VIP Equity-Income Service  

Class 2

Subaccount

 

Fidelity® VIP Index 500 Service

Class 2

Subaccount

   

  Franklin Small Cap Value Class 2  

Shares

Subaccount

   

  Franklin Small-Mid Cap Growth  
Class 2 Shares

Subaccount

 

Net Assets as of December 31, 2022:

   $ 1,242,007     $ 5,277,795     $ 1,753,706     $ 1,876,716  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    22,180       72,555       9,186       -  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    22,180       72,555       9,186       -  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    38,061       53,645       99,584       -  

Realized Gain (Loss) on Investments

    9,480       229,714       (30,130     (21,597
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    47,541       283,359       69,454       (21,597

Net Change in Unrealized Appreciation (Depreciation)

    55,939       979,770       135,976       519,494  
 

 

 

 

Net Gain (Loss) on Investment

    103,480       1,263,129       205,430       497,897  

Net Increase (Decrease) in Net Assets Resulting from Operations

    125,660       1,335,684       214,616       497,897  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (40,214     (279,701     (113,909     (42,452
 

 

 

 

Total Increase (Decrease) in Net Assets

    85,446       1,055,983       100,707       455,445  
 

 

 

 

Net Assets as of December 31, 2023:

   $ 1,327,453     $ 6,333,778     $ 1,854,413     $ 2,332,161  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    23,286       74,972       17,892       -  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    23,286       74,972       17,892       -  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    87,201       4,386       44,222       -  

Realized Gain (Loss) on Investments

    5,693       268,025       (10,666     (66,275
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    92,894       272,411       33,556       (66,275

Net Change in Unrealized Appreciation (Depreciation)

    80,620       1,185,432       161,663       310,091  
 

 

 

 

Net Gain (Loss) on Investment

    173,514       1,457,843       195,219       243,816  

Net Increase (Decrease) in Net Assets Resulting from Operations

    196,800       1,532,815       213,111       243,816  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (52,947     (381,665     (88,036     (201,856
 

 

 

 

Total Increase (Decrease) in Net Assets

    143,853       1,151,150       125,075       41,960  
 

 

 

 

Net Assets as of December 31, 2024:

   $ 1,471,306     $ 7,484,928     $ 1,979,488     $ 2,374,121  
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  9


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

   

  Invesco V.I. High Yield Series I  
Shares

Subaccount

 

Janus Henderson - Balanced Service
Shares

Subaccount

   

  Janus Henderson - Global Research  
Service Shares

Subaccount

   

  MFS® Growth Initial Class  

Subaccount

 

Net Assets as of December 31, 2022:

   $ 635,628     $ 1,339,017     $ 1,418,180     $ 1,627,948  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    34,685       24,837       12,211       -  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    34,685       24,837       12,211       -  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       -       45,693       149,616  

Realized Gain (Loss) on Investments

    (12,245     28,438       38,549       50,954  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    (12,245     28,438       84,242       200,570  

Net Change in Unrealized Appreciation (Depreciation)

    40,146       142,729       271,962       375,982  
 

 

 

 

Net Gain (Loss) on Investment

    27,901       171,167       356,204       576,552  

Net Increase (Decrease) in Net Assets Resulting from Operations

    62,586       196,004       368,415       576,552  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (59,187     (83,415     (54,050     (74,703
 

 

 

 

Total Increase (Decrease) in Net Assets

    3,399       112,589       314,365       501,849  
 

 

 

 

Net Assets as of December 31, 2023:

   $ 639,027     $ 1,451,606     $ 1,732,545     $ 2,129,797  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    38,917       26,949       10,433       -  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    38,917       26,949       10,433       -  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       -       56,777       193,314  

Realized Gain (Loss) on Investments

    (3,328     47,459       183,365       68,473  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    (3,328     47,459       240,142       261,787  

Net Change in Unrealized Appreciation (Depreciation)

    15,280       140,123       123,343       399,995  
 

 

 

 

Net Gain (Loss) on Investment

    11,952       187,582       363,485       661,782  

Net Increase (Decrease) in Net Assets Resulting from Operations

    50,869       214,531       373,918       661,782  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    16,042       (93,830     (261,615     (90,091
 

 

 

 

Total Increase (Decrease) in Net Assets

    66,911       120,701       112,303       571,691  
 

 

 

 

Net Assets as of December 31, 2024:

   $ 705,938     $ 1,572,307     $ 1,844,848     $ 2,701,488  
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  10


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

   

  MFS® Investors Trust Initial Class  

Subaccount

 

MFS® Research Initial Class

Subaccount

   

  MS VIF Emerging Markets Equity  
Class I Shares

Subaccount

   

  MS VIF Global Strategist Class I  

Shares

Subaccount

 

Net Assets as of December 31, 2022:

   $ 455,098     $ 310,187     $ 1,121,921     $ 865,099  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    3,377       1,708       18,636       15,004  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    3,377       1,708       18,636       15,004  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    25,990       18,051       20,173       -  

Realized Gain (Loss) on Investments

    8,782       10,903       (5,175     (33,117
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    34,772       28,954       14,998       (33,117

Net Change in Unrealized Appreciation (Depreciation)

    43,644       36,251       97,633       136,638  
 

 

 

 

Net Gain (Loss) on Investment

    78,416       65,205       112,631       103,521  

Net Increase (Decrease) in Net Assets Resulting from Operations

    81,793       66,913       131,267       118,525  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (58,229     (26,358     (49,897     (67,567
 

 

 

 

Total Increase (Decrease) in Net Assets

    23,564       40,555       81,370       50,958  
 

 

 

 

Net Assets as of December 31, 2023:

   $ 478,662     $ 350,742     $ 1,203,291     $ 916,057  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    3,712       2,226       17,303       -  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    3,712       2,226       17,303       -  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    37,768       21,401       -       -  

Realized Gain (Loss) on Investments

    5,406       6,820       2,604       (21,838
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    43,174       28,221       2,604       (21,838

Net Change in Unrealized Appreciation (Depreciation)

    45,522       33,979       74,107       90,794  
 

 

 

 

Net Gain (Loss) on Investment

    88,696       62,200       76,711       68,956  

Net Increase (Decrease) in Net Assets Resulting from Operations

    92,408       64,426       94,014       68,956  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (16,406     (28,748     (31,911     (73,443
 

 

 

 

Total Increase (Decrease) in Net Assets

    76,002       35,678       62,103       (4,487
 

 

 

 

Net Assets as of December 31, 2024:

   $ 554,664     $ 386,420     $ 1,265,394     $ 911,570  
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  11


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

   

  PIMCO Real Return Administrative  
Class

Subaccount

 

TA Aegon Bond Initial Class

Subaccount

   

  TA Aegon Sustainable Equity  

Income Initial Class

Subaccount

      TA Aegon U.S. Government  
Securities Initial Class
Subaccount
 

Net Assets as of December 31, 2022:

   $ 545,505     $ 1,537,711     $ 2,199,925     $ 440,517  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    14,454       14,588       48,040       7,915  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    14,454       14,588       48,040       7,915  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       -       -       -  

Realized Gain (Loss) on Investments

    (8,331     (22,638     24,020       (13,787
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    (8,331     (22,638     24,020       (13,787

Net Change in Unrealized Appreciation (Depreciation)

    12,878       106,342       63,389       23,505  
 

 

 

 

Net Gain (Loss) on Investment

    4,547       83,704       87,409       9,718  

Net Increase (Decrease) in Net Assets Resulting from Operations

    19,001       98,292       135,449       17,633  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (83,481     (39,167     (48,764     (12,825
 

 

 

 

Total Increase (Decrease) in Net Assets

    (64,480     59,125       86,685       4,808  
 

 

 

 

Net Assets as of December 31, 2023:

   $ 481,025     $ 1,596,836     $ 2,286,610     $ 445,325  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    12,756       55,855       47,534       16,934  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    12,756       55,855       47,534       16,934  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       -       -       -  

Realized Gain (Loss) on Investments

    (1,538     (82,630     110,979       (4,564
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    (1,538     (82,630     110,979       (4,564

Net Change in Unrealized Appreciation (Depreciation)

    (580     51,842       206,028       (10,779
 

 

 

 

Net Gain (Loss) on Investment

    (2,118     (30,788     317,007       (15,343

Net Increase (Decrease) in Net Assets Resulting from Operations

    10,638       25,067       364,541       1,591  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    91       (287,368     (283,569     15,041  
 

 

 

 

Total Increase (Decrease) in Net Assets

    10,729       (262,301     80,972       16,632  
 

 

 

 

Net Assets as of December 31, 2024:

   $ 491,754     $ 1,334,535     $ 2,367,582     $ 461,957  
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  12


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

   

TA BlackRock Government Money
Market Initial Class

Subaccount

 

TA BlackRock iShares Edge 40 Initial
Class

Subaccount

   

TA BlackRock Real Estate Securities
Initial Class

Subaccount

   

TA Janus Mid-Cap Growth Initial
Class

Subaccount

 

Net Assets as of December 31, 2022:

   $ 1,458,903     $ 124,079     $ 719,921     $ 1,625,679  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    85,323       2,952       43,746       -  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    85,323       2,952       43,746       -  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       2,008       -       292,173  

Realized Gain (Loss) on Investments

    -       (662     (3,587     30,314  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    -       1,346       (3,587     322,487  

Net Change in Unrealized Appreciation (Depreciation)

    -       7,442       54,760       (56,966
 

 

 

 

Net Gain (Loss) on Investment

    -       8,788       51,173       265,521  

Net Increase (Decrease) in Net Assets Resulting from Operations

    85,323       11,740       94,919       265,521  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    594,629       514       (11,866     (128,093
 

 

 

 

Total Increase (Decrease) in Net Assets

    679,952       12,254       83,053       137,428  
 

 

 

 

Net Assets as of December 31, 2023:

   $ 2,138,855     $ 136,333     $ 802,974     $ 1,763,107  
 

 

 

 

Investment Income:

       

Reinvested Dividends

    111,450       3,862       17,686       2,471  

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -  
 

 

 

 

Net Investment Income (Loss)

    111,450       3,862       17,686       2,471  

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       2,154       -       110,488  

Realized Gain (Loss) on Investments

    -       (788     (1,915     8,740  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    -       1,366       (1,915     119,228  

Net Change in Unrealized Appreciation (Depreciation)

    -       3,788       (5,154     128,959  
 

 

 

 

Net Gain (Loss) on Investment

    -       5,154       (7,069     248,187  

Net Increase (Decrease) in Net Assets Resulting from Operations

    111,450       9,016       10,617       250,658  
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    47,453       5,676       (676     (56,682
 

 

 

 

Total Increase (Decrease) in Net Assets

    158,903       14,692       9,941       193,976  
 

 

 

 

Net Assets as of December 31, 2024:

   $ 2,297,758     $ 151,025     $ 812,915     $ 1,957,083  
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  13


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

   

 TA JPMorgan Asset Allocation - 

Conservative Initial Class

Subaccount

   

 TA JPMorgan Asset Allocation - 

Growth Initial Class

Subaccount

   

 TA JPMorgan Asset Allocation - 

Moderate Initial Class

Subaccount

   

 TA JPMorgan Asset Allocation - 

Moderate Growth Initial Class

Subaccount

 

Net Assets as of December 31, 2022:

   $ 465,983     $ 6,009,337     $ 690,686     $ 4,851,700   
 

 

 

 

Investment Income:

       

Reinvested Dividends

    10,482       107,361       13,115       99,317   

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -   
 

 

 

 

Net Investment Income (Loss)

    10,482       107,361       13,115       99,317   

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       87,503       4,736       219,793   

Realized Gain (Loss) on Investments

    (6,168     (46,965     779       (9,048)  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    (6,168     40,538       5,515       210,745   

Net Change in Unrealized Appreciation (Depreciation)

    27,571       999,352       36,750       259,527   
 

 

 

 

Net Gain (Loss) on Investment

    21,403       1,039,890       42,265       470,272   

Net Increase (Decrease) in Net Assets Resulting from Operations

    31,885       1,147,251       55,380       569,589   
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (16,207     (863,674     (118,310     (361,553)  
 

 

 

 

Total Increase (Decrease) in Net Assets

    15,678       283,577       (62,930     208,036   
 

 

 

 

Net Assets as of December 31, 2023:

   $ 481,661     $ 6,292,914     $ 627,756     $ 5,059,736   
 

 

 

 

Investment Income:

       

Reinvested Dividends

    10,114       84,128       9,879       62,780   

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -   
 

 

 

 

Net Investment Income (Loss)

    10,114       84,128       9,879       62,780   

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       117,324       -       -   

Realized Gain (Loss) on Investments

    (3,004     (61,634     (8,968     (76,932)  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    (3,004     55,690       (8,968     (76,932)  

Net Change in Unrealized Appreciation (Depreciation)

    20,147       828,590       50,119       551,737   
 

 

 

 

Net Gain (Loss) on Investment

    17,143       884,280       41,151       474,805   

Net Increase (Decrease) in Net Assets Resulting from Operations

    27,257       968,408       51,030       537,585   
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    (4,531     (732,311     (197,025     (329,319)  
 

 

 

 

Total Increase (Decrease) in Net Assets

    22,726       236,097       (145,995     208,266   
 

 

 

 

Net Assets as of December 31, 2024:

   $ 504,387     $ 6,529,011     $ 481,761     $ 5,268,002   
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  14


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

   

 TA JPMorgan Tactical Allocation 

Initial Class

Subaccount

   

 TA Morgan Stanley Capital Growth 

Initial Class

Subaccount

     TA Small/Mid Cap Value Initial Class 
Subaccount
   

TA TSW Mid Cap Value

 Opportunities Initial Class 
Subaccount

 

Net Assets as of December 31, 2022:

   $ 1,227,171     $ 723,880     $ 1,718,171     $ 413,876   
 

 

 

 

Investment Income:

       

Reinvested Dividends

    24,453       -       17,993       6,320   

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -   
 

 

 

 

Net Investment Income (Loss)

    24,453       -       17,993       6,320   

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       -       165,495       38,778   

Realized Gain (Loss) on Investments

    (11,768     (245,620     (14,348     (6,953)  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    (11,768     (245,620     151,147       31,825   

Net Change in Unrealized Appreciation (Depreciation)

    101,708       579,471       34,007       8,279   
 

 

 

 

Net Gain (Loss) on Investment

    89,940       333,851       185,154       40,104   

Net Increase (Decrease) in Net Assets Resulting from Operations

    114,393       333,851       203,147       46,424   
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    53,416       (52,430     (117,678     5,326   
 

 

 

 

Total Increase (Decrease) in Net Assets

    167,809       281,421       85,469       51,750   
 

 

 

 

Net Assets as of December 31, 2023:

   $ 1,394,980     $ 1,005,301     $ 1,803,640     $ 465,626   
 

 

 

 

Investment Income:

       

Reinvested Dividends

    40,454       -       17,862       5,455   

Investment Expense:

       

Mortality and Expense Risk and Administrative Charges

    -       -       -       -   
 

 

 

 

Net Investment Income (Loss)

    40,454       -       17,862       5,455   

Increase (Decrease) in Net Assets from Operations:

       

Capital Gain Distributions

    -       -       59,775       60,805   

Realized Gain (Loss) on Investments

    (13,335     (232,827     (10,476     (21,252)  
 

 

 

 

Net Realized Capital Gains (Losses) on Investments

    (13,335     (232,827     49,299       39,553   

Net Change in Unrealized Appreciation (Depreciation)

    31,644       661,414       92,030       (10,567)  
 

 

 

 

Net Gain (Loss) on Investment

    18,309       428,587       141,329       28,986   

Net Increase (Decrease) in Net Assets Resulting from Operations

    58,763       428,587       159,191       34,441   
 

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

    428       (51,674     (49,102     (129,802)  
 

 

 

 

Total Increase (Decrease) in Net Assets

    59,191       376,913       110,089       (95,361)  
 

 

 

 

Net Assets as of December 31, 2024:

   $ 1,454,171     $ 1,382,214     $ 1,913,729     $ 370,265   
 

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  15


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Statements of Operations and Changes in Net Assets

Years Ended December 31, 2024 and 2023

 

    

 TA WMC US Growth Initial Class 

Subaccount

 

Net Assets as of December 31, 2022:

    $ 6,471,911   
  

 

 

 

Investment Income:

  

Reinvested Dividends

     3,157   

Investment Expense:

  

Mortality and Expense Risk and Administrative Charges

     -   
  

 

 

 

Net Investment Income (Loss)

     3,157   

Increase (Decrease) in Net Assets from Operations:

  

Capital Gain Distributions

     222,352   

Realized Gain (Loss) on Investments

     72,979   
  

 

 

 

Net Realized Capital Gains (Losses) on Investments

     295,331  

Net Change in Unrealized Appreciation (Depreciation)

     2,393,183   
  

 

 

 

Net Gain (Loss) on Investment

     2,688,514   

Net Increase (Decrease) in Net Assets Resulting from Operations

     2,691,671   
  

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

     (206,186)  
  

 

 

 

Total Increase (Decrease) in Net Assets

     2,485,485   
  

 

 

 

Net Assets as of December 31, 2023:

    $ 8,957,396   
  

 

 

 

Investment Income:

  

Reinvested Dividends

     1,125   

Investment Expense:

  

Mortality and Expense Risk and Administrative Charges

     -   
  

 

 

 

Net Investment Income (Loss)

     1,125   

Increase (Decrease) in Net Assets from Operations:

  

Capital Gain Distributions

     915,912   

Realized Gain (Loss) on Investments

     210,208   
  

 

 

 

Net Realized Capital Gains (Losses) on Investments

     1,126,120   

Net Change in Unrealized Appreciation (Depreciation)

     1,391,109   
  

 

 

 

Net Gain (Loss) on Investment

     2,517,229   

Net Increase (Decrease) in Net Assets Resulting from Operations

     2,518,354   
  

 

 

 

Increase (Decrease) in Net Assets from Contract Transactions

     (562,817)  
  

 

 

 

Total Increase (Decrease) in Net Assets

     1,955,537   
  

 

 

 

Net Assets as of December 31, 2024:

    $ 10,912,933   
  

 

 

 

 

See Accompanying Notes.

(1) See Footnote 1

  16


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

 

1. Organization

Transamerica Life Insurance Co Separate Account VUL-6 (the Separate Account) is a segregated investment account of Transamerica Life Insurance Company (TLIC), an indirect wholly owned subsidiary of Aegon Ltd., a holding company organized under the laws of Bermuda.

The Separate Account is registered with the Securities and Exchange Commission as a Unit Investment Trust pursuant to provisions of the Investment Company Act of 1940. TLIC and the Separate Account are regulated by the Securities and Exchange Commission. The assets and liabilities of the Separate Account are clearly identified and distinguished from TLIC’s other assets and liabilities. The Separate Account consists of multiple investment subaccounts. Each subaccount invests exclusively in the corresponding portfolio of a Mutual Fund. Each Mutual Fund is registered as an open-end management investment company under the Investment Company Act of 1940, as amended. Activity in these specified investment subaccounts is available to contract owners of TransAccumulator.

Subaccount Investment by Mutual Fund:

 

Subaccount    Mutual Fund

AB Variable Products Series Fund, Inc.

  

AB Variable Products Series Fund, Inc.

AB Large Cap Growth Class B Shares

  

AB Large Cap Growth Portfolio Class B Shares

AB Relative Value Class B Shares

  

AB Relative Value Portfolio Class B Shares

The Alger Portfolios

  

The Alger Portfolios

Alger Growth & Income Class I-2 Shares

  

Alger Growth & Income Portfolio Class I-2 Shares

BNY Mellon Funds

  

BNY Mellon Funds

BNY Mellon MidCap Stock Initial Shares

  

BNY Mellon MidCap Stock Portfolio Initial Shares

BNY Mellon Sustainable U.S. Equity Initial Shares

  

BNY Mellon Sustainable U.S. Equity Portfolio Initial Shares

BNY Mellon VIF Appreciation Initial Shares

  

BNY Mellon VIF Appreciation Portfolio Initial Shares

BNY Mellon VIF Opportunistic Small Cap Initial Shares

  

BNY Mellon VIF Opportunistic Small Cap Portfolio Initial Shares

Fidelity® Variable Insurance Products Fund

  

Fidelity® Variable Insurance Products Fund

Fidelity® VIP Contrafund® Service Class 2

  

Fidelity® VIP Contrafund® Portfolio Service Class 2

Fidelity® VIP Equity-Income Service Class 2

  

Fidelity® VIP Equity-Income Portfolio Service Class 2

Fidelity® VIP Index 500 Service Class 2

  

Fidelity® VIP Index 500 Portfolio Service Class 2

Franklin Templeton Variable Insurance Products Trust

  

Franklin Templeton Variable Insurance Products Trust

Franklin Small Cap Value Class 2 Shares

  

Franklin Small Cap Value Fund Class 2 Shares

Franklin Small-Mid Cap Growth Class 2 Shares

  

Franklin Small-Mid Cap Growth Fund Class 2 Shares

AIM Variable Insurance Funds (Invesco Variable Insurance Funds)

  

AIM Variable Insurance Funds (Invesco Variable Insurance Funds)

Invesco V.I. High Yield Series I Shares

  

Invesco V.I. High Yield fund Series I Shares

Janus Aspen Series

  

Janus Aspen Series

Janus Henderson - Balanced Service Shares

  

Janus Henderson - Balanced Portfolio Service Shares

Janus Henderson - Global Research Service Shares

  

Janus Henderson - Global Research Portfolio Service Shares

MFS® Variable Insurance Trust

  

MFS® Variable Insurance Trust

MFS® Growth Initial Class

  

MFS® Growth Series Initial Class

MFS® Investors Trust Initial Class

  

MFS® Investors Trust Series Initial Class

MFS® Research Initial Class

  

MFS® Research Series Initial Class

Morgan Stanley Variable Insurance Fund, Inc.

  

Morgan Stanley Variable Insurance Fund, Inc.

MS VIF Emerging Markets Equity Class I Shares

  

MS VIF Emerging Markets Equity Portfolio Class I Shares

MS VIF Global Strategist Class I Shares

  

MS VIF Global Strategist Portfolio Class I Shares

PIMCO Variable Insurance Trust

  

PIMCO Variable Insurance Trust

PIMCO Real Return Administrative Class

  

PIMCO Real Return Portfolio Administrative Class

 

17


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

1. Organization (continued)

 

Subaccount Investment by Mutual Fund:

 

Subaccount    Mutual Fund

Transamerica Series Trust

  

Transamerica Series Trust

TA Aegon Bond Initial Class

  

Transamerica Aegon Bond VP Initial Class

TA Aegon Sustainable Equity Income Initial Class

  

Transamerica Aegon Sustainable Equity Income VP Initial Class

TA Aegon U.S. Government Securities Initial Class

  

Transamerica Aegon U.S. Government Securities VP Initial Class

TA BlackRock Government Money Market Initial Class

  

Transamerica BlackRock Government Money Market VP Initial Class

TA BlackRock iShares Edge 40 Initial Class

  

Transamerica BlackRock iShares Edge 40 VP Initial Class

TA BlackRock Real Estate Securities Initial Class

  

Transamerica BlackRock Real Estate Securities VP Initial Class

TA Janus Mid-Cap Growth Initial Class

  

Transamerica Janus Mid-Cap Growth VP Initial Class

TA JPMorgan Asset Allocation - Conservative Initial Class

  

Transamerica JPMorgan Asset Allocation - Conservative VP Initial Class

TA JPMorgan Asset Allocation - Growth Initial Class

  

Transamerica JPMorgan Asset Allocation - Growth VP Initial Class

TA JPMorgan Asset Allocation - Moderate Initial Class

  

Transamerica JPMorgan Asset Allocation - Moderate VP Initial Class

TA JPMorgan Asset Allocation - Moderate Growth Initial Class

  

Transamerica JPMorgan Asset Allocation - Moderate Growth VP Initial Class

TA TSW Mid Cap Value Opportunities Initial Class

  

Transamerica TSW Mid Cap Value Opportunities VP Initial Class

TA JPMorgan Tactical Allocation Initial Class

  

Transamerica JPMorgan Tactical Allocation VP Initial Class

TA Morgan Stanley Capital Growth Initial Class

  

Transamerica Morgan Stanley Capital Growth VP Initial Class

TA Small/Mid Cap Value Initial Class

  

Transamerica Small/Mid Cap Value VP Initial Class

TA WMC US Growth Initial Class

  

Transamerica WMC US Growth VP Initial Class

The following subaccount name changes were made effective during the fiscal year ended December 31, 2024:

 

Subaccount    Formerly

TA TSW Mid Cap Value Opportunities Initial Class

  

TA JPMorgan Mid Cap Value Initial Class

 

18


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

 

2. Summary of Significant Accounting Policies

The financial statements included herein have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for variable life separate accounts registered as unit investment trusts. The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions regarding matters that affect the reported amount of assets and liabilities. Actual results could differ from those estimates.

Investments

Net purchase payments received by the Separate Account are invested in the portfolios of the Mutual Funds as selected by the contract owner. Investments are stated at the closing net asset values per share on December 31, 2024.

Realized capital gains and losses from sales of shares in the Separate Account are determined on the first-in, first-out basis. Investment transactions are accounted for on the trade date (date the order to buy or sell is executed) and dividend income is recorded on the ex-dividend date. Unrealized gains or losses from investments in the Mutual Funds are included in the Statements of Operations and Changes in Net Assets.

Dividend Income

Dividends received from the Mutual Fund investments are reinvested to purchase additional mutual fund shares.

Fair Value Measurements and Fair Value Hierarchy

The Accounting Standards Codification™ (ASC) 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the nature of inputs used to measure fair value and enhances disclosure requirements for fair value measurements.

The Separate Account has categorized its financial instruments into a three level hierarchy which is based on the priority of the inputs to the valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument.

Financial assets and liabilities recorded at fair value on the Statements of Assets and Liabilities are categorized as follows:

Level 1. Unadjusted quoted prices for identical assets or liabilities in an active market.

Level 2. Quoted prices in markets that are not active or inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:

a) Quoted prices for similar assets or liabilities in active markets

b) Quoted prices for identical or similar assets or liabilities in non-active markets

c) Inputs other than quoted market prices that are observable

d) Inputs that are derived principally from or corroborated by observable market data through correlation or other means.

Level 3. Prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. They reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

All investments in the Mutual Funds included in the Statements of Assets and Liabilities are stated at fair value and are based upon published closing NAV per share and therefore are considered Level 1.

There were no transfers between Level 1, Level 2 and Level 3 during the year ended December 31, 2024.

 

19


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

 

3. Investments

The aggregate cost of purchases and proceeds from sales of investments for the period ended December 31, 2024 were as follows:

 

 Subaccount   Purchases     Sales  

 AB Large Cap Growth Class B Shares

  $             361,170     $           255,736  

 AB Relative Value Class B Shares

    546,756       148,509  

 Alger Growth & Income Class I-2 Shares

    25,694       273,920  

 BNY Mellon MidCap Stock Initial Shares

    73,517       404,626  

 BNY Mellon Sustainable U.S. Equity Initial Shares

    26,729       34,888  

 BNY Mellon VIF Appreciation Initial Shares

    131,370       69,560  

 BNY Mellon VIF Opportunistic Small Cap Initial Shares

    43,905       98,952  

 Fidelity® VIP Contrafund® Service Class 2

    651,543       536,535  

 Fidelity® VIP Equity-Income Service Class 2

    128,683       71,143  

 Fidelity® VIP Index 500 Service Class 2

    154,122       456,432  

 Franklin Small Cap Value Class 2 Shares

    94,107       120,029  

 Franklin Small-Mid Cap Growth Class 2 Shares

    66,456       268,312  

 Invesco V.I. High Yield Series I Shares

    86,277       31,319  

 Janus Henderson - Balanced Service Shares

    50,271       117,152  

 Janus Henderson - Global Research Service Shares

    127,867       322,272  

 MFS® Growth Initial Class

    206,144       102,921  

 MFS® Investors Trust Initial Class

    44,430       19,356  

 MFS® Research Initial Class

    26,437       31,557  

 MS VIF Emerging Markets Equity Class I Shares

    61,754       76,362  

 MS VIF Global Strategist Class I Shares

    35,526       108,968  

 PIMCO Real Return Administrative Class

    43,445       30,598  

 TA Aegon Bond Initial Class

    139,681       371,194  

 TA Aegon Sustainable Equity Income Initial Class

    98,525       334,561  

 TA Aegon U.S. Government Securities Initial Class

    44,861       12,887  

 TA BlackRock Government Money Market Initial Class

    306,475       147,575  

 TA BlackRock iShares Edge 40 Initial Class

    18,945       7,253  

 TA BlackRock Real Estate Securities Initial Class

    46,978       29,968  

 TA Janus Mid-Cap Growth Initial Class

    146,330       90,052  

 TA JPMorgan Asset Allocation - Conservative Initial Class

    23,144       17,560  

 TA JPMorgan Asset Allocation - Growth Initial Class

    321,892       852,753  

 TA JPMorgan Asset Allocation - Moderate Initial Class

    18,197       205,344  

 TA JPMorgan Asset Allocation - Moderate Growth Initial Class

    149,019       415,556  

 TA JPMorgan Tactical Allocation Initial Class

    103,648       62,767  

 TA Morgan Stanley Capital Growth Initial Class

    5,666       57,340  

 TA Small/Mid Cap Value Initial Class

    103,606       75,071  

 TA TSW Mid Cap Value Opportunities Initial Class

    75,713       139,254  

 TA WMC US Growth Initial Class

    1,084,639       730,416  

 

20


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

 

4. Change in Units

The change in units outstanding were as follows:

 

     Year Ended December 31, 2024            Year Ended December 31, 2023  
 Subaccount    Units Purchased      

Units Redeemed

and Transferred

to/from

   

Net Increase

(Decrease)

           Units Purchased      

Units Redeemed

and Transferred

to/from

   

Net Increase

(Decrease)

 

 AB Large Cap Growth Class B Shares

     3,341        (3,232     109          333        (1,037     (704

 AB Relative Value Class B Shares

     8,705        (2,747     5,958          404        (1,316     (912

 Alger Growth & Income Class I-2 Shares

     219        (4,624     (4,405        195        (3,142     (2,947

 BNY Mellon MidCap Stock Initial Shares

     552        (7,105     (6,553        566        (1,595     (1,029

 BNY Mellon Sustainable U.S. Equity Initial Shares

     415        (618     (203        154        (111     43  

 BNY Mellon VIF Appreciation Initial Shares

     474        (1,114     (640        328        (1,280     (952

 BNY Mellon VIF Opportunistic Small Cap Initial Shares

     1,093        (2,926     (1,833        467        (1,358     (891

 Fidelity® VIP Contrafund® Service Class 2

     969        (5,776     (4,807        1,230        (6,508     (5,278

 Fidelity® VIP Equity-Income Service Class 2

     370        (1,465     (1,095        602        (1,579     (977

 Fidelity® VIP Index 500 Service Class 2

     1,088        (6,266     (5,178        2,991        (7,913     (4,922

 Franklin Small Cap Value Class 2 Shares

     553        (2,042     (1,489        785        (3,005     (2,220

 Franklin Small-Mid Cap Growth Class 2 Shares

     1,280        (5,032     (3,752        647        (1,543     (896

 Invesco V.I. High Yield Series I Shares

     2,790        (1,809     981          642        (4,336     (3,694

 Janus Henderson - Balanced Service Shares

     430        (2,142     (1,712        304        (2,094     (1,790

 Janus Henderson - Global Research Service Shares

     1,447        (7,872     (6,425        833        (2,495     (1,662

 MFS® Growth Initial Class

     131        (1,069     (938        191        (1,217     (1,026

 MFS® Investors Trust Initial Class

     45        (301     (256        101        (1,204     (1,103

 MFS® Research Initial Class

     40        (443     (403        58        (513     (455

 MS VIF Emerging Markets Equity Class I Shares

     995        (1,687     (692        854        (2,090     (1,236

 MS VIF Global Strategist Class I Shares

     1,142        (3,396     (2,254        1,029        (3,381     (2,352

 PIMCO Real Return Administrative Class

     1,644        (1,619     25          1,622        (6,224     (4,602

 TA Aegon Bond Initial Class

     4,203        (18,868     (14,665        2,812        (4,834     (2,022

 TA Aegon Sustainable Equity Income Initial Class

     1,596        (10,327     (8,731        1,723        (3,440     (1,717

 TA Aegon U.S. Government Securities Initial Class

     1,757        (813     944          1,777        (2,577     (800

 TA BlackRock Government Money Market Initial Class

     145,238        (108,486     36,752          649,289        (189,150     460,139  

 TA BlackRock iShares Edge 40 Initial Class

     542        (309     233          197        (174     23  

 TA BlackRock Real Estate Securities Initial Class

     1,204        (1,209     (5        983        (1,504     (521

 TA Janus Mid-Cap Growth Initial Class

     605        (1,654     (1,049        430        (3,238     (2,808

 

21


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

4. Change in Units (continued)

 

 

   

 

Year Ended December 31, 2024

          Year Ended December 31, 2023  
 Subaccount   Units Purchased     

Units Redeemed

and Transferred

to/from

   

Net Increase

(Decrease)

          Units Purchased     

Units Redeemed

and Transferred

to/from

   

Net Increase

(Decrease)

 

 TA JPMorgan Asset Allocation - Conservative Initial Class

    547       (750     (203       260       (1,022     (762

 TA JPMorgan Asset Allocation - Growth Initial Class

    2,906       (21,272     (18,366       2,305       (27,567     (25,262

 TA JPMorgan Asset Allocation - Moderate Initial Class

    294       (7,146     (6,852       667       (5,409     (4,742

 TA JPMorgan Asset Allocation - Moderate Growth Initial Class

    2,638       (12,946     (10,308       3,286       (15,838     (12,552

 TA JPMorgan Tactical Allocation Initial Class

    2,606       (2,619     (13       4,594       (2,112     2,482  

 TA Morgan Stanley Capital Growth Initial Class

    375       (3,767     (3,392       2,285       (6,369     (4,084

 TA Small/Mid Cap Value Initial Class

    951       (2,681     (1,730       1,155       (5,988     (4,833

 TA TSW Mid Cap Value Opportunities Initial Class

    181       (2,738     (2,557       682       (538     144  

 TA WMC US Growth Initial Class

    1,930       (8,366     (6,436       908       (3,986     (3,078

 

22


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

4. Change in Unit Dollars (continued)

 

    Year Ended December 31, 2024           Year Ended December 31, 2023  
 Subaccount  

Units Purchased in

Dollars

   

Units Redeemed

and Transferred

to/from in Dollars

    Dollar Net Increase
(Decrease)
         

Units Purchased in

Dollars

   

Units Redeemed

and Transferred

to/from in Dollars

   

Dollar Net Increase

(Decrease)

 

 AB Large Cap Growth Class B Shares

  $ 255,843     $ (255,735   $ 108       $ 20,109     $ (64,336   $ (44,227

 AB Relative Value Class B Shares

    453,303       (148,508     304,795         17,931       (60,182     (42,251

 Alger Growth & Income Class I-2 Shares

    12,967       (273,919     (260,952       9,140       (154,574     (145,434

 BNY Mellon MidCap Stock Initial Shares

    32,179       (404,626     (372,447       27,284       (80,347     (53,063

 BNY Mellon Sustainable U.S. Equity Initial Shares

    24,116       (34,888     (10,772       6,310       (4,938     1,372  

 BNY Mellon VIF Appreciation Initial Shares

    29,262       (69,560     (40,298       18,211       (68,753     (50,542

 BNY Mellon VIF Opportunistic Small Cap Initial Shares

    36,257       (98,952     (62,695       14,515       (43,113     (28,598

 Fidelity® VIP Contrafund® Service Class 2

    98,926       (536,535     (437,609       86,279       (450,538     (364,259

 Fidelity® VIP Equity-Income Service Class 2

    18,196       (71,143     (52,947       25,102       (65,316     (40,214

 Fidelity® VIP Index 500 Service Class 2

    74,763       (456,428     (381,665       175,530       (455,231     (279,701

 Franklin Small Cap Value Class 2 Shares

    31,993       (120,029     (88,036       40,380       (154,289     (113,909

 Franklin Small-Mid Cap Growth Class 2 Shares

    66,456       (268,312     (201,856       29,499       (71,951     (42,452

 Invesco V.I. High Yield Series I Shares

    47,361       (31,319     16,042         10,055       (69,242     (59,187

 Janus Henderson - Balanced Service Shares

    23,321       (117,151     (93,830       14,124       (97,539     (83,415

 Janus Henderson - Global Research Service Shares

    60,656       (322,271     (261,615       27,491       (81,541     (54,050

 MFS® Growth Initial Class

    12,830       (102,921     (90,091       13,120       (87,823     (74,703

 MFS® Investors Trust Initial Class

    2,950       (19,356     (16,406       5,147       (63,376     (58,229

 MFS® Research Initial Class

    2,810       (31,558     (28,748       3,284       (29,642     (26,358

 MS VIF Emerging Markets Equity Class I Shares

    44,451       (76,362     (31,911       34,365       (84,262     (49,897

 MS VIF Global Strategist Class I Shares

    35,525       (108,968     (73,443       28,898       (96,465     (67,567

 PIMCO Real Return Administrative Class

    30,689       (30,598     91         29,037       (112,518     (83,481

 TA Aegon Bond Initial Class

    83,827       (371,195     (287,368       53,384       (92,551     (39,167

 TA Aegon Sustainable Equity Income Initial Class

    50,991       (334,560     (283,569       48,267       (97,031     (48,764

 TA Aegon U.S. Government Securities Initial Class

    27,926       (12,885     15,041         27,724       (40,549     (12,825

 TA BlackRock Government Money Market Initial Class

    195,024       (147,571     47,453         841,264       (246,635     594,629  

 TA BlackRock iShares Edge 40 Initial Class

    12,929       (7,253     5,676         4,153       (3,639     514  

 TA BlackRock Real Estate Securities Initial Class

    29,291       (29,967     (676       22,025       (33,891     (11,866

 TA Janus Mid-Cap Growth Initial Class

    33,371       (90,053     (56,682       19,737       (147,830     (128,093

 

23


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

4. Change in Unit Dollars (continued)

 

    Year Ended December 31, 2024           Year Ended December 31, 2023  
 Subaccount  

Units Purchased in

Dollars

   

Units Redeemed

and Transferred

to/from in Dollars

    Dollar Net Increase
(Decrease)
         

Units Purchased in

Dollars

   

Units Redeemed

and Transferred

to/from in Dollars

   

Dollar Net Increase

(Decrease)

 

TA JPMorgan Asset Allocation - Conservative Initial Class

  $ 13,030     $ (17,561   $ (4,531     $ 5,483     $ (21,690   $ (16,207

TA JPMorgan Asset Allocation - Growth Initial Class

    120,440       (852,751     (732,311       77,299       (940,973     (863,674

TA JPMorgan Asset Allocation - Moderate Initial Class

    8,318       (205,343     (197,025       16,529       (134,839     (118,310

TA JPMorgan Asset Allocation - Moderate Growth Initial Class

    86,239       (415,558     (329,319       93,375       (454,928     (361,553

TA JPMorgan Tactical Allocation Initial Class

    63,194       (62,766     428         100,661       (47,245     53,416  

TA Morgan Stanley Capital Growth Initial Class

    5,665       (57,339     (51,674       28,687       (81,117     (52,430

TA Small/Mid Cap Value Initial Class

    25,969       (75,071     (49,102       28,975       (146,653     (117,678

TA TSW Mid Cap Value Opportunities Initial Class

    9,453       (139,255     (129,802       29,816       (24,490     5,326  

TA WMC US Growth Initial Class

    167,602       (730,419     (562,817       56,398       (262,584     (206,186

 

24


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

 

5. Financial Highlights

The Separate Account offers various death benefit options, which have differing fees that are charged against the contract owner’s account balance. These charges are discussed in more detail in the individual’s policy. Differences in the fee structures for these units result in different unit values, expense ratios, and total returns.

 

     At December 31     For the Year Ended December 31  
Subaccount      Units      

Unit Fair Value

Corresponding to

Lowest to Highest

Expense
Ratio

    

Net

  Assets  

   

Investment

Income

Ratio*

   

Expense

Ratio**

Lowest to

Highest

    

Total Return***

Corresponding to

Lowest to Highest
Expense Ratio

 

 

   

 

 

 

AB Large Cap Growth Class B Shares

                             

12/31/2024

     28,728       $86.81       to       $86.81      $ 2,493,829        -  %      0.00  %      to       0.00  %         24.95  %      to        24.95  % 

12/31/2023

     28,619       69.47       to       69.47        1,988,193        -       0.00       to       0.00          34.79       to        34.79  

12/31/2022

     29,323       51.54       to       51.54        1,511,353        -       0.00       to       0.00          (28.69     to        (28.69

12/31/2021

     16,238       72.28       to       72.28        1,173,639        -       0.00       to       0.00          28.65       to        28.65  

12/31/2020

     17,691       56.18       to       56.18        993,878        -       0.00       to       0.00          35.15       to        35.15  

AB Relative Value Class B Shares

                             

12/31/2024

     35,307       54.48       to       54.48        1,923,410        1.36       0.00       to       0.00          12.76       to        12.76  

12/31/2023

     29,349       48.31       to       48.31        1,417,875        1.29       0.00       to       0.00          11.72       to        11.72  

12/31/2022

     30,261       43.24       to       43.24        1,308,562        1.11       0.00       to       0.00          (4.42     to        (4.42

12/31/2021

     30,668       45.24       to       45.24        1,387,471        0.63       0.00       to       0.00          27.84       to        27.84  

12/31/2020

     33,649       35.39       to       35.39        1,190,838        1.38       0.00       to       0.00          2.47       to        2.47  

Alger Growth & Income Class I-2 Shares

 

                          

12/31/2024

     20,831       64.02       to       64.02        1,333,696        0.60       0.00       to       0.00          22.66       to        22.66  

12/31/2023

     25,236       52.19       to       52.19        1,317,189        1.40       0.00       to       0.00          23.93       to        23.93  

12/31/2022

     28,183       42.12       to       42.12        1,186,967        1.42       0.00       to       0.00          (14.98     to        (14.98

12/31/2021

     29,427       49.54       to       49.54        1,457,697        1.15       0.00       to       0.00          31.66       to        31.66  

12/31/2020

     30,503       37.62       to       37.62        1,147,666        1.40       0.00       to       0.00          14.88       to        14.88  

BNY Mellon MidCap Stock Initial Shares

 

                          

12/31/2024

     25,797       60.80       to       60.80        1,568,481        0.93       0.00       to       0.00          12.62       to        12.62  

12/31/2023

     32,350       53.99       to       53.99        1,746,542        0.78       0.00       to       0.00          18.31       to        18.31  

12/31/2022

     33,379       45.63       to       45.63        1,523,216        0.66       0.00       to       0.00          (14.08     to        (14.08

12/31/2021

     61,278       53.11       to       53.11        3,254,497        0.66       0.00       to       0.00          25.88       to        25.88  

12/31/2020

     71,367       42.19       to       42.19        3,011,001        0.81       0.00       to       0.00          8.11       to        8.11  

BNY Mellon Sustainable U.S. Equity Initial Shares

 

                        

12/31/2024

     3,877       61.55       to       61.55        238,595        0.53       0.00       to       0.00          24.89       to        24.89  

12/31/2023

     4,080       49.28       to       49.28        201,065        0.73       0.00       to       0.00          23.82       to        23.82  

12/31/2022

     4,037       39.80       to       39.80        160,653        0.52       0.00       to       0.00          (22.87     to        (22.87

12/31/2021

     4,064       51.60       to       51.60        209,701        0.79       0.00       to       0.00          27.00       to        27.00  

12/31/2020

     6,315       40.63       to       40.63        256,603        1.07       0.00       to       0.00          24.14       to        24.14  

BNY Mellon VIF Appreciation Initial Shares

 

                          

12/31/2024

     21,331       65.05       to       65.05        1,387,630        0.42       0.00       to       0.00          12.81       to        12.81  

12/31/2023

     21,971       57.67       to       57.67        1,266,985        0.72       0.00       to       0.00          20.97       to        20.97  

12/31/2022

     22,923       47.67       to       47.67        1,092,750        0.67       0.00       to       0.00          (18.06     to        (18.06

12/31/2021

     23,092       58.18       to       58.18        1,343,510        0.44       0.00       to       0.00          27.13       to        27.13  

12/31/2020

     23,433       45.77       to       45.77        1,072,435        0.80       0.00       to       0.00          23.69       to        23.69  

BNY Mellon VIF Opportunistic Small Cap Initial Shares

 

                        

12/31/2024

     31,403       34.96       to       34.96        1,097,832        0.69       0.00       to       0.00          4.62       to        4.62  

12/31/2023

     33,236       33.42       to       33.42        1,110,618        0.33       0.00       to       0.00          9.28       to        9.28  

12/31/2022

     34,127       30.58       to       30.58        1,043,533        -       0.00       to       0.00          (16.62     to        (16.62

12/31/2021

     34,861       36.67       to       36.67        1,278,456        0.11       0.00       to       0.00          16.46       to        16.46  

12/31/2020

     37,703       31.49       to       31.49        1,187,247       0.65       0.00       to       0.00          19.89       to        19.89  

Fidelity® VIP Contrafund® Service Class 2

 

                          

12/31/2024

     45,772       103.55       to       103.55        4,739,757        0.03       0.00       to       0.00          33.45       to        33.45  

12/31/2023

     50,579       77.60       to       77.60        3,924,728        0.26       0.00       to       0.00          33.12       to        33.12  

12/31/2022

     55,857       58.29       to       58.29        3,255,980        0.27       0.00       to       0.00          (26.49     to        (26.49

12/31/2021

     58,344       79.30       to       79.30        4,626,409        0.03       0.00       to       0.00          27.51       to        27.51  

12/31/2020

     63,163        62.19       to       62.19        3,927,945        0.08       0.00       to       0.00          30.23       to        30.23  

 

25


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

5. Financial Highlights (continued)

 

     At December 31     For the Year Ended December 31  
Subaccount      Units      

Unit Fair Value

Corresponding to

Lowest to Highest

Expense Ratio

    

Net

  Assets  

   

Investment

Income

Ratio*

   

Expense

Ratio**

Lowest to

Highest

   

Total Return***

Corresponding to

Lowest to Highest
Expense Ratio

 

 

   

 

 

 

Fidelity® VIP Equity-Income Service Class 2

                            

12/31/2024

     28,753       $51.17       to       $51.17      $ 1,471,306        1.62  %      0.00  %      to         0.00  %      15.06  %      to        15.06  % 

12/31/2023

     29,848       44.47       to       44.47        1,327,453        1.78       0.00       to         0.00       10.38       to        10.38  

12/31/2022

     30,825       40.29       to       40.29        1,242,007        1.72       0.00       to         0.00       (5.24     to        (5.24

12/31/2021

     31,886       42.52       to       42.52        1,355,859        1.69       0.00       to         0.00       24.60       to        24.60  

12/31/2020

     31,892       34.13       to       34.13        1,088,361        1.63       0.00       to         0.00       6.44       to        6.44  

Fidelity® VIP Index 500 Service Class 2

                            

12/31/2024

     95,430       78.43       to       78.43        7,484,928        1.05       0.00       to         0.00       24.59       to        24.59  

12/31/2023

     100,608       62.96       to       62.96        6,333,778        1.25       0.00       to         0.00       25.88       to        25.88  

12/31/2022

     105,530       50.01       to       50.01        5,277,795        1.23       0.00       to         0.00       (18.42     to        (18.42

12/31/2021

     122,594       61.30       to       61.30        7,515,452        1.02       0.00       to         0.00       28.26       to        28.26  

12/31/2020

     136,074       47.80       to       47.80        6,503,987        1.54       0.00       to         0.00       17.95       to        17.95  

Franklin Small Cap Value Class 2 Shares

                            

12/31/2024

     32,045       61.77       to       61.77        1,979,488        0.93       0.00       to         0.00       11.71       to        11.71  

12/31/2023

     33,534       55.30       to       55.30        1,854,413        0.52       0.00       to         0.00       12.75       to        12.75  

12/31/2022

     35,754       49.05       to       49.05        1,753,706        0.91       0.00       to         0.00       (10.06     to        (10.06

12/31/2021

     58,418       54.54       to       54.54        3,185,951        0.97       0.00       to         0.00       25.37       to        25.37  

12/31/2020

     66,520       43.50       to       43.50        2,893,818        1.48       0.00       to         0.00       5.19       to        5.19  

Franklin Small-Mid Cap Growth Class 2 Shares

                            

12/31/2024

     41,345       57.42       to       57.42        2,374,121        -       0.00       to         0.00       11.04       to        11.04  

12/31/2023

     45,097       51.71       to       51.71        2,332,161        -       0.00       to         0.00       26.74       to        26.74  

12/31/2022

     45,993       40.80       to       40.80        1,876,716        -       0.00       to         0.00       (33.69     to        (33.69

12/31/2021

     29,493       61.54       to       61.54        1,814,931        -       0.00       to         0.00       10.01       to        10.01  

12/31/2020

     35,202       55.94       to       55.94        1,969,023        -       0.00       to         0.00       55.09       to        55.09  

Invesco V.I. High Yield Series I Shares

                            

12/31/2024

     39,503       17.87       to       17.87        705,938        5.70       0.00       to         0.00       7.73       to        7.73  

12/31/2023

     38,522       16.59       to       16.59        639,027        5.34       0.00       to         0.00       10.18       to        10.18  

12/31/2022

     42,216       15.06       to       15.06        635,628        4.65       0.00       to         0.00       (9.55     to        (9.55

12/31/2021

     43,212       16.65       to       16.65        719,352        4.73       0.00       to         0.00       4.38       to        4.38  

12/31/2020

     43,676       15.95       to       15.95        696,552        5.99       0.00       to         0.00       3.32       to        3.32  

Janus Henderson - Balanced Service Shares

                            

12/31/2024

     27,144       57.93       to       57.93        1,572,307        1.76       0.00       to         0.00       15.15       to        15.15  

12/31/2023

     28,856       50.31       to       50.31        1,451,606        1.78       0.00       to         0.00       15.13       to        15.13  

12/31/2022

     30,646       43.69       to       43.69        1,339,017        1.17       0.00       to         0.00       (16.62     to        (16.62

12/31/2021

     23,164       52.40       to       52.40        1,213,833        0.87       0.00       to         0.00       16.91       to        16.91  

12/31/2020

     26,650       44.82       to       44.82        1,194,524        2.09       0.00       to         0.00       14.03       to        14.03  

Janus Henderson - Global Research Service Shares

                            

12/31/2024

     40,765       45.26       to       45.26        1,844,848        0.58       0.00       to         0.00       23.27       to        23.27  

12/31/2023

     47,190       36.71       to       36.71        1,732,545        0.78       0.00       to         0.00       26.47       to        26.47  

12/31/2022

     48,852       29.03       to       29.03        1,418,180        1.50       0.00       to         0.00       (19.61     to        (19.61

12/31/2021

     50,279       36.11       to       36.11        1,815,648        0.37       0.00       to         0.00       17.80       to        17.80  

12/31/2020

     51,761       30.66       to       30.66        1,586,786        0.65       0.00       to         0.00       19.76       to        19.76  

MFS® Growth Initial Class

                            

12/31/2024

     25,734       104.98       to       104.98        2,701,488        -       0.00       to         0.00       31.47       to        31.47  

12/31/2023

     26,672       79.85       to       79.85        2,129,797        -       0.00       to         0.00       35.86       to        35.86  

12/31/2022

     27,698       58.77       to       58.77        1,627,948        -       0.00       to         0.00       (31.63     to        (31.63

12/31/2021

     17,644       85.97       to       85.97        1,516,882        -       0.00       to         0.00       23.53       to        23.53  

12/31/2020

     18,024       69.59       to       69.59        1,254,355        -       0.00       to         0.00       31.86       to        31.86  

MFS® Investors Trust Initial Class

                            

12/31/2024

     8,148       68.07       to       68.07        554,664        0.70       0.00       to         0.00       19.52       to        19.52  

12/31/2023

     8,404       56.95       to       56.95        478,662        0.72       0.00       to         0.00       18.98       to        18.98  

12/31/2022

     9,507       47.87       to       47.87        455,098        0.68       0.00       to         0.00       (16.49     to        (16.49

12/31/2021

     9,720       57.32       to       57.32        557,137        0.65       0.00       to         0.00       26.81       to        26.81  

12/31/2020

     10,909        45.20       to       45.20        493,105        0.64       0.00       to         0.00       13.87       to        13.87  

 

26


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

5. Financial Highlights (continued)

 

     At December 31     For the Year Ended December 31  
Subaccount      Units      

Unit Fair Value

Corresponding to

Lowest to Highest

Expense Ratio

    

Net

  Assets  

   

Investment

Income

Ratio*

   

Expense

Ratio**

Lowest to

Highest

   

Total Return***

Corresponding to

Lowest to Highest
Expense Ratio

 

 

   

 

 

 

MFS® Research Initial Class

                          

12/31/2024

     5,104     $ 75.71       to     $ 75.71      $ 386,420        0.59  %      0.00  %      to       0.00  %      18.87  %      to        18.87  % 

12/31/2023

     5,507       63.69       to       63.69        350,742        0.52       0.00       to       0.00       22.42       to        22.42  

12/31/2022

     5,962       52.03       to       52.03        310,187        0.48       0.00       to       0.00       (17.21     to        (17.21

12/31/2021

     6,447       62.84       to       62.84        405,141        0.55       0.00       to       0.00       24.80       to        24.80  

12/31/2020

     6,530       50.36       to       50.36        328,832        0.74       0.00       to       0.00       16.59       to        16.59  

MS VIF Emerging Markets Equity Class I Shares

                          

12/31/2024

     27,387       46.20       to       46.20        1,265,394        1.36       0.00       to       0.00       7.82       to        7.82  

12/31/2023

     28,079       42.85       to       42.85        1,203,291        1.62       0.00       to       0.00       11.97       to        11.97  

12/31/2022

     29,315       38.27       to       38.27        1,121,921        0.43       0.00       to       0.00       (25.08     to        (25.08

12/31/2021

     28,707       51.08       to       51.08        1,466,483        0.83       0.00       to       0.00       2.99       to        2.99  

12/31/2020

     27,839       49.60       to       49.60        1,380,895        1.39       0.00       to       0.00       14.44       to        14.44  

MS VIF Global Strategist Class I Shares

                          

12/31/2024

     28,189       32.34       to       32.34        911,570        -       0.00       to       0.00       7.47       to        7.47  

12/31/2023

     30,443       30.09       to       30.09        916,057        1.67       0.00       to       0.00       14.07       to        14.07  

12/31/2022

     32,795       26.38       to       26.38        865,099        -       0.00       to       0.00       (16.94     to        (16.94

12/31/2021

     52,542       31.76       to       31.76        1,668,727        1.71       0.00       to       0.00       8.37       to        8.37  

12/31/2020

     64,860       29.31       to       29.31        1,900,901        1.47       0.00       to       0.00       10.92       to        10.92  

PIMCO Real Return Administrative Class

                          

12/31/2024

     26,224       18.75       to       18.75        491,754        2.61       0.00       to       0.00       2.13       to        2.13  

12/31/2023

     26,199       18.36       to       18.36        481,025        2.96       0.00       to       0.00       3.67       to        3.67  

12/31/2022

     30,801       17.71       to       17.71        545,505        7.21       0.00       to       0.00       (11.90     to        (11.90

12/31/2021

     27,236       20.10       to       20.10        547,549        4.97       0.00       to       0.00       5.59       to        5.59  

12/31/2020

     27,112       19.04       to       19.04        516,206        1.43       0.00       to       0.00       11.71       to        11.71  

TA Aegon Bond Initial Class

                          

12/31/2024

     66,015       20.22       to       20.22        1,334,535        3.92       0.00       to       0.00       2.14       to        2.14  

12/31/2023

     80,680       19.79       to       19.79        1,596,836        0.94       0.00       to       0.00       6.45       to        6.45  

12/31/2022

     82,702       18.59       to       18.59        1,537,711        2.68       0.00       to       0.00       (14.84     to        (14.84

12/31/2021

     82,520       21.83       to       21.83        1,801,670        1.58       0.00       to       0.00       (0.87     to        (0.87

12/31/2020

     77,426       22.03       to       22.03        1,705,348        4.27       0.00       to       0.00       7.68       to        7.68  

TA Aegon Sustainable Equity Income Initial Class

                          

12/31/2024

     67,523       35.06       to       35.06        2,367,582        2.00       0.00       to       0.00       16.93       to        16.93  

12/31/2023

     76,254       29.99       to       29.99        2,286,610        2.23       0.00       to       0.00       6.28       to        6.28  

12/31/2022

     77,971       28.21       to       28.21        2,199,925        2.20       0.00       to       0.00       (11.63     to        (11.63

12/31/2021

     79,208       31.93       to       31.93        2,528,898        2.13       0.00       to       0.00       22.42       to        22.42  

12/31/2020

     82,931       26.08       to       26.08        2,162,808        3.08       0.00       to       0.00       (7.35     to        (7.35

TA Aegon U.S. Government Securities Initial Class

                          

12/31/2024

     28,756       16.06       to       16.06        461,957        3.73       0.00       to       0.00       0.33       to        0.33  

12/31/2023

     27,812       16.01       to       16.01        445,325        1.79       0.00       to       0.00       4.00       to        4.00  

12/31/2022

     28,612       15.40       to       15.40        440,517        1.07       0.00       to       0.00       (13.03     to        (13.03

12/31/2021

     26,924       17.70       to       17.70        476,620        2.16       0.00       to       0.00       (2.39     to        (2.39

12/31/2020

     30,510       18.14       to       18.14        553,314        1.78       0.00       to       0.00       8.97       to        8.97  

TA BlackRock Government Money Market Initial Class

                          

12/31/2024

     1,652,695       1.39       to       1.39        2,297,758        4.92       0.00       to       0.00       5.04       to        5.04  

12/31/2023

     1,615,943       1.32       to       1.32        2,138,855        4.81       0.00       to       0.00       4.86       to        4.86  

12/31/2022

     1,155,804       1.26       to       1.26        1,458,903        1.41       0.00       to       0.00       1.40       to        1.40  

12/31/2021

     1,104,057       1.24       to       1.24        1,374,285        0.00       0.00       to       0.00       0.00       to        0.00  

12/31/2020

     1,198,752       1.24       to       1.24        1,492,103        0.29       0.00       to       0.00       0.29       to        0.29  

TA BlackRock iShares Edge 40 Initial Class

                          

12/31/2024

     6,335       23.84       to       23.84        151,025        2.71       0.00       to       0.00       6.71       to        6.71  

12/31/2023

     6,102       22.34       to       22.34        136,333        2.31       0.00       to       0.00       9.45       to        9.45  

12/31/2022

     6,079       20.41       to       20.41        124,079        1.83       0.00       to       0.00       (14.24     to        (14.24

12/31/2021

     6,547       23.80       to       23.80        155,844        1.78       0.00       to       0.00       6.09       to        6.09  

12/31/2020

     6,466        22.44       to       22.44        145,068        2.45       0.00       to       0.00       9.65       to        9.65  

 

27


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

5. Financial Highlights (continued)

 

     At December 31     For the Year Ended December 31  
Subaccount      Units      

Unit Fair Value

Corresponding to

Lowest to Highest

Expense Ratio

    

Net

  Assets  

   

Investment

Income

Ratio*

   

Expense

Ratio**

Lowest to

Highest

   

Total Return***

Corresponding to

Lowest to Highest
Expense Ratio

 

 

   

 

 

 

TA BlackRock Real Estate Securities Initial Class

                          

12/31/2024

     32,445     $ 25.06       to     $ 25.06      $ 812,915        2.18  %      0.00  %      to       0.00  %      1.25  %      to        1.25  % 

12/31/2023

     32,450       24.74       to       24.74        802,974        5.97       0.00       to       0.00       13.33       to        13.33  

12/31/2022

     32,971       21.83       to       21.83        719,921        3.47       0.00       to       0.00       (28.19     to        (28.19

12/31/2021

     32,403       30.41       to       30.41        985,259        2.52       0.00       to       0.00       26.22       to        26.22  

12/31/2020

     32,450       24.09       to       24.09        781,687        12.39       0.00       to       0.00       (0.31     to        (0.31

TA Janus Mid-Cap Growth Initial Class

                          

12/31/2024

     34,407       56.88       to       56.88        1,957,083        0.13       0.00       to       0.00       14.39       to        14.39  

12/31/2023

     35,456       49.73       to       49.73        1,763,107        -       0.00       to       0.00       17.04       to        17.04  

12/31/2022

     38,264       42.49       to       42.49        1,625,679        -       0.00       to       0.00       (16.72     to        (16.72

12/31/2021

     41,746       51.01       to       51.01        2,129,574        0.27       0.00       to       0.00       17.30       to        17.30  

12/31/2020

     42,993       43.49       to       43.49        1,869,756        0.23       0.00       to       0.00       19.20       to        19.20  

TA JPMorgan Asset Allocation - Conservative Initial Class

                          

12/31/2024

     21,169       23.83       to       23.83        504,387        2.04       0.00       to       0.00       5.72       to        5.72  

12/31/2023

     21,372       22.54       to       22.54        481,661        2.28       0.00       to       0.00       7.05       to        7.05  

12/31/2022

     22,134       21.05       to       21.05        465,983        6.76       0.00       to       0.00       (15.35     to        (15.35

12/31/2021

     6,233       24.87       to       24.87        155,035        2.35       0.00       to       0.00       5.90       to        5.90  

12/31/2020

     7,392       23.49       to       23.49        173,611        2.54       0.00       to       0.00       11.47       to        11.47  

TA JPMorgan Asset Allocation - Growth Initial Class

                          

12/31/2024

     150,976       43.25       to       43.25        6,529,011        1.31       0.00       to       0.00       16.37       to        16.37  

12/31/2023

     169,342       37.16       to       37.16        6,292,914        1.72       0.00       to       0.00       20.34       to        20.34  

12/31/2022

     194,604       30.88       to       30.88        6,009,337        5.80       0.00       to       0.00       (22.57     to        (22.57

12/31/2021

     209,763       39.88       to       39.88        8,365,304        1.65       0.00       to       0.00       19.64       to        19.64  

12/31/2020

     202,897       33.33       to       33.33        6,763,154        1.62       0.00       to       0.00       24.74       to        24.74  

TA JPMorgan Asset Allocation - Moderate Initial Class

                          

12/31/2024

     16,811       28.66       to       28.66        481,761        1.62       0.00       to       0.00       8.02       to        8.02  

12/31/2023

     23,663       26.53       to       26.53        627,756        2.03       0.00       to       0.00       9.10       to        9.10  

12/31/2022

     28,405       24.32       to       24.32        690,686        5.34       0.00       to       0.00       (16.08     to        (16.08

12/31/2021

     28,555       28.97       to       28.97        827,327        1.90       0.00       to       0.00       9.18       to        9.18  

12/31/2020

     29,017       26.54       to       26.54        770,028        2.17       0.00       to       0.00       12.60       to        12.60  

TA JPMorgan Asset Allocation - Moderate Growth Initial Class

                          

12/31/2024

     154,834       34.02       to       34.02        5,268,002        1.21       0.00       to       0.00       11.05       to        11.05  

12/31/2023

     165,142       30.64       to       30.64        5,059,736        2.02       0.00       to       0.00       12.21       to        12.21  

12/31/2022

     177,694       27.30       to       27.30        4,851,700        5.33       0.00       to       0.00       (17.35     to        (17.35

12/31/2021

     188,399       33.04       to       33.04        6,224,137        2.18       0.00       to       0.00       13.95       to        13.95  

12/31/2020

     195,494       28.99       to       28.99        5,667,987        2.06       0.00       to       0.00       15.07       to        15.07  

TA JPMorgan Tactical Allocation Initial Class

                          

12/31/2024

     59,110       24.60       to       24.60        1,454,171        2.84       0.00       to       0.00       4.27       to        4.27  

12/31/2023

     59,123       23.59       to       23.59        1,394,980        1.93       0.00       to       0.00       8.90       to        8.90  

12/31/2022

     56,641       21.67       to       21.67        1,227,171        1.91       0.00       to       0.00       (14.81     to        (14.81

12/31/2021

     69,346       25.43       to       25.43        1,763,530        1.74       0.00       to       0.00       4.91       to        4.91  

12/31/2020

     83,706       24.24       to       24.24        2,029,150        2.43       0.00       to       0.00       12.36       to        12.36  

TA Morgan Stanley Capital Growth Initial Class

                          

12/31/2024

     69,078       20.01       to       20.01        1,382,214        -       0.00       to       0.00       44.24       to        44.24  

12/31/2023

     72,470       13.87       to       13.87        1,005,301        -       0.00       to       0.00       46.70       to        46.70  

12/31/2022

     76,554       9.46       to       9.46        723,880        -       0.00       to       0.00       (59.84     to        (59.84

12/31/2021

     34,582       23.55       to       23.55        814,267        -       0.00       to       0.00       (0.53     to        (0.53

12/31/2020

     36,815       23.67       to       23.67        871,480        -       0.00       to       0.00       117.87       to        117.87  

TA Small/Mid Cap Value Initial Class

                          

12/31/2024

     66,620       28.73       to       28.73        1,913,729        0.95       0.00       to       0.00       8.86       to        8.86  

12/31/2023

     68,350       26.39       to       26.39        1,803,640        1.05       0.00       to       0.00       12.40       to        12.40  

12/31/2022

     73,183       23.48       to       23.48        1,718,171        0.60       0.00       to       0.00       (8.31     to        (8.31

12/31/2021

     76,215       25.61       to       25.61        1,951,526        0.65       0.00       to       0.00       28.12       to        28.12  

12/31/2020

     80,813        19.98       to       19.98        1,615,049        1.21       0.00       to       0.00       4.04       to        4.04  

 

28


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

5. Financial Highlights (continued)

 

     At December 31     For the Year Ended December 31  
Subaccount      Units      

Unit Fair Value

Corresponding to

Lowest to Highest

Expense Ratio

    

Net

  Assets  

   

Investment

Income

Ratio*

   

Expense

Ratio**

Lowest to

Highest

   

Total Return***

Corresponding to

Lowest to Highest
Expense Ratio

 

 

   

 

 

 

TA TSW Mid Cap Value Opportunities Initial Class

                          

12/31/2024

     7,020     $ 52.74       to     $ 52.74      $ 370,265        1.32  %      0.00  %      to       0.00  %      8.48  %      to        8.48  % 

12/31/2023

     9,577       48.62       to       48.62        465,626        1.50       0.00       to       0.00       10.81       to        10.81  

12/31/2022

     9,433       43.88       to       43.88        413,876        0.83       0.00       to       0.00       (8.23     to        (8.23

12/31/2021

     9,960       47.81       to       47.81        476,196        0.71       0.00       to       0.00       29.19       to        29.19  

12/31/2020

     12,592       37.01       to       37.01        466,026        1.25       0.00       to       0.00       1.35       to        1.35  

TA WMC US Growth Initial Class

                          

12/31/2024

     109,458       99.70       to       99.70        10,912,933        0.01       0.00       to       0.00       28.99       to        28.99  

12/31/2023

     115,894       77.29       to       77.29        8,957,396        0.04       0.00       to       0.00       42.08       to        42.08  

12/31/2022

     118,972       54.40       to       54.40        6,471,911        -       0.00       to       0.00       (31.35     to        (31.35

12/31/2021

     123,166       79.24       to       79.24        9,759,248        0.08       0.00       to       0.00       20.67       to        20.67  

12/31/2020

     130,665        65.67       to       65.67        8,580,311        0.11       0.00       to       0.00       37.30       to        37.30  

 

  (1) 

See Footnote 1

 

   *

These amounts represent the dividends, excluding distributions of capital gains, received by the subaccount from the Mutual Fund, net of management fees assessed by the fund manager, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that are assessed against contract owner accounts either through reductions in the unit values or the redemption of units. The recognition of investment income by the subaccount is affected by the timing of the declaration of dividends by the Mutual Fund in which the subaccounts invest.

 

   **

These amounts represent the annualized contract expenses of the subaccount, consisting primarily of mortality and expense charges, for each period indicated. These ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the Mutual Fund have been excluded.

 

  ***

These amounts represent the total return for the periods indicated, including changes in the value of the Mutual Fund, and expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options with a date notation indicate the effective date of that investment option in the variable account. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. Total returns reflect a full twelve month period and total returns for subaccounts opened during the year have not been disclosed as they may not be indicative of a full year return. Expense ratios not in effect for the full twelve months are not reflected in the total return as they may not be indicative of a full year return.

 

29


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

 

6. Administrative and Mortality and Expense Risk Charges

A monthly charge is assessed on each monthly policy date against the accumulation value of the subaccounts of the base policy and for each policy layer. This rate varies by the length of time the policy has been in force. The monthly rate is 1/12 of the annual rate. For policy years one through 10, the annual rate is 0.65%. The annual rate currently charged during policy years 11 through 20 is 0.15%, and for policy years 21 and later, 0.00%. However, any rate not in excess of the maximum guaranteed mortality and expense risk charge may be charged. The maximum guaranteed mortality and expense risk charge on an annual basis is 0.65% during policy years one through 10, 0.40% in policy years 11 through 20, and 0.25% in policy years 21 and later.

An administrative charge is deducted by TLIC prior to allocation of policyowner payments to the subaccounts, which is equal to 7.6% of the premium payments allocated to basic coverage, up to target amounts, during policy or layer years 1-10; and 3.6% of premium payments allocated to basic coverage in excess of target amounts during policy or layer years 1-10 and on all amounts allocated to basic coverage during policy or layer years 11 and later.

Currently, all premiums allocated to supplemental coverage are subject to an administrative charge equal to 3.6% of the premium payment. TLIC may assess an administrative charge of up to 8.6% of premium payments allocated to supplemental coverage, up to target amounts, during the first ten rider or rider layer years. The first 18 transfers in a policy year are free. TLIC may impose a charge of up to $25 for each transfer in excess of 18 transfers during a policy year, but currently TLIC does not impose such fee.

Surrender charges may also apply to partial withdrawals, full surrenders, and decreases in face amount of insurance. Under all forms of the policy, monthly charges against policy cash values are made to compensate TLIC for costs of insurance provided. Charges reflected above are those currently assessed and may be subject to change. Contract owners should see their actual policy and any related attachments to determine their specific charges.

7. Income Tax

Operations of the Separate Account form a part of TLIC, which is taxed as a life insurance company under Subchapter L of the Internal Revenue Code of 1986, as amended (the Code). The operations of the Separate Account are accounted for separately from other operations of TLIC for purposes of federal income taxation. The Separate Account is not separately taxable as a regulated investment company under Subchapter M of the Code and is not otherwise taxable as an entity separate from TLIC. Under existing federal income tax laws, the income of the Separate Account is not taxable to TLIC, as long as earnings are credited under the variable life contracts.

 

30


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

 

8. Subsequent Events

The Separate Account has evaluated the financial statements for subsequent events through the date which the financial statements were issued. During this period, there were no subsequent events requiring recognition in the financial statements.

9. Related Parties

Transamerica Capital, Inc. (TCI), a wholesaling broker-dealer, is an affiliated entity of TLIC and an indirect wholly owned subsidiary of Aegon Ltd. TCI distributes TLIC’s products through broker-dealers and other financial intermediaries.

The subaccounts invest in the mutual funds listed in Footnote 1. These investments include funds managed by Transamerica Asset Management, Inc. (TAM). Transamerica Fund Services, Inc. (TFS) serves as a transfer agent to TAM, and Aegon USA Asset Management Holding, LLC (AAM) serves as a sub-advisor for certain funds managed by TAM. TAM, TFS and AAM are affiliated entities of TLIC and indirect wholly owned subsidiaries of Aegon Ltd. Funds managed by TAM are identified by their fund name, which includes reference to Aegon, Transamerica or both. The Separate Account pays management fees to the related funds as detailed in the fund prospectus.

No charges other than those disclosed in Footnote 6 are deducted for the service rendered by related parties.

Contract owners may transfer funds between available subaccount options within the Separate Account. These transfers are performed at unit value at the time of the transfer.

 

31


Transamerica Life Insurance Company

Transamerica Life Insurance Co Separate Account VUL-6

Notes to Financial Statements

December 31, 2024

 

10. Segment Reporting

Each fund of the Separate Account constitutes a single operating segment and therefore, a single reportable segment because the Chief Operating Decision Maker (CODM) manages the activities of the Separate Account using information of each fund. The Separate Account is engaged in a single line of business as a registered unit investment trust. The Separate Account is a funding vehicle for individual variable annuity contracts with the assets owned by TLIC to support the liabilities of the applicable insurance contracts. The subaccounts have identified the President and Chief Operating Officer as the CODM as the Separate Account does not have employees and is not a separate legal entity.

The CODM uses increase (decrease) in net assets from operations as their performance measure in order to make operational decisions while monitoring the net assets of each of the funds within the Separate Account. The Accounting policies used to measure profit and loss of the segments are the same as those described in the Summary of Significant Accounting Policies (see note 2). The measure of segment assets is reported on the balance sheet as total consolidated assets. Refer to the Statements of Operations and Changes in Net Assets for each fund’s operating segment and related footnotes for significant expenses principle and the existing segment requirements as of December 31, 2024 and for the year ended December 31, 2024 and December 31, 2023.

 

32



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings